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Intellectual disability 
Intellectual disability (ID) is defined in the Diagnostic and Statistical Manual of Mental 
Disorder edition 5 (DSM-5) as a neurodevelopmental disorder with an onset during 
childhood and includes both difficulties in adaptive and intellectual functioning of the 
conceptual, social, and practical domains [1]. ID is diagnosed by the following three criteria: 
(1) an intelligence quotient (IQ) below 70, (2) significant limitations in adaptive behaviour 
such as communication, self-care, social skills, community use, self-direction, health, and 
safety, and (3) an onset before the age of eighteen [1]. A further classification is made 
based on the level of mental impairment: profound (IQ<20), severe (IQ 20-34), moderate 
(IQ 35-49), and mild (IQ 50-69) [2]. ID can manifest as “non-syndromic” where it is the sole 
recognizable symptom, or as “syndromic” where it is accompanied by additional mental 
and physical hallmarks such as dysmorphic features, metabolic or congenital defects [2]. 
Estimates of the prevalence are between 1 to 3 percent of the Western population [3] and 
recent estimates point towards 400.000 children born per year worldwide due to de novo 
mutations [4]. These numbers exceed the prevalence of many other mental illnesses and 
with the need for lifelong care, it is a challenge for our health care system and for caretakers 
[5]. Thus, ID represents one of the largest unsolved socio-economic challenges for society. 
Approximately half of all the ID cases are of genetic origin and genetic testing 
has been a large contributor to the diagnosis of ID. Historically, examination of a common 
karyogram could confirm trisomy 21 under a microscope and thereby identify Down 
syndrome [6]. Later, technologies improved and cytogenetic banding and chromosomal 
abnormalities could be used to identify novel common causes of ID [7]. For example, 
mapping of breakpoints of translocations and deletions by fluorescent in situ hybridization 
(FISH) and linkage analysis combined with Sanger sequencing could target specific 
chromosomal regions [8]. Around 2000, genome wide array techniques were introduced 
which identified numerous novel micro deletion and duplication syndromes [9]. Nowadays, 
in the era of next generation sequencing, mutations are identified at a high frequency in 
trio-based approaches of exome sequencing [10-13]. 
Currently, nearly 1000 genes have been implicated in ID ([14] and http://sysid.
cmbi.umcn.nl/) and new associations are still occurring at a high frequency [4, 10, 13, 15]. 
These genes vary a lot in function, however, certain common functionality can be identified. 
Systematic analysis of common themes identified highly enriched functional categories of 
similar biological function and phenotypes in human [14] and fly [16]. Well known examples 
are genes involved in synapse formation, intracellular signaling cascades, or mitochondria. 
Another group that has been identified, and examples of this group are discussed in 
this thesis, is related to chromatin regulators which all have a function in epigenetics and/ or 
gene expression [17, 18]. This group consists of over 55 genes and generally encode epigenetic 
regulators such as histone modifiers, RNA binding proteins, and transcription factors [14, 19]. 
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Epigenetic regulation of gene expression
The term “epigenetics” was coined by Conrad H. Waddington (1905-1975) as “the branch 
of biology which studies the causal interactions between genes and their products, 
which brings the phenotype into being” [20]. Epigenetics refers to the Greek prefix “epi” 
which means “on top of” or “in addition to” the traditional genetic basis of inheritance. 
Epigenetic modifications allow for heritable changes in gene expression through cell 
division without changing the DNA sequence. These changes often include alterations in 
the chromatin template. Nucleosomes are the building blocks of chromatin and consists 
of 147 basepairs DNA, linker histone H1, and dimers of histone H2A, H2B, H3, and H4 that 
form an octamer. The N-terminal “tails” of the four core histones and the C-terminal tail 
of histone H2A protrude from the nucleosome. These tails can be subjected to post-
translational covalent modification of chemical groups and, classically, produce densely 
packed heterochromatin and more loosely packed euchromatin, directly influencing 
the accessibility of RNA polymerase. However, with recent technical and computational 
advances, local chromatin states have been described for a number of genomes [21-25]. 
These chromatin states are determined by co-association between epigenetic factors such 
as local histone modifications, transcription factor binding, non-coding RNA molecules, 
and nucleosome positioning. For example, the transcription start sites of active genes 
are marked by histone H3 Lysine (K) 4 trimethylation. On the other hand, silent regions of 
transcription are enriched for H3K9 di- and trimethylation, or H3K27 trimethylation [26]. 
Besides these classical, well studied histone modifications, many more posttranslational 
histone modifications have been identified, including more than 60 different residues on 
histones that can be modified by methylation, acetylation, phosphorylation, ubiquitylation, 
sumoylation, or ADP ribosylation [27, 28]. These findings could uncover totally new fields of 
epigenetic regulation of gene expression. 
Another epigenetic mark influencing transcription is DNA methylation. The 
most abundant modified base in the mammalian genome is 5-methylcytosine, often 
clustered at CpG islands. These islands are often enriched at the promoter regions of 
genes and are generally associated with transcriptional repression when methylated. 
Active oxidation of 5-methylcytosine is catalyzed by ten eleven translocation enzymes 
to form 5-hydroxymethylcytosine, 5-formylcytosine, and 5-carboxylcytosine [29]. 
5-hydroxymethylcytosine is shown to be highly present in the human brain and may 
uncover a new mechanism for epigenetic regulation of gene expression [30]. Additionally, 
adenine residues (N(6)methyladenine) are associated with transcriptional repression of long 
interspersed nuclear elements (LINE) transposons [31]. 
The above mentioned epigenetic processes play a crucial role during development 
of organisms. The totipotent zygote forms the specific germ layers endoderm, mesoderm, 
and ectoderm and develops into an embryo via many cell divisions [32]. During neurulation, 
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the ectoderm forms the neural plate that invaginates to form the neural tube and will later 
differentiate to the brain and spinal cord [32]. The early human brain first consists of the 
three primary vesicles prosencephalon, mesencephalon, and rhombencephalon and are 
later organized into the many brain regions formed by the walls and cavities [32]. These 
developmental processes require tightly controlled spatial and temporal regulation of 
neuronal gene expression [33]. When mutations occur in genes encoding for epigenetic 
regulators that mediate these transcriptional processes, normal development of an organism 
can be disrupted. In addition, epigenetic processes are crucial for proper processing of 
extracellular signals that lead to transcriptional changes during adulthood (see underneath) 
[34]. Kleefstra syndrome is an example of an ID disorder in which an epigenetic factor is 
affected. 
Kleefstra syndrome
Kleefstra syndrome is an ID syndrome characterized by moderate to severe ID, developmental 
delay, childhood hypotonia, and characteristic craniofacial features like microcephaly, 
brachcephaly, hypertelorism, flat facies, midface hypoplasia, synophrys, arched eyebrows, 
anteverted nares, short nose, open mouth with protruding tongue, everted thicker lower 
lip, thin upper lip [35-37] (Figure 1). Neurobehavioral analysis of Kleefstra syndrome patients 
revealed a very high prevalence of autism spectrum disorder, extra vulnerability to develop 
obsessive–compulsive disorder and increased levels of depression compared to a control 
group that consists of non-related ID [38]. 
Kleefstra syndrome was first reported in 1994 by identification of a patient with 
ID and a cytogenetically visible terminal deletion of the chromosome band 9q34.3 [39], 
hence its former name 9q subtelomeric deletion syndrome. Three years later there was 
a second report of a patient with a similar genotype and phenotype [40]. In 2004, these 
reports were brought together with seventeen newly identified patients and this narrowed 
the deletion down to 1.2Mb spanning at that time 14 known genes [41]. This region was 
further limited to one affected gene, euchromatin histone methyltransferase1 (EHMT1) by the 
description of two patients with the same clinical features [42]. It is now widely accepted 
that heterozygous dominant deletions and mutations affecting the EHMT1 gene cause 
Kleefstra syndrome (OMIM #610253) and more than 100 patients have been described [35, 
42-47]. The syndrome has been identified in all ethnic groups, worldwide, and in both males 
and females [37, 48]. 
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Figure 1: Kleefstra syndrome patients at different ages showing clinical hallmarks. Figure from Kleefstra et al. (2009) 
[43] and reprinted with permission. 
The EHMT protein family 
In mammals there are two EHMT paralogs, EHMT1 and EHMT2. Both proteins are widely 
expressed and contain ankyrin repeat sequences followed by a C-terminal pre-SET and 
SET domain [49-51]. The ankyrin repeats are known to be required for protein-protein 
interaction and are shown to bind H3K9me1 an H3K9me2 [52]. The SET/Pre-SET domains 
are capable of catalyzing mono- di- and trimethylation and are conserved during evolution 
as a family of proteins [53]. The acronym SET is named after the Drosophila genes Su(var)3-9, 
Enhancer of zeste, and Trithorax. In vitro experiments showed that EHMT1 and EHMT2 are 
required for methylation of histone H1 and H3 on lysine 9 (K9) and 27 (K27) [49, 54]. More 
specifically, it was shown that EHMT1 and EHMT2 are mainly responsible for H3K9 mono- 
and dimethylation in vitro at transcriptionally active euchromatic regions of the genome 
[55], in contrast to H3K9me3 which is enriched at pericentromric heterochromatin [56, 57]. 
Moreover, chemical inhibition of EHMT1 and EHMT2 in cultured cells lowers dimethylation 
of H3K9 [58]. Cultured mouse embryonic stem cells from EHMT1 or EHMT2 knockout mice 
also showed a reduction of mono- and dimethylation of H3K9 [59, 60]. Monomethylation 
of H3K9 is associated with actively transcribed genes, whereas H3K9me2 is associated 
Koemans.indd   14 10-1-2018   12:24:45
15
General introduction, thesis aims and outline
1
with transcriptional silencing [26]. Thus, EHMT1 and EHMT2 are considered to regulate 
transcription via H3K9me1 and H3K9me2 in euchromatin. 
 EHMT proteins are also associated with a range co-repression proteins and 
complexes. First, a direct protein-protein interaction was shown with repressor element-1 
silencing transcription factor (REST) [61, 62] (chapter 5). In addition, the polycomb repressive 
complex [63, 64], a Suv39/EHMT1/EHMT2/SETBP1 module [65], a repressive complex that 
functions in the G0-phase of cell division [66], and CDP/cut associated repression [67] were 
shown to contain EHMT proteins. One other well studied repressive mechanism is the 
interaction with widely interspaced zinc finger (WIZ) [68] and ZNF644 [69]. It was shown 
that EHMT1 and EHMT2 can form a heterodimer via their c-terminal catalytic domains 
[60] in which EHMT1 binds WIZ and EHMT2 binds ZNF644 and contribute to DNA target 
specificity [70]. WIZ also contains pro c-terminal-binding protein1 (CtBP) binding sites 
which is associated with transcription repression [68, 71]. 
 In contrast, EHMT proteins also mediate transcription activation which has mainly 
been studied in adipose cells. In brown adipose cells, deletion of EHMT1 causes obesity and 
insulin resistance [72]. In white adipose cells, EHMT2 has been shown to facilitate Wnt10a 
expression, which inhibits adipogenesis [73]. Subsequently, adipose-specific deletion 
of EHMT2 increases adipogenic gene expression and adipose tissue weight [73]. Taken 
together, EHMT proteins are involved in many gene regulatory protein complexes and are 
studied mainly via their role in H3K9me2.
EHMT proteins in synaptic plasticity
The brain is an organ made up of billions of neurons that form complex cellular networks 
and allows organisms to learn, memorize, forget, and adapt behavior. On the molecular 
level, memory acquisition can be initiated via activation of post-synaptic NMDA and AMPA 
receptors and leads to a depolarization of the postsynaptic neuron and an influx of Ca2+ [74]. 
Increased levels of Ca2+ activate multiple biochemical cascades and kinases. For instance, 
the kinase Ca2+/calmodulin-dependent protein kinase II (CaMKII) can phosphorylate NMDA 
[75] and AMPA receptors [76] leading to a clustering of receptors and strengthening of 
the activated synapse [77]. Long lasting activated CaMKII induces intracellular signaling 
cascades such as cyclic AMP (cAMP) [78], MAPK/ERK [79], and CaMK [80] converging on the 
transcription factor cAMP response element binding protein (CREB) [81]. The transcription 
factor CREB can regulate activity of genes important for learning and memory, however, 
other transcription factors and chromatin regulators are also involved [82]. 
 Evidence for a role of EHMT proteins in transcriptional plasticity of learning and 
memory comes from contextual fear memory in rats [83]. Contextual fear memory is a 
classical paradigm in which animals are placed in a new cage with or without a foot shock. It 
is shown that H3K9me2 levels are increased after one hour in rats with and without the foot 
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shock [83]. H3K9me2 decreases after 24 hours, with the exception of the entorhinal cortex 
[84]. In this brain region, H3K9me2 levels are increased upon contextual fear conditioning 
after 24 hours [84]. Pharmacological blocking of EHMT proteins in the hippocampus and 
lateral amygdala reduced long-term memory (LTM) upon contextual fear conditioning 
and auditory fear conditioning [84, 85]. In mouse knockout models, loss of Ehmt1 causes 
phenotypes that are reminiscent of Kleefstra syndrome, including deficits in learning and 
memory, increased anxiety, hypotonia, cranial abnormalities, and developmental delay [86-
89].
 More recent work has investigated the role of EHMT1 in synaptic plasticity in 
cultured neurons. Cultured neurons in general tend to self-assemble into functional 
networks, from which the connectivity and activity can be measured using multi electrode 
arrays and whole-cell patch-clamp [90]. Upon knockdown of EHMT1, these neurons show 
impaired spontaneous network activity and lowered firing rates [91]. Additionally, after 
a period of delayed network bursting these networks show irregularity in the timing of 
network bursts [91]. Proper formation of neuronal networks is also essential for synaptic 
scaling, a process affected in EHMT deficient neurons in vivo and in vitro [92]. During 
synaptic scaling, EHMT1 and EHMT2 are required for brain-derived neurotrophic factor 
(BDNF) repression via H3K9me2 [92]. Dimethylation of H3K9 at the promoter of BDNF is 
shown to be dynamically regulated in an activity-dependent manner. This altered synaptic 
scaling could be related to neurogenesis in the dentate gyrus region of the hippocampus, 
shown to be increased in EHMT1 deficient neurons [93]. Thus, EHMT proteins are suggested 
to be essential for synaptic plasticity.
EHMT in Drosophila melanogaster
Drosophila has a single EHMT ortholog called G9a. Similar to the mammalian counterparts, 
it contains a series of ankyrin domains, followed by C-terminal pre-SET and SET domains 
(chapter 5, figure 2A). In Drosophila embryos, G9a translocates from the cytoplasm to the 
nucleus during nuclear division 8-11 [94]. In the nucleus, it is shown that G9a is responsible 
for downregulation of genes involved in many neurodevelopmental processes such 
as notch signaling and neuron differentiation [94]. G9a mutant flies are fully viable [95], 
but do show phenotypic differences compared to wildtype flies. Homozygous knockout 
Drosophila embryos are developmental delayed as observed by a longer time to hatch 
[94]. As flies progress into larval stages, G9a is required for proper dendrite branching of 
the sensory multidendrite neurons [96]. Additionally, larval foraging behaviour based on 
crawling is significantly reduced [96]. 
 At adult stages, other cognitive functions can be tested such as habituation and 
courtship conditioning. Habituation is a simple form of non-associative learning and can 
be tested in flies using the light-off jump-reflex paradigm. An initial strong behavioural 
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response towards a repeated, non-threatening stimulus gradually wanes in control flies 
[97-99]. However, this decline was reduced in G9a knockout flies[96]. A more complex 
form of memory, Drosophila courtship conditioning, was tested in which male flies learn to 
discriminate between receptive and non-receptive females [100-102] (chapter 2). Trained 
control males reduce their courtship attempts after a training period with non-receptive 
females compared to socially naïve males. G9a mutant males are shown to have courtship 
conditioning short-term memory (STM) and LTM defects while the general learning capacity 
was unchanged [96] (Figure 2A). Moreover, it was shown that upon re-expression of G9a 
in the whole nervous system or neurons labeled by 7B-gal4 this courtship STM memory 
could be restored [96] (Figure 2B). 7B-gal4 is mainly expressed in the mushroom bodies, a 
brain region known to be involved in many forms learning and memory [103-105]. Lastly, it 
was shown that re-expression of G9a only in adult stages also rescues the STM phenotype 
(Figure 2C). Thus, G9a is involved in STM and LTM, but not in general learning. The memory 
phenotype can be rescued by re-expression of G9a in distinct brain regions such as the 
mushroom body or only in adult stages excluding developmental influences. 
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Figure 2: G9a (EHMT) in courtship conditioning learning and memory. 
(A) The learning index (LI) of G9a mutant males (EHMTDD1) was not in affected in general learning, but was 
significantly reduced at 30 minutes (short-term memory, STM) and 24 hours (long-term memory, LTM) after 
training. (B) The learning index of the EHMTDD2 was affected in STM and was rescued by re-expression of G9a 
by the pan-neuronal driver elav-Gal4 and the mushroom body driver 7B-Gal4. Note the reduction of LI upon re-
expression of G9a in the 7B-Gal4 expressing neurons, while the LI is not reduced in pan-neuronal re-expression 
(black bars). (C) Re-expression of G9a in adult stages by heat-shock induction did not alter the LI the control line 
(upper two bars) while the LI is significantly improved in the mutant background. + indicates G9a re-expression 
activated, - indicates not activated. * indicates a significant difference (Kruskall-Wallis and Mann-Whitney tests). This 
figure is adapted from Kramer et al. (2011) [96]. 
 
A
C
B
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Kleefstra syndrome phenotypic spectrum#
Kleefstra syndrome is defined by mutations in EHMT1 with the core features ID, autism 
spectrum disorder (ASD), childhood hypotonia, and distinctive facial features. However, 
within a clinically defined cohort of individuals with the core features of Kleefstra syndrome 
there is also heterogeneity of for instance renal anomalies and hearing loss. Around 25% of 
this cohort harbors EHMT1 loss-of-function mutations. The other 75% was termed Kleefstra 
syndrome phenotypic spectrum (KSS) and it was hypothesized that these individuals have 
mutations in genes that share a biological function with EHMT1. Via a next generation 
sequencing approach, four genes with potentially causative de novo mutations were 
identified in four patients [106]. These genes are methyl binding domain 5 (MBD5), SWI/
SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 
(SMARCB1), nuclear receptor 1I3 (NR1I3), and mixed-lineage leukemia 3 (MLL3 (KMT2C)). The 
biochemical function of the proteins these genes encode have been well characterized. 
MBD5 contains a methyl binding domain which is required for localization to chromatin 
[107]. SMARCB1 is a member of the switch/sucrose nonfermentable (SWI/SNF) family 
of ATP-dependent chromatin-remodeling complexes, which affects transcription by 
destabilizing histone-DNA interactions and altering nucleosome positions [108]. NR1I3 
is a nuclear hormone receptor that is associated with recruitment of chromatin-modifying 
complexes [109]. KMT2C trimethylates histone H3 at lysine 4 and is a central component of 
the activating signal cointegrator-2 (ASC-2) complex ASCOM, which acts as a transcriptional 
coactivator for nuclear hormone receptors [110, 111]. Taken together, mutations in multiple 
genes with comparable function give rise to a striking similar phenotype. 
 To validate a functional relationship between EHMT1 and the four genes with 
de novo mutations, genetic interaction studies in the developing Drosophila wing were 
conducted [112]. Overexpression of Drosophila G9a in the wing consistently causes extra 
veins in defined regions of the wing [106]. Modulation of this G9a-induced wing phenotype 
was performed by manipulating expression of the orthologs of the four genes (six banded 
(sba) for MBD5, trithorax related (trr) for KMT2C, Snf5-related-1 (snr1) for SMARCB1 and the 
ecdysone receptor (EcR) for NR1I3) [106]. A synergistic interaction with G9a was established 
for MBD5/snr1 and NR1I3/EcR (Figure 3, green dotted lines) and an antagonistic interaction 
was established with KMT2C/trr (Figure 3, red dotted line). Together with published genetic 
interactions and protein-protein interactions, these studies identified an epigenetic module 
underlying clinically related ID syndromes (Figure 3) [106]. 
#: published in Kleefstra et al., 2012 (AJHG) [16]
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Figure 3#: An epigenetic network underlying KSS. 
Functional studies indicate that genes implicated in KSS occur in a common chromatin-regulating module. This 
evidence comes from investigation of direct protein-protein interactions (solid lines) and from genetic interaction 
studies with Drosophila melanogaster (dashed lines). Green dashed lines indicate a synergistic interaction, and 
red dashed lines indicate an antagonistic interaction. It has been demonstrated in this study that Drosophila 
EHMT interacts genetically with sba/MBD5, trr/MLL3, andEcR/NR1I3 (GI1, GI2, and GI3, respectively). Previously, 
genetic and physical interactions between trr and EcR (GI4 and DPI1, respectively), as well as physical association 
between SMARCB1 and MLL3 (DPI2), have been demonstrated. Figure from Kleefstra et al. (2012) and reprinted 
with permission. 
Interestingly, the genetic interaction between trr and G9a was very strong. Trr knockdown 
alone in the fly wing caused a mild phenotype, consisting of mild loss of wing veins and 
mild upwards curvature of the wing. Combining trr knockdown with G9a overexpression 
resulted in fully penetrant pupal lethality resulting from necrosis of the entire developing 
wing tissue [106]. Thus, this dramatic compound phenotype indicates a very strong 
antagonistic relationship between trr and G9a and the human orthologs are involved in 
clinically related syndromes. This interaction is further investigated and described in chapter 
3 of this thesis. 
The KMT protein family
Another important player in the field of epigenetics crucial to cognitive functioning is the 
histone lysine methyltransferase (KMT) family, previously known as mixed lineage leukemia 
(MLL). The KMT genes were first identified by the Drosophila screens for enhancers and 
suppressors of position-effect variegation [113, 114]. Many of these hits turned out to 
contain a SET domain protein sequence, similar to the EHMT protein family domain, that 
catalyze mono-, di-, and trimethylation of lysine residues of histones [53]. The human MLL1 
MLL3/trr
NR1I3/
EcR
MBD5/sba SMARCB1
direct protein-protein interaction (DPI)
genetic interaction in Drosophila (GI)
EHMT1/
EHMT
GI1
GI2
GI3
DPI1
DPI2
GI4
#: published in Kleefstra et al., 2012 (AJHG) [16]
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gene was first cloned after its identification of translocations in patients with hematological 
malignancies [115]. The complete human KMT protein family was identified later and 
contains Set1A (KMT2F), Set1B (KMT2G), and KMT2A, KMT2B, KMT2C, KMT2D, and KMT2E 
[116]. However, KMT2E appears to lack histone methyltransferase activity [117], which in 
principle disqualifies the “KMT” name. KMT2A/KMT2B, KMT2C/KMT2D and SET1A/SET1B, are 
the three branches of the conserved human protein family and are direct orthologs of yeast 
Set1 [118] (Figure 4). The six human proteins contain Ash2L, RbBP5, WDR5, and Dpy30 as 
core components [118] (Figure 4). 
 Besides these common core components, SET1A and SET1B contain the specific 
structural and functional binding partners CXXC1, HCF1 and WDR82 [119, 120] (Figure 
4). These complexes are key regulators of gene expression during development via 
trimethylation of H3K4 in mammalian cells [121]. KMT2A and KMT2B contain the specific 
structural and functional binding partners “menin tumor suppressor protein” and “HCF1” 
(Figure 4). KMT2B has been shown to trimethylate H3K4 at bivalent promoters of homeotic 
genes in mouse embryonic stem cells important for developmental processes [122]. KMT2C 
and KMT2D contain the specific structural and functional binding partners UTX (KDM6A), 
the PAX interacting protein 1 (PTIP), nuclear receptor coactivator 6 (NCOA6), and PTIP-
associated 1 (PA1) [116] (Figure 4). KMT2C and KMT2D are involved in regulating hormone 
responsive genes [123]. In addition, KMT2C/KMT2D are associated with monomethylation 
of H3K4, a mark associated with active enhancers [124].
 Next to the COMPASS complex, KMT2C/KMT2D have been associated with the 
activator signal cointegrator-2 (ASC-2) complex (ASCOM) complex. This large protein 
complex interacts with nuclear receptors and mediates H3K4 trimethylation, a hallmark 
of active transcription [110, 125]. In addition, SMARCB1 and KMT2C have been physically 
associated and were required for recruitment of the ATP dependant SWI/SNF complex and 
ASCOM to hormone response elements [126]. Although ASCOM and the COMPASS KMT2C/D 
branch have several subunits in common, there are clear distinctions. First, hDPY-30, PTIP, 
PA1, and UTX are absent from ASCOM [127, 128]. Second, α- and β-tubulins are absent 
from the COMPASS complex [128]. Third, KMT2C/D shows a more robust methyltransferase 
activity [127]. Taken together, the KMT protein family is a large protein family of conserved 
members involved in H3K4 methylation important for transcriptional regulation during 
development. 
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Figure 4: The yeast SET1 (COMPASS) is conserved in Drosophila melanogaster and human in three 
branches. 
Yeast SET1-COMPASS is the sole H3K4 methyltransferase capable of monomethylation, dimethylation, and 
trimethylation. In Drosophila, there are three methyltransferases. SET1A is is the ortholog of yeast SET1-COMPASS 
shown by a solid arrow and two COMPASS-like complexes shown by a dashed arrows: trithorax and trithorax-
related. In humans, SET1A and SET1B are homologues of Drosophila SET1A and yeast SET1-COMPASS. KMT2A 
(MLL1) and KMTB (MLL2) are homologs of Drosophila trithorax. KMT2C (MLL3) and KMT2D (MLL4) are homologs 
of Drosophila trithorax-related. The known common subunits shared between yeast, Drosophila and the human 
complexes are shown in grey. COMPASS component SWD2 (Cps35) in yeast and Drosophila and its homologue in 
human, WD repeat-containing protein (WDR82), are found only in COMPASS and the SET1A and SET1B complexes. 
The common subunits in COMPASS from yeast to human are shown in blue. Menin, a subunit of the trithorax and 
MLL and MLL2 complexes, is shown in purple. The shared subunits among the trithorax-related and MLL3 and 
MLL4 complexes are shown in green. Figure from Mohan et al. (2010) and reprinted with permission. 
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Drosophila trithorax related (trr)
The three branches of the human COMPASS complex are conserved in Drosophila by 
the single orthologs dSET1, trithorax (trx) and trithorax-related (trr) [123] (Figure 4). 
dSET1 is orthologous to human SET1A/B, trx is orthologous to human KMT2A/B, and trr 
is orthologous to human KMT2C/KMT2D. Drosophila dSET1 has been shown to be the 
main H3K4 di- and tri-methyltransferase during Drosophila development [129]. Drosophila 
trx mainly regulates homeotic gene expression [130]. Trr has a potential dual function in 
Drosophila. First, it interacts with the ecdysone receptor and is a co-activator of edcysone 
mediated gene expression during the larval to pupae transition [131]. In this developmental 
context, trr contains major H3K4 trimethylase activity [111]. Second, trr has been shown 
to contain H3K4 monomethylation activity [132]. Upon knockdown of trr in the wing 
imaginal disks, immunofluorescent imaging revealed a profound decrease of H3K4me1 
which is the histone modification associated with enhancer functioning [26, 132, 133]. 
Moreover, chromatin immunoprecipitation experiments revealed trr binding sites mainly at 
promoters and enhancers [132]. Thus, the Drosophila orthologs of the COMPASS complexes 
are functionally conserved.
KMT-related proteins in ID 
Autosomal dominant mutations in KMT2A have been associated with Wiedemann-Steiner 
syndrome (OMIM #605130) [134]. This syndrome is characterized by hypertrichosis cubiti 
(hairy elbows), short stature, facial features, mild to moderate ID, and behavioral difficulties 
[135]. A homozygous missense mutation in KMT2B have been identified in a Pakistani 
consanguineous family [136]. The three affected brothers had ID, short stature, childhood 
hypotonia and dysmorphic facial features. Remarkably, the phenotype of the boys had 
striking Kleefstra-like clinical features [136]. Mutations in KMT2D have been identified in 
Kabuki syndrome [137] (OMIM #147920) which is a rare, multiple malformation disorder 
characterized by postnatal dwarfism, a distinctive facial appearance, cardiac anomalies, 
skeletal abnormalities, immunological defects and mild to moderate ID [138] (Chapter 4). 
Kabuki syndrome 2 (OMIM #300867) is defined by mutations in UTX (KDM6A) and shows 
a phenotypic overlap [139, 140]. Moreover, a clinical overlap was found between the 
two types of Kabuki syndrome and Wiedemann-Steiner syndrome and comprises facial 
features, skeletal abnormalities of for instance the fingers, and neurological defects such 
as developmental delay, ID and hypotonia, growth problems, and problems of the internal 
organs [141]. Taken together, these ID syndromes with overlapping clinical features have 
shared underlying molecular mechanisms. 
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Modeling KSS in Drosophila melanogaster: Why the fly
Drosophila has been a model organism for fundamental biology and disease modeling for 
more than a century. Despite the evolutionary distance between human and fly, there are 
many similarities. First, comparative analysis showed a high conservation of important basic 
cellular and molecular processes between Drosophila and mammals [142]. Around 75% of 
human ID associated genes show sequence orthology [16]. Second, Drosophila is a very 
practical organism to work with. The generation time is very short and the housing and 
maintenance is inexpensive. Mutant fly lines can be generated by established protocols 
that for instance uses imprecise excision of transposable p-elements [143]. Briefly, these 
elements are incorporated into random positions of the genome. Imprecise DNA repair of 
the genome after p-element excision can also remove coding pieces of a gene of interest. 
This method has been used to generate the G9a null-mutant fly line [96], which is also used 
in the study described in chapter 3 of this thesis. 
 Besides the generation of a null-mutant, RNA interference (RNAi) can be used in 
Drosophila to study gene function. This can be done by expression of a double stranded 
RNA from a transgene. Using such transgenes in combination with the Gal4/UAS (upstream 
activating sequence) system, disruption of the expression levels of specific mRNA molecules 
can be achieved in vivo [144]. Worldwide stock centers have thousands of RNAi-lines and 
Gal4-lines that are available for research purposes. This enables gene specific knockdown 
in a time and tissue specific manner [145-147]. Thus, a gene of interest can be studied in a 
specific brain region or tissue as exemplified in chapters 2, 3, and 5 of this thesis. Putative 
overexpression of a gene can be induced by cloning the coding sequence behind the UAS 
element. This has been used in chapter 5 of this thesis. Thus, adding up all these benefits 
Drosophila has to offer, it provides a very good model to study Kleefstra syndrome and other 
clinical related ID syndromes. 
Thesis objectives and outline 
The functional analysis of genes involved in Kleefstra syndrome, KSS and other clinically 
related ID syndromes can help to provide insight in the molecular networks and mechanisms 
underlying human brain function in health and disease. I focus on the functional relationship 
between EHMT1/G9a and KMT2C/KMT2D/trr. In this way, I try to elucidate the following 
hypothesis: 
Genes involved in clinically overlapping ID disorders such as Kleefstra syndrome, 
KSS, and other clinically related disorders encode proteins that function in common 
biological processes or pathways. 
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The aim of my research is to identify and understand these pathways. 
The major objectives of my PhD thesis are: 
1. To indentify the role of trr in Drosophila memory
2. To identify common gene expression regulation by factors associated with ID 
syndromes that have overlapping aspects with Kleefstra syndrome
3. To identify novel contributors of the EHMT1 molecular network
In order to achieve these objectives, I first optimized an established protocol for courtship 
conditioning to test learning, STM, and LTM in Drosophila [148] which is described in chapter 
2. These optimizations include several novel practical aspects and an R-script to perform 
statistical validation. In chapter 3 I show five additional patients with mutations in KMT2C 
which results in a clinically overlapping syndrome with Kleefstra syndrome and I performed 
genomic analysis to show that the Drosophila orthologs of EHMT1 and KMT2C, G9a and 
trr respectively, have molecular convergence. Chapter 4 shows molecular convergence 
between EHMT1 and KMT2D. In this chapter I report differentially expressed genes in blood 
of Kleefstra syndrome (EHMT1 mutations) and Kabuki syndrome (KMT2D mutations) and a 
significant subset of these genes that are commonly misexpressed. Chapter 5 reports on 
the identification of novel contributors to the EHMT1 molecular network. I identified a novel 
zinc finger protein (CG9932) as interaction partner of Drosophila G9a. Finally, the results 
presented in this thesis are discussed in chapter 6 in which I also evaluate more syndromes 
that have clinical overlap with Kleefstra syndrome and discuss the respective molecular 
functions that partly overlap with the function of EHMT1. Furthermore, prospects for future 
work are provided. 
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Short abstract 
This protocol describes a Drosophila learning and memory assay called courtship 
conditioning. This classic assay is based on a reduction of male courtship behavior after 
sexual rejection by a non-receptive premated female. This natural form of behavioral 
plasticity can be used to test learning, short-term memory, and long-term memory. 
Long abstract
Many insights into the molecular mechanisms underlying learning and memory have been 
elucidated through the use of simple behavioral assays in model organisms such as the fruit 
fly, Drosophila melanogaster. Drosophila is useful for understanding the basic neurobiology 
underlying cognitive deficits resulting from mutations in genes associated with human 
cognitive disorders, such as intellectual disability (ID) and autism. This work describes 
a methodology for testing learning and memory using a classic paradigm in Drosophila 
known as courtship conditioning. Male flies court females using a distinct pattern of easily 
recognizable behaviors. Premated females are not receptive to mating and will reject the 
male’s copulation attempts. In response to this rejection, male flies reduce their courtship 
behavior. This learned reduction in courtship behavior is measured over time, serving 
as an indicator of learning and memory. The basic numerical output of this assay is the 
courtship index (CI), which is defined as the percentage of time that a male spends courting 
during a 10-min interval. The learning index (LI) is the relative reduction of CI in flies that 
have been exposed to a premated female compared to naïve flies with no previous social 
encounters. For the statistical comparison of LIs between genotypes, a randomization test 
with bootstrapping is used. To illustrate how the assay can be used to address the role of a 
gene relating to learning and memory, the pan-neuronal knockdown of Dihydroxyacetone 
phosphate acyltransferase (Dhap-at) was characterized here. The human ortholog of Dhap-
at, glyceronephosphate O-acyltransferase (GNPT), is involved in rhizomelic chondrodysplasia 
punctata type 2, an autosomal-recessive syndrome characterized by severe ID. Using the 
courtship conditioning assay, it was determined that Dhap-at is required for long-term 
memory, but not for short-term memory. This result serves as a basis for further investigation 
of the underlying molecular mechanisms. 
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Introduction
The molecular mechanisms underlying learning and memory are conserved throughout 
many species. The pioneering work screening Drosophila melanogaster mutant lines for 
defects in olfactory learning and memory has provided key molecular insights into the 
processes underlying learning and memory [1]. These studies identified some of the first 
genes involved in learning and memory, such as rutabaga [2], amnesiac [3], and dunce [4], 
revealing a critical role for cyclic adenosine monophosphate (cAMP) signaling [5]. 
Early genetic screens for memory mutants were primarily conducted using 
olfactory conditioning. However, several methods to measure other forms of learning and 
memory have emerged over time. One of the most widely used learning and memory 
paradigms, and the assay described here, is known as courtship conditioning, which was 
first described by Siegel and Hall [6] and was later refined by several other research groups 
[7-9]. Courtship conditioning is dependent upon the presence of a specific pheromone, 
cis-vaccenyl acetate (cVA), on the female abdomen, which is deposited by the male during 
copulation. Sensing cVA on the female abdomen naturally reduces courtship behavior, 
and when coupled with the act of rejection by the female, the effect of cVA on male 
courtship reduction is dramatically enhanced. The response of male flies in this assay can 
be easily quantified by observing their distinct courtship behavior, which is characterized 
by orienting towards and following the female, tapping, extending and vibrating the wing, 
licking, and attempting copulation [10] (Figure 1A). Male flies learn to distinguish between 
receptive virgin and non-receptive mated females [11], and after sexual rejection, they 
display reduced courtship behavior towards non-receptive females for up to 9 days [8]. This 
natural behavior can be used to elucidate the mechanisms underlying learning, short term 
memory (STM), and long term memory (LTM) [8,9,12]. Learning is defined as the immediate 
reduction in courtship behavior that occurs during the training period and is often referred 
to as immediate recall memory, measured 0-30 min after exposure to a mated female [6,8]. 
STM is measured between 30 min and 1 h after training, while LTM is most often measured 
24 h after training [8] (Figure 1B). STM can be induced using a 1-h training period, but it 
only lasts for 2-3 h [6,8]. In most learning paradigms, LTM can only be induced by spaced 
bouts of repeated training. Mcbride et al. (1999) [8] showed that three spaced, 1-h training 
sessions were sufficient to induce courtship memory lasting for up to 9 days, in contrast to 
the 2-3 h induced by a single 1-h training session. McBride et al. [8] also demonstrated that 
a single 5-h training session produced a similar LTM response for up to 9 days. Flies do not 
court constantly during this 5-h period, in effect producing their own spaced training to 
induce LTM in a single training session. This is very important from a practical perspective, 
vastly increasing the ease with which this assay can be used to investigate LTM. Current 
protocols predominantly use a single training session of 7-h for LTM [11,12]. Several studies 
have investigated different mutant conditions that have specific defects in different aspects 
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of courtship learning. For example, mushroom body ablation aff ects STM and LTM, but not 
learning [8]. Mutations in the amnesiac gene, which was fi rst defi ned as a specifi c regulator 
of memory using olfactory conditioning [3], aff ect STM but not learning [6]. Disruption of 
the translation regulator orb2 (oo18 RNA-binding (orb) CPEB2 subfamily) and ecdysone 
signaling exclusively eff ect LTM [9,13]. Thus, courtship conditioning is a useful paradigm to 
dissect the mechanisms underlying the diff erent stages of learning and memory. 
This work demonstrates an optimized experimental setup that allows for the 
relatively high-throughput testing of courtship conditioning. Furthermore, it describes 
a statistical analysis script and discusses critical factors of the assay. It is shown here that 
the Drosophila gene Dihydroxyacetone phosphate acyltransferase (Dhap-at) is required in 
neurons for LTM, but not for STM. The human ortholog of this gene, glyceronephosphate 
O-acyltransferase (GNPAT), is mutated in rhizomelic chondrodysplasia punctata type 2 [14], 
an autosomal-recessive disorder characterized by severe intellectual disability, seizures, and 
several other clinical characteristics [15]. In this context, courtship conditioning can be used 
to functionally validate the role of human disease genes in learning and memory, providing 
a basis for mechanistic studies. 
Figure 1: Determination of the courtship index and experimental overview. 
(A) Images showing stereotypical male courtship behavior towards a female fl y. Diff erent stages of courtship 
behavior are shown: orientation (I), following (II), wing vibration (extension) and tapping (III), licking (IV), and 
attempted copulation (V). (B) Schematic overview of training and testing times relative to the incubator light 
cycle, marked in hours. Training times are indicated with bars, resting periods for STM and LTM are indicated with a 
dashed line, and the testing start point is indicated as an arrow. Note that the testing time for LTM is the day after 
after training. 
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Protocol
NOTE: In the protocol outlined below, one replicate of collection, training, and testing is 
described. In order to test the reproducibility of the results, these steps should be repeated 
in parallel, on multiple days, and with separate groups of flies (Table 1). The protocol is 
based on a 10-day life cycle from egg to adult, which is normal when rearing flies under 
constant conditions of 25 °C, 70% humidity, and a 12-h light/dark cycle. All aspects of 
this protocol assume that the conditions are kept constant throughout the entire assay. 
Times are indicated as hours before lights turn on (BLO) or after lights turn on (ALO) in the 
incubator, as this can be conveniently set depending on the researcher’s preferred time of 
day. Use CO
2
 gas only for the initial collection of naïve male flies and for the collection of 
premated females. This protocol for courtship conditioning is composed of the following 
steps: 
1. Establishment of premated female collection cultures
2. Establishment of cultures for the collection of male test subjects
3. Preparation of housing blocks
4. Establishment of mating vials for the production of standardized premated females
5. Collection of male test subjects
6. Training
7. Testing 
8. Video data analysis and statistics 
Table 1: Example timeline for testing LTM over three replicates on individual days
  General Collect Train Test
day -11 Start premated female collection cultures (step 1.3)    
day -10 Start cultures for the collection of male test subjects (step 2.2)    
day 1  rep. 1
day 2  rep. 2  
day 3  rep. 3
day 4  rep. 4 rep. 1
day 5   rep. 2 rep. 1
day 6   rep. 3 rep. 2
day 7   rep. 4 rep. 3
day 8    rep. 4
day 9 Video data analysis and statistics (step 8)    
rep = repeat
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1. Establishment of premated female collection cultures
1.1. Prepare powerfood [16]. Boil 0.8% (w/v) agar, 8% (w/v) yeast, 2% (w/v) yeast 
extract, 2% (w/v) peptone, 3% (w/v) sucrose, 6% (w/v) glucose, 0.05% (w/v) 
MgSO
4
, and 0.05% (w/v) CaCl
2
 in water for 15 min. Allow the solution to cool 
to 70 °C before adding 0.05% (w/v) methylparabene (CAUTION: toxic) and 0.5% 
(v/v) propionic acid (CAUTION: toxic). Mix well by stirring while cooling further to 
50 °C to obtain a homogeneous solution.
1.2. Before the food solidifies at room temperature, add ~50 mL of powerfood to 
each 175-mL plastic vial. Allow the food to cool further. Close the vial with a plug. 
NOTE: Powerfood is a specialized food mixture formulated specifically for the 
production of large numbers of flies, presumably by inducing egg laying. 
Powerfood is not used to produce male flies that will be used for behavior 
analysis (step 2) because the atypical diet and potential crowding might 
influence development. 
1.3. On day -11 (Table 1), start 5-20 wildtype cultures with approximately 60-100 flies 
(a mix of males and females) in powerfood vials; these will be used in step 4 
to produce standardized premated females [17]. Add a filter paper to each vial 
to increase the area upon which the larvae can pupate; this will increase the 
number of flies that can eclose. 
1.4. Periodically repeat steps 1.1-1.3 throughout the experiment to obtain sufficient 
newly eclosing flies as input for the “establishment of mating vials for the 
production of standardized premated females” (step 4). 
2. Establishment of cultures for the collection of male test subjects
2.1. Prepare normal food [16], made with 0.5% (w/v) agar, 2.75% (w/v) yeast, 5.2% 
(w/v) corn flour, 11% (w/v) sugar, 0.05% (w/v) methylparabene, and 0.5% (v/v) 
propionic acid in water, as described in steps 1.1 and 1.2. Close the 175-mL 
plastic vials with a fly vial plug.
2.2. On day -10 (Table 1), place about 10-20 males with approximately 30-75 virgin 
females (Table of Specific Materials/Equipment) in each 175-mL vial containing 
normal food. Add a filter paper to increase the surface area for pupation and to 
maximize productivity.
2.3. Establish three to six 175-mL vials per genotype to obtain the required number 
of test subject males. 
NOTE: More vials may be needed, depending on the productivity of the desired 
genotype. 
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Figure 2: Equipment used for the Drosophila courtship conditioning assay. 
(A) The housing block is a flat, bottom block with 500 µL of powerfood per well. It is sealed with a qPCR adhesive 
film with at least 4 holes per well that were created using a syringe needle with a 0.8-mm diameter. Individual 
rows are cut lengthwise into strips using a razor blade to allow opening and closing. (B) The aspirator is required 
for the gentle transfer of male and female flies without the use of anesthesia. The inset shows the tip of the 
aspirator, closed with a piece of cotton to keep the flies within the tip. (C) Setup of a two-camera system for the 
simultaneous recording of two courtship chambers. (D) A courtship chamber with 18 arenas. Sliding entry holes 
are used to place the flies in the arenas. The white dividers can be simultaneously opened to initiate interaction 
between the males and females. 
A
DC
B
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3. Preparation of housing blocks (Figure 2A)
3.1. Melt approximately 50 mL of powerfood per housing block in a microwave, or 
prepare it fresh.
3.2. Add 500 µL of powerfood to each well of a 96-well, flat-bottom block using a 
multidispenser pipette.
3.3. Allow the food to solidify at room temperature.
3.4. Cover the blocks with PCR adhesive film and use a needle to make a least 4 holes 
per well to provide fresh air to the flies. 
3.5. In order to be able to open each well, use a razor blade to cut the adhesive film 
lengthwise between each row. Leave the film intact on one end of the block. 
3.6. The blocks can be stored at 4 °C for up to 2 d. 
NOTE: Allow the blocks to re-equilibrate to room temperature prior to use. 
4. Establishment of mating vials for the production of standardized 
premated females
4.1. On day -1, remove and discard all adult wildtype flies from premated female 
collection cultures at 2-5 h BLO.
4.2. Collect flies using the aspirator (Figure 2B) from these vials in 2- to 3-h intervals 
(e.g., at 30 min, 2.5 h, and 5 h ALO) and place them in a new powerfood vial 
supplemented with a small amount of yeast paste and filter paper. 
4.3. To avoid crowding and to promote an optimal mating atmosphere, do not 
transfer more than 150-200 flies to each new vial. Ensure the mating of all females 
by providing at least 25% males. Ensure that sufficient females are present in the 
mating vials to accommodate the size of the experiment. 
NOTE: As this is a crucial step in the protocol, make sure that only freshly eclosed 
flies and no old flies, larvae, or pupae are transferred to the new mating vial.
4.4. Incubate these “mating vials” for four days to allow sufficient time for all females 
to have mated. 
5. Collection of male test subjects
5.1. On day 1 (Table 1) at 2-3 h BLO, use CO
2
 to remove all adult flies from the male 
collection vials (step 2),
 
but let more flies eclose over the next few hours.
5.2. Over the next 5-6 h, remove newly eclosed flies every 20-30 min using CO
2
 
and put each male in an individual well of the housing block (step 3) using the 
aspirator (Figure 2B). 
5.3. Re-seal the well with the adhesive PCR film. 
NOTE: This is a crucial step in the protocol. The males should be collected 
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frequently. Collected males should be isolated in the housing block close to the 
time of eclosion, when they demonstrate pale pigmentation and the presence 
of the meconium in the translucent abdomen. 
NOTE: Gentle use of the aspirator allows the transfer of flies; however, inappropriate 
use will stress the flies, causing variance in the assay (see the Discussion). 
5.4. Aim to collect up to 48 males per genotype. This provides a small excess to the 
maximal number of males needed for the analysis of both naïve and trained 
conditions, allowing for some loss during later transfer steps. 
6. Training
6.1. Remove the flies from the mating vial (step 4.2) using CO
2
 and separate the 
premated females from the males. 
6.2. Using the aspirator, add a single anesthetized, premated female to each well in 
one row of a new housing block.
6.3. Using the aspirator and without anesthesia, transfer an individual naïve male from 
the housing block set up in step 5.2 to the well containing a premated female. 
After the male is placed into the well, re-seal immediately with the adhesive film; 
do not allow the male to escape. 
NOTE: Transfer male flies from the aspirator to the housing block by taking 
advantage of their natural “negative geotaxis” behavior (see the Discussion). 
6.4. Repeat steps 6.2-6.3 until enough male-female pairs are established. Ideally, 
establish 24 pairs, two full rows of a housing block, per genotype. Leave the 
remaining naïve males in the original housing block set up in step 5.2. 
6.5. Leave the male-female pairs undisturbed during the training period (Table 2, 
Figure 1B).
NOTE: During this time, the male will court and be rejected by the premated 
female. For learning and STM, the training period is 1 h and for LTM, the training 
period is 7-9 h. 
6.6. End the training (Table 2, Figure 1B) by using an aspirator to gently separate the 
male from the premated female; do not use anesthesia. Place the separated male 
in a new housing block. 
6.7. Use the aspirator to transfer all naïve males gently and without anesthesia from 
the housing block set up in step 5.2 to a new housing block.
NOTE: This step is optional for STM and learning, but it is very important for LTM 
because the flies are housed for an additional 24 h to test LTM.
6.8. For STM and LTM, allow the males to rest for 1 h and ~24 h, respectively (Table 2, 
Figure 1B) before testing (step 7).
6.9. For learning, immediately test the trained and naïve males (step 7). 
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Table 2: Training duration, training times, and testing times for learning, STM, and LTM
Learning STM LTM
Training time 1 h. 1 h. 8 h.
Resting time 0 h. 1 h. ~ 24 h.
start training 0 h. ALO 0 h. ALO 4 h. BLO
stop training 1 h. ALO 1 h. ALO 4 h. ALO
start test 1 h. ALO 2 h. ALO 0 h. ALO (next day)
ALO = after lights turn on, BLO = before lights turn on, STM = short term memory, 
LTM = long term memory 
7. Testing
7.1. Collect flies from mating vials (step 4.2) using CO
2
 and separate the premated 
females from the males. 
7.2. Let the females recover from the anesthesia for at least 1 h in a vial containing 
normal food.
7.3. Mount the video recorders in advance (Figure 2C), in order to have all equipment 
ready before the testing starts.
7.4. Start the testing according to the different timelines for learning, STM, and LTM 
(Table 2, Figure 1B). Perform testing immediately after training for learning, 1 h 
after training for STM, and 24 h after training for LTM. 
7.5. Using the aspirator, gently transfer an individual male from the resting housing 
block or from the training housing block if learning is being tested (step 6.7, 
trained; step 6.8, naïve) to one half of a courtship arena with the divider closed 
(Figure 2D; see File S1 for a building plan). 
NOTE: The use of the natural “negative geotaxis” behavior should be sufficient 
to transfer the male flies from the aspirator to the courtship arena (Discussion).
7.6. Quickly but gently move the entry hole to the next arena and repeat step 7.5 
until all 18 arenas contain one male. 
7.7. Using the aspirator and without CO
2
, add one premated female (collected in step 
7.2) to the other half of all 18 arenas.
7.8. Carefully place the courtship chamber under the camera, with the opening of 
the wells facing down (Figure 2C).
7.9. Remove the divider of the arenas to allow direct interaction between the males 
and premated females.
7.10. Immediately start recording the behavior for at least 10 min.
NOTE: When using a two-camera setup, the parallel recording of two courtship 
plates can be done in overlapping timeframes to maximize efficiency.
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7.11. Empty the courtship arenas using a hand-held vacuum cleaner and allow the 
courtship chamber to ventilate before re-use.
7.12. Repeat step 7.4-7.11 until the testing of all genotypes and conditions (i.e., naïve 
and trained) have been completed. 
8. Video data analysis and statistics 
8.1. Calculate the courtship index (CI), defined as the percentage of time that the 
male courts during the first 10 min of the testing period, for each individual male 
fly.
NOTE: This can be done manually by observing stereotypical courtship behavior 
(Figure 1A) or by using computer software for automated quantification of 
courtship behavior (Discussion). 
NOTE: It is recommended to analyze 40-60 males per condition over the course 
of three days in order to achieve sufficient statistical power and to judge the 
consistency of the CI data.
8.2. Calculate the learning index (LI), defined as the percent reduction in the mean CI 
of trained males compared to naïve males (LI = (CI
naive
 – CI
trained
) / CI
naive
). Evaluate 
the LI for each day of testing and compare it to the cumulative LI calculated from 
all testing days combined.
8.3. Make a separate two-column tab data file with “Genotype” and “CI” as the headers.
NOTE: These headings are case sensitive. The name of the genotype for each CI 
must consist of a description of the genotype followed by an underscore and the 
training condition (e.g., genotype_N and genotype_LTM, etc., where N = naïve 
and LTM = long term memory; see Supplemental File S2 for an example). This 
annotation is essential, as the function analearn will identify trained and naïve 
flies based on the characters present after the first underscore in the “Genotype” 
column.
8.4. Use the analearn R script (Supplemental File S3) to perform a randomization 
test to judge the statistical significance of differences between the LI values from 
different genotypes. 
Source the script (Supplemental File S3) into R [18], which defines a function 
called “analearn.”
NOTE: The function definition is: analearn <- function(nboot = 10000, naivelevel 
= ‘N’, refmutation = NA, datname = NA, header = TRUE, seed = NA, writeoutput 
= TRUE). 
Start the function by entering “analearn()” in the R command line and selecting 
the data file to be analyzed (produced in step 8.3) via the pop-up window. 
Choose the reference mutation, which is the control genotype, by entering the 
8.4.1
8.4.2
8.4.3
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corresponding number and pressing enter.
NOTE: After selecting the reference genotype, the script takes several seconds to 
perform 10,000 bootstrap replicates.
Observe the output table (Table 3), which contains the genotype, learning 
condition (i.e., learning, STM, or LTM), mean CI naïve, mean CI trained, LI, the 
difference between the LI of the control compared to the experimental condition 
(LI dif ), the lower limit (LL) and upper limit (UL) of the 95% confidence interval 
of the LI dif, and the p-value indicating the probability that there is no significant 
difference. 
NOTE: analearn will store an output text file in the directory where the data file 
is located. However, the output table also appears in the R-Studio console. The 
default name is constructed based on the name of the data file provided.
There are several arguments in the analearn function that can be used to alter the 
default settings of the function to adjust the parameters of the bootstrapping. 
NOTE: “nboot” defines the number of bootstrap replicates and is set to 10,000 
by default. This value can be changed into any integer number larger than zero. 
Table 4 enlists several arguments that can be used to alter the default settings of 
the function. However, it is not recommended to use data that is produced with 
a low number of bootstrap replicates. 
Table 3: Statistical data produced from the analearn script
Genotype Learning  
condition
CI  
naive
CI  
trained
LI LI  
difference
Lower limit 
(95% 
conficence 
interval)
Upper limit 
(95% 
conficence 
interval)
p-value
Control STM 0.467 0.116 0.752 NA NA NA NA
Dhap-at-RNAi STM 0.699 0.257 0.633 0.119 -0.030 0.265 0.116
Control LTM 0.590 0.384 0.348 NA NA NA NA
Dhap-at-RNAi LTM 0.697 0.650 0.068 0.280 0.103 0.446 0.003
Statistical data produced from the analearn script. The output file of the bootstrapping R-script containing the 
genotype, learning condition (i.e., learning, STM, or LTM), mean CI naïve, mean CI trained, LI, difference between 
LI of the control compared to experimental condition (LI dif ), the lower limit (LL) and upper limit (UL) of the 95% 
confidence interval of LI dif, and the p-value indicating the probability that there is no significant difference.
8.4.4
8.4.5
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Table 4: Arguments used in the analearn function that can alter the default settings of the function to 
adjust the parameters of the bootstrapping
“naivelevel” determines the text that will identify naïve values for each genotype. The default is “N,” but this can 
be changed into any other alphanumerical text.
“refmutation” is set to “NA” (not applicable) by default, but can be changed to the name of the control or the 
genotype in order to perform statistical comparisons.  
This will cause the script to automatically select the control genotype.
“datname” refers to the name of the data file and can be specified in this argument instead of the default file 
selection. 
“header” can be used to indicate whether or not the data file contains column headers.  
The default is “TRUE,” but a file with no headers can be used when this argument is changed to “FALSE.” 
“seed” initializes the random number generator. This is set by default to “NA” and ensures a random number 
each time the script is used.  
By design, a bootstrap analysis will give slightly different results each time it is run, even when using the same 
data file.  
When the seed is specified by any integer number larger than zero, the same set of random bootstrap samples 
is obtained. 
“writeoutput” can be set to “TRUE” or “FALSE” in order to determine whether an output file will be generated. 
The default is “TRUE.”
Results
The courtship conditioning assay can be used to measure learning and memory in 
Drosophila. In order to demonstrate this, the results presented here analyze STM and LTM 
in control flies compared to flies with the neuron-specific knockdown of Dhap-at. Control 
males express an RNA interference hairpin sequence targeting a Caenorhabditis elegans-
specific gene, putative zinc finger protein C02F5.12 [19]. This control strain ensures an equal 
number of upstream activating sequence (UAS) elements between the knockdown and 
control in the same genetic background, and the control RNAi hairpin accounts for any 
non-specific effects of the RNAi system. Control males (genotype: UAS-dcr2/+; P{KK108109}
VIE-260B/+; elav-Gal4/+) show a significant reduction in CI in trained versus naïve for both 
STM (Figure 3A, p = 1.2x10-4, Mann-Whitney U-test) and LTM (Figure 3B, p = 1.2 x 10-4, 
Mann-Whitney U-test). This result reflects the normal capacity for learning and memory 
in these flies. Dhap-at knockdown flies (genotype: UAS-dcr2/+; P{KK101437}VIE-260B/+; 
elav-Gal4/+) also show a significant reduction of CI in trained versus naïve flies for STM 
(Figure 3A, p = 1.2 x 10-4, Mann-Whitney U-test). However, they do not show a significant 
reduction in CI after LTM training (Figure 3B, p = 0.33, Mann-Whitney U-test). The Mann-
Whitney U-test was used to compare the mean CI of naïve and trained flies due to the 
non-parametric distribution of the CI data for some conditions (Figure 3A and 3B). The 
differences observed through the analysis of CIs are reflected by the LI for each genotype, 
which measures the percent reduction in CI in naïve versus trained flies (Figure 3C). There is 
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no significant difference in LI between controls and Dhap-at knockdown flies for STM (p = 
0.115, 10,000 bootstrap replicates, Figure 3C, Table 3), whereas the LI for LTM is significantly 
lower in Dhap-at knockdown flies (p = 0.0034, 10,000 bootstrap replicates, Figure 3C, Table 
3). For the comparison of LI between genotypes, a randomization test [20] adapted from 
a method first recommended by Kamyshev et al. [7] was used. Since the LI is a single value 
derived from population data (i.e., mean CI-naïve and mean CI-trained), standard statistical 
methods that rely on experimentally derived distributions do not apply. The randomization 
test is distribution-free and uses bootstrapping (i.e., random sampling with replacement) to 
generate hypothetical data sets that are derived from the actual data. The analearn script 
(File S3) generates a set of hypothetical LIs for each genotype and calculates the difference 
between the control and the test genotype (LIdiff ). This process is repeated 10,000 times, 
and the resulting values are used to determine the 95% confidence interval of LIdiff (Table 
3). This data is used to generate a p-value indicating the probability that the LI of the two 
genotypes is different. The results shown here demonstrate that Dhap-at is required in 
neurons for LTM but not for STM. 
In order to control for day-to-day variability, CIs and LIs are compared between replicate 
days (Table 5). Although some fluctuation in LI is observed from day to day, the results are 
generally reproducible. It is important to note that CI data can vary greatly depending on 
the control strain used and the environmental conditions of testing. The CI data shown here 
is typical for this control genotype, but other genotypes may exhibit a higher or lower mean 
CI and distribution. 
Table 5: CI and LI values obtained on separate testing days
Control Dhap-at-RNAi
 
Average CI 
naïve
Average CI 
trained LI
Average CI 
naïve
Average CI 
trained LI
STM Day 1 0.300 0.125 0.584 0.679 0.239 0.648
 Day 2 0.634 0.107 0.831 0.720 0.276 0.617
 All Days 0.467 0.116 0.752 0.699 0.257 0.633
LTM Day 1 0.590 0.441 0.252 0.630 0.646 -0.027
 Day 2 0.640 0.363 0.432 0.709 0.710 -0.002
 Day 3 0.547 0.349 0.363 0.738 0.598 0.190
 All Days 0.590 0.384 0.348 0.697 0.650 0.068
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Figure 3: Analysis of STM and LTM in control and Dhap-at knockdown flies. 
(A-B) Boxplots showing the distribution of CI values for naïve (N) and trained (T) flies of the control (gray) and Dhap-
at knockdown (white) genotypes tested for STM (A) and LTM (B). (C) Corresponding LI values for control and Dhap-
at knockdown flies tested for STM and LTM. Differences in LI between control and knockdown genotypes were 
compared using a randomization test (10,000 bootstrap replicates). Error bars indicate the standard error of the 
mean derived from the LI values calculated on different test days. The genotypes are: w+, UAS-dcr2/+; P{KK108109}
VIE-260B/+; and elav-Gal4/+ (Control) and w+, UAS-dcr2/+; P{KK101437}VIE-260B/+; and elav-Gal4/+ (Dhap-at-RNAi). 
Discussion
The courtship conditioning assay is a classic paradigm for the analysis of learning and 
memory in Drosophila. The protocol presented here follows the general methodology 
described previously [6-9] but includes unique aspects such as practical guidelines, 
specialized equipment, and a data analysis script [9,12] for randomization tests. Using this 
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protocol, it is possible to analyze large numbers of flies in parallel using 96-well flat-bottom 
blocks (Figure 2A) to collect and train males. The blocks are sealed with PCR adhesive film, 
which makes the flies easily accessible when required. Additionally, the unique courtship 
chambers described here allow for the simultaneous pairing of 18 male-female pairs in 
a nearly two-dimensional space that is optimal for video analysis. The custom-designed 
courtship chambers are easy to use, and a building plan is provided (File S1, Figure 2D). 
This protocol, from the establishment of the cultures used to collect test subjects to the 
acquisition of video data, takes approximately 20 days (Table 1). Additional time is required 
for the analysis of video data. In our experience, the STM assay is extremely robust. The LTM 
assay is also quite robust, but it is more sensitive to confounding environmental variables 
and therefore can be more difficult to master. 
Animal behavior can be quite variable. Therefore, critical steps in the protocol must 
be performed with care to reduce this variance. First, gentle use of the aspirator (Figure 
2B) will reduce the stress that can be imposed by rough handling or by blowing out too 
strongly. A suggested method of transferring individual flies out of the aspirator is by using 
negative geotaxis. As flies tend to walk up, one can simply point the tip of the aspirator up; 
just before the fly reaches the tip, a gentle blow is sufficient to let the fly out. Additionally, 
to let the males into the courtship chambers before testing, a blow is often not necessary.
  Another important step is the collection and generation of male test subjects. All 
males must be collected when they are very young and socially naïve. This can be achieved 
by frequent collection during the peak periods of eclosion (step 5.2). If males are not 
collected in this tight timeframe, they can have early social interactions, which may result 
in poor learning or high variability in CI. Another factor of male test subjects that should be 
assessed is the genetic background. Different genetic backgrounds will exhibit different 
levels of naïve courtship and may also differ in general activity or locomotor ability. When 
comparing multiple genotypes, care should be taken with regard to genetic background 
in order to avoid these confounding factors that may influence LI scores. Additionally, the 
distribution of CI data should be carefully assessed. CI data can be both parametric and 
non-parametric, depending on the genotype or other environmental factors. In some cases, 
if the distribution of CI is dramatically skewed away from a normal distribution, it may be 
better to use the median CI rather than the mean for the calculation of LIs. However, in 
our experience, the use of median or mean CI does not make a difference in the statistical 
interpretation of the data, and the use of the mean CI is the common practice in the 
literature.
For successful courtship conditioning, the active rejection of male courtship attempts by 
premated females is crucial during the training period. It is important to ensure that the 
premated females used in this assay have been efficiently mated and are thus not allowing 
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copulation. This premating is established in the mating vials prepared in step 4, where male 
and females flies are housed together for 4 days (Table 1). Subsequently, mating can be 
monitored by regular examination of testing videos and by observing male-female pairs 
during training. If mating does occur, there are several measures that can be taken during the 
preparation of premated females. First, premated females should be reared under optimal 
breeding conditions. Vials can be supplemented with yeast paste and a folded filter paper to 
increase potential mating surfaces. The incubation of flies under the conditions described 
here has produced robust premated females in the past, but this may vary in different labs 
and with the use of different genetic strains. Therefore, it may be necessary to optimize the 
generation of premated females by varying the incubation time and conditions.
Quantification of courtship behavior is another critical step in this protocol. 
This can be done manually or automatically using specialized software programs [9]. 
Automated quantification is fast and, in principle, unbiased. Several programs have been 
published[21-23]; however, they are not straightforward to use, often requiring specialized 
video formats and advanced computational skills. Manual quantification is easy and 
accurate, but it is highly labor intensive and subject to individual variability and bias. It is 
important to emphasize that this protocol does not address the requirements for video 
formatting that are potentially required for the automated quantification of CIs. For manual 
quantification, use any simple video recording device that has the potential to produce 
a video of sufficient quality to accurately observe courtship behavior. For automated 
quantification, there will likely be different requirements depending on the software used, 
and users should investigate this thoroughly if automated quantification is desired.
In combination with the extensive tools that are available for the genetic 
manipulation of flies, the courtship conditioning assay provides a robust readout that can 
be used to dissect molecular mechanisms and neuronal networks involved in learning and 
memory. 
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Supplemental File S1: Building plan of a courtship chamber. The file can be opened with any 
application that allows .stp extensions (CAD-files).  
Supplemental File S2: Example of an input file for the analearn script.
Genotype CI
CG4625_N 0.819
CG4625_N 0.657
CG4625_N 0.805
CG4625_N 0.481
CG4625_N 0.696
CG4625_LTM 0.451
CG4625_LTM 0.548
CG4625_LTM 0.542
CG4625_LTM 0.947
CG4625_LTM 0.448
etc.
Supplemental File S3:  The analearn.R script. The file can be opened with R-studio [18].
analearn <- function(nboot = 10000, naivelevel = ‘N’, refmutation = NA, 
datname = NA, header = TRUE, seed = NA, writeoutput = TRUE) {
 if (!is.na(seed)) set.seed(seed)
 if (is.na(datname)) datname <- file.choose()
 datfile <- read.table(datname,header = header,stringsAsFactors = FALSE)
 idstr <- strsplit(datfile[,1],’_’)
 datfile$mutation <- as.factor(unlist(lapply(idstr,’[[‘,1)))
 if (is.na(refmutation) || !(refmutation %in% levels(datfile$mutation))){
  cat(‘The following mutations are observed:\n’)
  for(i in seq_along(levels(datfile$mutation))) {
   cat(i,’: ‘,levels(datfile$mutation)[i],’\n’, sep = “”)
  }
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  cat(‘Please indicate the reference mutation by giving a number from 1 to 
‘,length(levels(datfile$mutation)),’ followed by <Enter>.\n’,sep = “”)
  refnum <- readline()
  refmutation <- levels(datfile$mutation)[as.numeric(refnum)]}
 datfile$mutation <- relevel(datfile$mutation,refmutation)
 datfile$learncon <- as.factor(unlist(lapply(idstr,’[[‘,2)))
 datfile$learncon <- relevel(datfile$learncon,naivelevel)
 aggrdat <- aggregate(CI ~ mutation + learncon, data = datfile, FUN = mean)
 LIout <- data.frame(mutation = “”, learningcondition = “”, CInaive = 
0, CItrained = 0, LI = 0, LIdif = 0,LL95CI = 0, UL95CI = 0 ,p = 0, 
stringsAsFactors = FALSE)
 k = 0
 for (i in levels(aggrdat$learncon)[-1]) {
  k <- k + 1
  LIout[k,”mutation”] <- levels(aggrdat$mutation)[1]
  LIout[k,”learningcondition”] <- i
  LIout[k,”CInaive”] <- aggrdat[aggrdat$mutation == LIout[k,”mutation”] & 
aggrdat$learncon == naivelevel,”CI”]
  LIout[k,”CItrained”] <- aggrdat[aggrdat$mutation == LIout[k,”mutation”] & 
aggrdat$learncon == i,”CI”]
  LIout[k,”LI”] <- (LIout[k,”CInaive”] - LIout[k,”CItrained”])/
LIout[k,”CInaive”]
  LIout[k,”LIdif”] <- NA
  LIout[k,”LL95CI”] <- NA
  LIout[k,”UL95CI”] <- NA
  LIout[k,”p”]<- NA
  for(j in levels(aggrdat$mutation)[-1]) { 
   k <- k + 1
   LIout[k,”mutation”] <- j
   LIout[k,”learningcondition”] <- i
   LIout[k,”CInaive”] <- aggrdat[aggrdat$mutation == j & aggrdat$learncon == 
naivelevel,”CI”]
   LIout[k,”CItrained”] <- aggrdat[aggrdat$mutation == j & aggrdat$learncon 
== i,”CI”]
   LIout[k,”LI”] <- (LIout[k,”CInaive”] - LIout[k,”CItrained”])/
LIout[k,”CInaive”]
   LIout[k,”LIdif”] <- LIout[LIout$mutation == levels(aggrdat$mutation)[1] 
& LIout$learningcondition == i,”LI”] - LIout[k,”LI”]
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   LIout[k,”LL95CI”] <- NA
   LIout[k,”UL95CI”] <- NA
   LIout[k,”p”]<- NA
   
  }
 }
 datsplit <- with(datfile, split(datfile, list(mutation,learncon)))
 bootres = matrix(0, nrow = nboot, ncol = (length(levels(aggrdat$mutation))-
1)*(length(levels(aggrdat$learncon))-1))
 CIsplit = list()
 for (i in seq_len(nboot)) {
  for (j in names(datsplit)) {
   datstuk <- datsplit[[j]]
   CIsplit[j]<- mean(datstuk[sample(NROW(datstuk),replace = TRUE),”CI”])
  }
  CInames <- matrix(unlist(strsplit(names(CIsplit),’\\.’)),ncol = 2, byrow 
= TRUE)
  aggrtemp <- data.frame(mutation = as.factor(CInames[,1]), learncon = 
as.factor(CInames[,2]),CI = unlist(CIsplit))
  aggrtemp$mutation <- relevel(aggrtemp$mutation,levels(datfile$mutation)
[1])
  aggrtemp$learncon <- relevel(aggrtemp$learncon,naivelevel)
  for (l in levels(aggrtemp$learncon)[-1]) {
   for (m in levels(aggrtemp$mutation)){
    aggrtemp[aggrtemp$mutation==m & aggrtemp$learncon == l,’LI’] <- 
(aggrtemp[aggrtemp$mutation==m & aggrtemp$learncon == naivelevel,’CI’] 
- aggrtemp[aggrtemp$mutation==m & aggrtemp$learncon == l,’CI’])/
aggrtemp[aggrtemp$mutation==m & aggrtemp$learncon == naivelevel,’CI’]
   }
  }
  k <- 0
  for (l in levels(aggrtemp$learncon)[-1]) {
   for (m in levels(aggrtemp$mutation)[-1]){
    k <- k + 1
    bootres[i,k] <- aggrtemp[aggrtemp$mutation==levels(aggrtemp$mutation)
[1] & aggrtemp$learncon == l,’LI’] - aggrtemp[aggrtemp$mutation==m & 
aggrtemp$learncon == l,’LI’]
   }
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  }
  
 }
 k <- 0
 for (i in levels(aggrtemp$learncon)[-1]) {
  for(j in levels(aggrtemp$mutation)[-1]) {
   k <- k + 1
   LIout[LIout$mutation == j & LIout$learningcondition == i,”LL95CI”] <- 
quantile(bootres[,k],probs = 0.025)
   LIout[LIout$mutation == j & LIout$learningcondition == i,”UL95CI”] <- 
quantile(bootres[,k],probs = 0.975)
   p <- mean(bootres[,k]>0)
   if(p>0.5) p <- 1 - p
   if (p < 1) p <- p*2
   LIout[LIout$mutation == j & LIout$learningcondition == i,”p”] <- p
   
  }
 } 
 if (writeoutput) {
  outname <- unlist(strsplit(datname,’\\.’))
  outname[length(outname)-1] <- paste(outname[length(outname)-1],’out’,sep 
= ‘’)
  outname <- paste(outname, sep = ‘’, collapse = ‘.’)
  if (file.exists(outname)) {
   cat(‘Output file ‘, outname, ‘ already exists. Overwrite? <y/n>\n’)
   if(!readline() == ‘y’) outname <- file.choose()
  }
  sink(outname)
  cat(‘Analyzing file ‘,datname,’\n’)
  cat(‘Based on ‘,nboot,’ bootstrap replications.\n\n’)
  print(LIout)
  sink()
 }
 LIout
}
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Table of specific materials
Name of Reagent/ 
Equipment
Company
Catalog 
Number
Comments/Description
General
P{KK101437}VIE-260B VDRC 101437 Gpat-RNAi in 60100 background 
P{KK108109}VIE-260B
- - Control-RNAi in 60100 background (gift 
from K. Keleman)
w+, UAS-dcr2/yhh;;elav-Gal4 (III) - - Panneuronal driver line
Containers for plant tissue 
culture
VWR 960177 175ml plastic vials
folded filters
Whatman 10311643 Filter paper to enlarge area flies can pupate 
on 
Flat-bottom blocks (96-wells) Qiagen 19579 Housing blocks
MicroAmp Clear Adhesive Film
Applied 
Biosystems
4306311 PCR adhesive film as lid on flat-bottom 
blocks
razor blade - - Any sharp will do
needle (0.8 mm diameter)
- - Don’t use too big diameter as flies can 
escape
aspirator - - Cut a 1ml pipet tip with scissors in order 
to have two pieces. The narrow tip of 
the pipettip is placed as fly entrance in 
a ~80cm flexible hose. To prevent a fly 
from getting in the hose, a normal piece 
of cotton or small mesh gaze is placed in 
between the tip and the hose. The other 
half of the pipettip can be used as mouth 
piece at the end of the hose. 
courtship chambers
- - File S1 can be opened with indicated CAD 
software 
camcorder Sony - >4M pixels, full HD
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Name of Reagent/ 
Equipment
Company
Catalog 
Number
Comments/Description
Power food
agar Sigma A7002
yeast Bruggeman -
yeast extract MP biomedicals 0210330391
peptone Sigma P6838
sucrose Sigma S9378
glucose Sigma G7021
MgSO
4
Sigma M2643
CaCl
2
Merck 1023780500
methylparabene (CAUTION) Sigma H5501
propionic acid (CAUTION) Sigma P1386
demineralized water - -
yeast paste - - Yeast grains and water mixture in a 1:1 ratio
Normal food
agar MP biomedicals 215017890 -
yeast bruggeman - -
corn flour de Molen - -
sugar de Molen - -
methylparabene (CAUTION) Sigma H5501 -
propionic acid (CAUTION) Sigma P1386 -
demineralized water - - -
Table of specific materials (continued)
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Abstract
Kleefstra syndrome (KS), caused by haploinsufficiency of euchromatin histone 
methyltransferase 1 (EHMT1), is characterized by intellectual disability (ID), autism spectrum 
disorder (ASD), characteristic facial dysmorphisms, and other variable clinical features. In 
addition to EHMT1 mutations, de novo variants were reported in four additional genes (MBD5, 
SMARCB1, NR1I3, and KMT2C), in single individuals with clinical characteristics overlapping 
KS. Here, we present a novel cohort of five patients with de novo loss of function mutations 
affecting the histone methyltransferase KMT2C. Our clinical data delineates the KMT2C 
phenotypic spectrum and reinforces the phenotypic overlap with KS and other related 
ID disorders. To elucidate the common molecular basis of the neuropathology associated 
with mutations in KMT2C and EHMT1, we characterized the role of the Drosophila KMT2C 
ortholog, trithorax related (trr), in the nervous system. Similar to the Drosophila EHMT1 
ortholog, G9a, trr is required in the mushroom body for short term memory. Trr ChIP-
seq identified 3371 binding sites, mainly in the promoter of genes involved in neuronal 
processes. Transcriptional profiling of pan-neuronal trr knockdown and G9a null mutant fly 
heads identified 613 and 1123 misregulated genes, respectively. These gene sets show a 
significant overlap and are associated with nearly identical gene ontology enrichments. The 
majority of the observed biological convergence is derived from predicted indirect target 
genes. However, trr and G9a also have common direct targets, including the Drosophila 
ortholog of Arc (Arc1), a key regulator of synaptic plasticity. Our data highlights the clinical 
and molecular convergence between the KMT2 and EHMT protein families, which may 
contribute to a molecular network underlying a larger group of ID/ASD-related disorders.
Author summary
Neurodevelopmental disorders (NDDs) like intellectual disability (ID) and autism spectrum 
disorder (ASD) present an enormous challenge to affected individuals, their families, and 
society. Understanding the mechanisms underlying NDDs may lead to the development of 
targeted therapeutics, but this is complicated by the great clinical and genetic heterogeneity 
seen in patients. Mutations in hundreds of genes have been implicated in NDDs, giving 
rise to diverse clinical presentations. However, evidence suggests that many of these genes 
lie in common biological pathways, and mutations in genes that are involved in similar 
biological functions give rise to more similar clinical phenotypes. Here, we define a novel 
ID disorder with comorbid ASD (ID/ASD) caused by mutations in KMT2C. This disorder is 
defined by clinical features that overlap with a group of other disorders, including Kleefstra 
syndrome, which is caused by EHMT1 mutations. In the fruit fly, we show that the KMT2 
and EHMT protein families regulate a highly converging set of biological processes. Both 
EHMT1 and KMT2C, encode histone methyltransferases, which regulate gene transcription 
by modifying chromatin structure. Further understanding of the common gene regulatory 
networks associated with this group of ID- and ASD-related disorders may lead to the 
identification of novel therapeutic targets.
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Introduction
Kleefstra syndrome (OMIM #610253) is a neurodevelopmental disorder that is caused 
by haploinsufficiency of EHMT1 [1, 2]. EHMT1 encodes a histone methyltransferase that 
regulates gene expression through modification of chromatin structure and through 
interactions with other transcription factors [2-4]. The core phenotype of Kleefstra syndrome 
is characterized by intellectual disability (ID), childhood hypotonia, and distinctive 
facial characteristics. Autism spectrum disorder(ASD ) and other behavioural problems 
such as sleep disturbances and feeding difficulties are also frequently observed [5, 6]. 
Kleefstra syndrome shares considerable phenotypic overlap with several other disorders 
characterized by ID, ASD, other behavioural problems and hypotonia [7, 8]. These disorders 
include Pitt-Hopkins syndrome, Smith-Magenis syndrome, Rett syndrome, MBD5 deletion/
duplication, and Angelman syndrome. We have collected a cohort of individuals with 
clinical characteristics that fit within this clinical spectrum. In the pre-exome sequencing 
era, around 25% of these cases were positive for EHMT1 haploinsufficiency characterizing 
Kleefstra syndrome [9]. Previously, we hypothesized that these unsolved, EHMT1 mutation-
negative individuals with overlapping clinical features may carry mutations in other genes 
that code for proteins acting in EHMT1-related molecular pathways or biological processes. 
Genetic analyses of four individuals within our cohort using next generation sequencing 
methods revealed potentially causative de novo mutations in four genes (MBD5, SMARCB1, 
NR1I3, and KMT2C), all of which encode proteins involved in regulation of gene expression 
and/or chromatin structure [9].
 Available physical interaction data between these proteins [10-14] and pairwise 
genetic interactions identified between the Drosophila orthologs of these genes [9], 
supported the hypothesis that EHMT1 and the genes identified in the individuals presenting 
with clinical overlap act in shared molecular pathways. In particular, a very strong antagonistic 
genetic interaction was observed between the Drosophila EMHT1 ortholog, G9a, and the 
KMT2C ortholog, trithorax related (trr), in the context of Drosophila wing development [9]. 
Genetic combination of G9a overexpression together with trr knockdown led to a complete 
developmental arrest and death of the targeted wing tissue, while the misregulation of 
either gene alone had only subtle effects on wing morphology [9]. Thus, although these 
data argued for a conserved functional relationship between the two genes, the underlying 
shared molecular basis remained unknown. 
 G9a and trr are both histone methyltransferases, but they have different substrates. 
G9a mediates mono- and dimethylation of histone H3 at lysine 9 (H3K9me2). This is 
generally regarded as a repressive histone mark, however, in mammals the EHMT1 protein 
has also been shown to activate gene expression independent of its methyltransferase 
activity [15, 16]. G9a mutant flies are fully viable [17, 18] but do show phenotypic differences 
compared to wildtype flies. Loss of Drosophila G9a delays embryonic development [19]. 
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In larval stages, G9a mutants show defects in the morphology of multidendrite neurons 
and have altered crawling behaviour [18]. Adult G9a mutants have defects in habituation 
learning, short and long term courtship memory, and show decreased tolerance to virus 
infections [18, 20]. Genome-wide identification of genomic regions with reduced H3K9me2 
in G9a mutant larvae revealed a large number of target sites in genes that are strongly 
enriched for neuronal functions [18]. In mouse knockout models, loss of Ehmt1 causes 
phenotypes that are reminiscent of Kleefstra Syndrome, including deficits in learning and 
memory, increased anxiety, hypotonia, cranial abnormalities, and developmental delay 
[21-24]. These studies show that the EHMT family of proteins are evolutionarily conserved 
regulators of neurodevelopmental processes and cognition. However, the underlying 
molecular mechanisms and functional partners of EHMT proteins in these processes are 
poorly understood. 
 Studies investigating the molecular biology of Drosophila trr and its binding 
partners have revealed a potential dual function for this protein in the regulation of gene 
expression. Trr mediates mono- and tri-methylation of histone H3 at Lysine 4 (H3K4me1 
and H3K4me3) [14, 25], histone modifications that are found at enhancers and active gene 
promoters, respectively [26]. On one hand, trr and its mammalian orthologs KMT2C and 
KMT2D, are present in a conserved COMPASS-like (complex of proteins associated with Set1) 
protein complex that mediates H3K4me1 at enhancers [27, 28]. Additionally, trr interacts 
with the ecdysone receptor and is a co-activator of ecdysone-mediated transcription that 
deposits H3K4 trimethylation at promoters [14]. The role of trr in the nervous system and 
how it relates to G9a is unknown. 
 Here, we describe the first human cohort with de novo loss of function mutations 
in the trr ortholog, KMT2C, allowing us to delineate the phenotypic spectrum and define 
the core phenotype associated with mutations in this gene. In agreement with the single 
previously reported patient, these individuals show clinical overlap with Kleefstra syndrome 
and other related neurodevelopmental disorders; reemphasizing (1) an important role for 
KMT2C in neurodevelopment, and (2) a biological link with EHMT1. We further show that 
Drosophila trr shares the essential role in neurodevelopment with its human ortholog, and 
provide evidence for biological convergence between trr and G9a. 
Results
De novo mutations in KMT2C cause ID and autism spectrum disorder 
Through the large scale application of diagnostic whole exome sequencing for unexplained 
neurodevelopmental disorders in the clinical genetics centers at the Radboudumc and 
Maastricht UMC [29], we identified five de novo KMT2C mutations. All these mutations are 
predicted to cause loss of function, including c.5216del (p.Pro1739Leufs*2) in individual 
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1, c.7550C>G (p.Ser2517*) in mosaic (≈30% of blood cells) in individual 2, c.1690A>T 
(p.Lys564*) in individual 3, and c.10812_10815del (p.Lys3605fs) in individual 4 (Figure 1A). 
Using microarray-based comparative genomic hybridization for patient 5, an intragenic 
203kb de novo deletion (Chr7: 151858920-152062163)x1 was identified (Figure 1A) and 
confirmed by locus-specific qPCR. 
Identification of these five novel mutations in addition to the previously published 
case [9] has allowed us to establish the clinical phenotype associated with KMT2C mutations 
(Table 1). All individuals had ID, ranging from mild to severe, language and motor delay, and 
autism or Pervasive Developmental Disorder (PDD), a condition in the autistic spectrum. 
Other recurrent clinical features were short stature (2/6), microcephaly (3/6), childhood 
hypotonia (3/6), kyphosis/scoliosis (3/6) and recurrent respiratory infections (2/6). Kleefstra-
like facial dysmorphisms, including flattened midface, prominent eyebrows, everted lower 
lip, thick ear helices were observed in several individuals (Figure 1B). 
Figure 1: Patients and identified KMT2C mutations. 
(A) Schematic view of the KMT2C protein with reported domains (purple: AT hook DNA binding domain; dark 
blue: zinc finger domain; yellow: cysteine rich; orange: High mobility group (HMG); dark red: Ring finger; light 
blue: “FY-rich” domain; dark green: SET and Post-SET domains) and identified frameshift mutations (open lollipops), 
nonsense mutations (closed lollipops) and deletion. Scale bar represents amino acid position. (B) Frontal and lateral 
photographs of individual 1 at age 29 years, individual 2 at age 31 years, individual 3 at age 15 years. Though there 
is variable facial features, KSS dysmorphisms are observed, including flattened midface (individual 1), prominent 
eyebrows (individuals 1 and 3), thick ear helices (individuals 1 and 3). 
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The Drosophila KMT2C ortholog, trr, is required for short term courtship 
memory 
To assess the functional role of KMT2C in neurons, we investigated the closest Drosophila 
melanogaster ortholog, trithorax related (trr), which shares a one-to-two evolutionary 
relationship with the human paralogs KMT2C and KMT2D [28]. Since homozygous mutations 
in trr are lethal [30], we used the UAS/Gal4 system [31] and inducible RNA interference 
(RNAi) [32] to assess the role of trr in the adult fly nervous system. Knockdown of trr was 
targeted specifically to the mushroom body (MB), the learning and memory center of 
the fly brain, using the R14H06-Gal4 driver line from the Janelia FlyLight collection [33]. 
To estimate the knockdown efficiency under these conditions we co-expressed UAS-trr-
RNAi with UAS-mCD8::GFP and performed immunohistochemistry using a trr antibody [34] 
(Figure 2A-2H). Trr protein is localized in the nuclei of the mushroom body calyx, as seen 
by colocalization with DAPI. A clear reduction of trr staining in cells expressing trr-RNAi, 
which are marked by UAS-mCD8::GFP, is observed (Figure 2E-2H). Under these conditions 
we observed no gross morphological defects in the MB upon trr knockdown (Figure 2I 
and 2J). Next, to test these MB-specific knockdown flies for defects in learning and memory 
we used a classic behaviour paradigm known as courtship conditioning. In this assay male 
flies exhibit a learned reduction of courtship behaviour after rejection by a non-receptive 
premated female [18, 35]. We tested short term memory by measuring the courtship 
index (CI) in naïve males compared to males exposed to sexual rejection for one hour by a 
premated female. Control flies expressed a transgenic RNAi construct targeting mCherry, 
which is inserted into the same genetic background as the trr-RNAi. These controls showed 
significant reduction in CI in rejected flies compared to naïve (Figure 2K). Flies expressing 
the trr-RNAi construct did not exhibit a significant reduction in CI in response to rejection 
(Figure 2K), and as a result, had a significantly lower learning index (LI) than the controls 
(Figure 2L). These data show that trr is required in the mushroom body for short term 
memory.
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Figure 2: Trr is required in the mushroom body for short term memory.  
Fluorescent confocal images of control (A-D) and trr knockdown (E-H) adult male brains. UAS-mCD8::GFP calyx (A, 
E) shows the expression domain of the R14H06-Gal4 driver in the mushroom body and is marked by yellow dashed 
lines and asterisk. The scale bar represents 10 µm. DAPI (B, F) is shown to identify nuclei and note the low nuclear 
density preduncle (p). Trr (C, G) is labeled by immunohistochemistry using an anti-trr antibody. The overlay of DAPI 
and trr signal (D, H) shows a reduction of trr in the target cells (blue and red channels). (I-J) Confocal projections 
showing the main axonal lobes of the mushroom body that are labeled by UAS-mDC8::GFP through expression 
with the R14H06-Gal4 driver in control flies (I) and trr knockdown flies (J). The scale bar represents 10 µm. (K) 
Standard boxplots representing the courtship indexes (CIs) resulting from courtship conditioning in control and 
trr knockdown flies. + indicates the mean. The mean CI for naïve and trained flies was compared using the Mann-
Whitney test. (L) Learning Indexes (LI) for controls and trr knockdown flies derived from the CIs. Trr knockdown 
males have a significantly reduced LI (randomization test, 10,000 bootstrap replicates). 
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Trr binds to the promoter of genes important for the nervous system
Given the known role of trr as a transcriptional co-activator [14], we sought to identify 
genomic binding regions of trr to gain insight into its target genes and the processes that it 
regulates in the nervous system. To do this, we conducted chromatin immunoprecipitation 
combined with next generation sequencing (ChIP-seq) using wildtype adult Drosophila 
heads and a validated ChIP grade antibody directed against trr [14, 34]. After exclusion 
of poorly aligned and ambiguously mapped reads (Table S1), the MACS2 (model based 
analysis of chip-seq) algorithm [36] was used to identify genomic regions that were 
significantly enriched for trr binding in two biological replicates (Table S1). This analysis 
identified 3371 trr binding sites (Table S2) covering 1.27% of the genome. About 75% of trr 
binding sites (2564) were located within 1kb up- or downstream of the transcription start 
sites (tss) of 2362 unique genes. The remaining 25% of trr binding sites were associated to 
other genomic features (low complexity, 5’- or 3’-prime region, transcription termination 
site, intron/exon), each at a low frequency (Figure 3A, Table S2). Taking the genome-wide 
abundance of annotated features into account, trr binding at the tss is six fold enriched 
compared to random genomic positions (Figure 3B). The average trr occupancy profile over 
the tss of all genes shows a clear enrichment for trr when compared to the input control 
(Figure 3C). The observed association of trr with promoter regions in fly heads is consistent 
with previously published trr ChIP-seq data from cultured S2 cells [25]. Gene Ontology (GO) 
enrichment analysis of the 2362 unique genes with trr binding at the tss revealed a strong 
enrichment for neuronal terms, such as “axon extension” and “neuron recognition”. Also 
enriched was the term “negative regulation of Ras protein signal transduction”, a process 
that is corrupted in a series of ID disorders referred to as RASopathies [37] (Figure 3D, Table 
S3). Taken together, our data demonstrate that, in fly heads, trr binds to the promoter of 
many genes involved in neuronal processes. 
G9a and trr show convergence in genomic targets
Given the clinical overlap between patients with KMT2C and EHMT1 mutations (Figure 1, 
Table 1), and our previous studies showing a very strong genetic interaction between the 
two Drosophila orthologs [9], we reasoned that trr and G9a may regulate the expression 
of common genes and/or biological pathways. We investigated whether G9a and trr have 
common direct target genes (Figure 3E-3F). For this we compared the genes associated 
with trr binding sites identified here (Figure 3A-3D) with previously determined G9a target 
genes that were identified by investigating loss of H3K9me2 in G9a mutants [18]. This 
analysis revealed a significant overlap of 1047 genes based on hypergeometric probability 
(p < 1.9*10-37, fold change = 1.35, Figure 3E). These genes are primarily enriched for GO-
terms associated with neuronal development and function, including “axon extension”, 
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“neuron recognition”, and again, “negative regulation of Ras protein signaling” (Figure 3F, 
Table S4). This suggests that trr and G9a have the potential to directly regulate a common 
set of genes with important functions in neurons.
Figure 3: Trr localizes to promoters of neuronal genes in Drosophila heads and shows a significant 
overlap with G9a targets. 
(A) Pie-chart representing the location of trr binding sites in annotated genomic features as specified by HOMER 
software. (B) Fold enrichment of trr binding sites in annotated genomic features compared to an equivalent group 
of random genomic positions. (C) Average trr occupancy (black) of all transcription start sites (tss) relative to the 
–1kb region compared to the average read depth in the input control (grey). (D) Gene ontology enrichment 
analysis of genes with a trr binding site near the tss. Shown here are the top 10 enriched terms. Enrichment is 
indicated by black bars (lower x-axis). The –log10 transformation of p-values is indicated by grey bars (upper x-axis). 
(E) Venn diagram showing the overlap between predicted trr target genes identified here, and predicted G9a 
targets that were previously published [18]. The overlap of 1047 genes is larger than expected by random chance, 
based on a hypergeometric test (p-value= 1.9*10-37 and 1.35 times enriched). (F) Top 10 enriched GO terms for 
biological processes identified for the 1047 overlapping predicted targets for G9a and trr. Enrichment is indicated 
by black bars (lower x-axis). The –log10 transformation of p-values is indicated by grey bars (upper x-axis).
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G9a and trr regulate the expression of common genes and biological 
processes 
To characterize the effect of trr and G9a mutations at the transcriptional level, we 
conducted whole-transcriptome mRNA sequencing (RNA-seq) on wildtype and mutant fly 
heads. Validation of pan-neuronal trr knockdown in fly heads was performed by RT-qPCR 
and revealed a 34% reduction in trr mRNA in whole fly heads, encompassing both the 
targeted neuronal knockdown cells and all other non-targeted cells (Figure S1). Only reads 
aligned unambiguously to exons were considered for RNA-seq analysis (Table S5). Upon 
trr knockdown, 613 genes were differentially expressed compared to controls (p-adj < 0.05, 
fold change > 1.5), with 341 genes downregulated, and 272 genes up regulated (Figure 4A, 
Table S6). GO enrichment analysis of the differentially expressed genes in trr knockdown 
heads revealed mainly terms related to metabolism (Figure 4B). In G9a null mutant heads, 
1123 genes were differentially expressed compared to controls (p-adj < 0.05, fold change > 
1.5), with 796 genes downregulated and 327 genes upregulated (Figure 4C, Table S7). These 
differentially expressed genes shared a striking overlap in GO enrichment when compared 
to differentially expressed genes in trr knockdown heads. In fact, 4 of the 6 GO terms that 
were enriched upon trr knockdown were also enriched in the analysis of G9a mutant heads 
(overlapping GO terms in bold, Figure 4B and D), including “gluconeogenesis”, “steroid 
metabolic processes”, “fatty acid beta oxidation”, and “respiratory electron transport chain”.
 In addition to the overlapping enriched GO terms, we identified 119 differentially 
expressed genes represented in both mutant conditions (Figure 4E-F). This overlap is 
significantly larger than expected by random chance (p < 6.4*10-23, fold change = 2.7, 
hypergeometric test) (Figure 4E). GO enrichment analysis of these 119 genes again revealed 
an nearly identical set of enriched GO terms, with 9 of the 11 enriched terms represented 
in the analysis of all genes dysregulated in G9a and trr mutant conditions (overlapping GO 
terms in bold, Figure 4F). The striking overlap of specific GO terms associated with genes 
that are differentially expressed upon loss of trr and G9a suggest a high level of functional 
convergence between the two proteins.
Of the 119 commonly mis-regulated genes identified in G9a mutants and 
trr knockdown flies 5 genes were upregulated in both conditions, while 47 genes were 
downregulated in both conditions; 18 genes were upregualted in G9a and downregualted 
in trr, while 49 genes were downregulated in G9a and upregualted in trr (Table S8). 
Although this distribution is not fully random, there is no clear pattern. The significant 
enrichment observed in the majority of the categories suggests that many of the common 
differentially expressed genes may result from indirect regulation. Notably, only five of the 
overlapping genomic targets (Figure 3E, 1047 genes) are also found to be differentially 
expressed (Figure 4E, 119 genes). These five genes - PCB, mTTF, Acer, Reg-2, and Arc1 -
represent potential common direct targets of G9a and trr that could act as hub genes to
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account for the high degree of biological convergence among secondary targets (Table 
S9, see discussion).
 To further explore the origin of the biological convergence of differentially 
expressed genes in trr RNAi and G9a mutant heads, we classified these genes into 
“potentially direct” and “potentially indirect” targets. Potentially direct targets for trr, a 
transcriptional activator, were defined as genes with an associated trr binding site that were 
down regulated in trr RNAi flies. Of 341 downregulated genes, 47 fulfill these criteria. For 
G9a, direct targets were defined as genes with an associated loss of H3K9me2 (a repressive 
modification) in G9a mutants (as defined in Kramer et al. [18]) that were up regulated in G9a 
mutant heads. Of the 327 genes upregulated in G9a mutant heads, 84 were identified as 
potential direct G9a targets using these criteria. GO enrichment analysis of predicted direct 
targets revealed metabolic terms and several terms relevant to learning and memory, such 
as “sensory perception” and “cellular calcium ion homeostasis” (Figure S2). However, no 
overlap in enriched GO terms was observed among the potentially direct target gene lists 
of trr and G9a. In contrast, GO enrichment analysis of predicted indirect targets (Figure S2) 
was nearly identical to that observed when all differentially expressed genes were analyzed 
(Figure 4) and the overlap of specific terms between G9a and trr datasets was even 
stronger (5 of the 6 GO terms that were enriched upon trr knockdown were also enriched 
in the analysis of G9a mutant heads) (Figure S2). Taken together, this analysis suggests 
that most of the biological convergence between dysregulated transcriptomes in trr and 
G9a mutant conditions happens via indirect regulation. This convergence could result 
from misregulation of a limited number of common direct targets, or by misregulation of 
different direct target genes that act in common biological pathways.
In summary, whole-transcriptome analysis revealed a large and significant overlap 
between genes and biological pathways that are differentially expressed upon loss of trr 
and G9a, suggesting functional convergence between these two proteins in the fly brain. 
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Figure 4: Differentially expressed genes in trr and G9a mutants show a strong biological overlap.
 (A,C) Scatter plots showing Log2 fold changes plotted against the Log2 normalized expression. Significantly up- 
and downregulated genes (p-adj < 0.05, FC > 1.5) are represented by red and blue dots respectively in the G9a (A) 
and trr (C) mutant. (B,D,F) Enriched gene ontology terms identified using the Panther software (GO-slim setting) 
for differentially expressed genes. The –log10 transformation of p-values is indicated by black bars (lower x-axis). 
Grey bars (upper x-axis) indicate enrichment. Bold gene ontology terms indicate the overlap between the terms. 
GO terms are indicated for Trr (B) and G9a mutant heads (D). (E) Venn Diagram showing the overlap of differential 
expressed genes between the two mutant conditions. The overlap of 119 is significantly more than expected 
by random chance, based on a hypergeometric test (p-value = 6.4*10-23 and 2.7 times enriched). (F) GO term 
enrichment of the overlapping genes between trr- and G9a differentially expressed genes. 
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Discussion
Dynamic regulation of gene expression is essential for brain development and function. To 
date, at least 68 genes encoding chromatin regulating proteins have been implicated in the 
etiology of ID [38-40]. It is possible that disruption of chromatin related biological networks 
through mutations in different genes results in an overlapping phenotypic spectrum in the 
corresponding disorders. Indeed, several chromatin-related disorders, such as Pitt-Hopkins 
syndrome, Smith-Magenis syndrome, Rett syndrome, MBD5 deletion/duplication, and 
Angelman syndrome, have a clear clinical overlap characterized by ID/ASD and additional 
behavioral and neurological problems [7, 8]. Here, we describe five patients with de novo 
heterozygous loss of function mutations in KMT2C, and demonstrate a clinical overlap with 
this group of ID/ASD disorders (Figure 1, Table 1). In Drosophila, we demonstrate molecular 
convergence between trr, the KMT2C/D ortholog, and G9a, the ortholog of EHMT1, which 
is involved in Kleefstra syndrome. The observed clinical and molecular convergence 
between the KMT2 and EHMT protein families suggests that they are important players in 
an overlapping gene regulatory network that is critical for normal neuronal development 
and function. 
KMT2 and EHMT histone methyltransferase families converge in the 
regulation of adult brain function
An increasing body of evidence suggests that chromatin modifiers contribute to gene 
regulatory networks that are important for complex brain processes like learning and 
memory. The molecular activity and protein interaction partners of trr have been well 
described, but only for early developmental stages and in cultured S2 cells [14, 25, 28]. Using 
conditional knockdown we showed that trr is required in post-mitotic MB neurons for normal 
short term courtship memory (Figure 2L). We did not observe any gross morphological 
defects in the MB upon trr knockdown (Figure 2I and 2J), and although we cannot rule 
out a subtle role for trr in MB morphogenesis, this suggests that trr may regulate behaviour 
and memory through a role in the post-developmental functioning of adult MB neurons. 
One key interaction partner for trr is the ecdysone receptor (EcR), a nuclear hormone 
receptor that binds to 20-hydroxyecdysone and requires trr-mediated H3K4me3 for optimal 
gene activation [14]. 20-hydroxyecdysone is actively synthesized in response to courtship 
conditioning and is required for long term courtship memory [41], supporting the idea that 
trr may be involved in the acute regulation of adult brain function through its role in EcR-
mediated transcription. Indeed, thirteen known ecdysone responsive genes were identified 
in our trr genomic binding sites (Table S2), consistent with the known trr-EcR interaction. 
Drosophila G9a is also required in adult neurons for normal courtship memory [18], and the 
mouse G9a orthologs, Ehmt1 and Ehmt2, have been implicated in postnatal regulation of 
Koemans.indd   79 10-1-2018   12:25:09
80
Chapter 3
fear memory [24]. Interestingly, the specific histone modifications that are deposited by 
the EHMT and KMT2 protein families (H3K9me2 and H3K4me3, respectively), are among 
the very few forms of histone methylation that are dynamically regulated in the rat brain 
in response to fear conditioning [42, 43]. Together, the evidence points towards a role for 
the EHMT and KMT2 families in adult brain plasticity, through active regulation of histone 
modifications and gene expression.
Molecular convergence of Drosophila G9a and trr
Here, we describe a high level of convergence in genes that are differentially expressed in 
trr and G9a mutant fly heads (Figure 4E). Although this overlap is significantly more than 
expected by random chance, the match at the level of biological processes is even more 
striking a nearly perfect overlap in the enriched GO terms between the two independent 
mutant conditions (bold GO-terms in Figure 4B and 4D). This suggests that trr and 
G9a may regulate; (1) distinct gene sets that operate in similar biological pathways, and /
or (2) a limited number of joint key target genes that influence these pathways. In total, 
we observed five potential hub genes that are differentially expressed in both mutant 
conditions and identified in ChIP experiments as potential direct targets for both G9a and trr 
(Table S9). Two of these genes, pyruvate carboxylase (PCB), and mitochondrial transcription 
termination factor (mTTF), have a clear link to mitochondrial metabolism [44, 45], therefore, 
their misregulation could affect aspects of metabolism that are reflected in the GO terms 
associated with the differentially expressed genes in trr and G9a mutant heads (Figure 4). 
Loss of function mutations in PCB give raise to several disorders that include developmental 
delay, ID and seizures, and its misregulation may thus contribute to manifestation of these 
features in EHMT1 and KMT2C patients.
 Interestingly, four of the five potential hub genes (Reg-2, ACER, PCB, and Arc-1) have 
a direct or indirect link to memory formation. Reg-2 and ACER are both linked to circadian 
rhythm [46, 47], which is known to be important for memory formation (reviewed in [48, 
49]). The metabolic protein PCB has been linked to age-induced memory impairment due 
to the cumulative damaging effect of metabolic free radicals in the aging brain [44]. Arc-1 
is the ortholog of mammalian Arc (activity regulated cytoskeletal protein), an immediate 
early gene that is activated in response to neuronal activity associated with learning and 
memory [50]. Arc is localized at the postsynaptic density and regulates many forms of 
synaptic plasticity including LTP, LTD and homeostatic synapse scaling [51]. A recent study 
has implicated mouse Ehmt1 in repression of Arc transcription in response to homeostatic 
synaptic scaling [52]. Arc was predicted to be indirectly regulated by Ehmt1 based on a 
lack of differential dimethylation of H3K9 at the Arc promoter [52]. Our data suggests that 
Drosophila G9a deposits H3K9me2 at the 3-prime end of Arc-1 [18], which has not been 
tested in mouse. Although, this might reflect a differential mechanism of gene regulation 
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between Drosophila and mammals, it appears that Arc and Arc-1 represent an evolutionarily 
conserved target for EHMT proteins. Having identified Arc-1 as a trr target gene in Drosophila, 
it will be interesting to see if this evolutionary relationship also holds true for KMT2 proteins.
 It is possible that direct misregulation of specific genes, like Arc-1, may underlie 
cognitive defects in human and Drosophila with mutations in KMT2 and EHMT genes. 
However, our analysis of candidate genomic target genes in Drosophila revealed hundreds 
of other genes that may be involved. At the level of genomic targets, we observed more 
than 1000 genes that are potentially regulated by both G9a and trr. These genes show a 
strong enrichment for neuronal GO terms, such as “synapse assembly”, “brain development”, 
and “cognition” (Table S4). Notably, “negative regulation of Ras protein signaling”, the 
most enriched GO-term (Figure 3F), is linked directly to a subset of ID disorders known as 
RASopathies [37]. However, the relevance of these targets remains in question as we do 
not observe differential expression for most of these genes in G9a and trr mutant fly heads, 
at least in the steady state conditions examined here. This, however, does not exclude the 
possibility that the histone modifications mediated by trr and G9a, may poise these genes for 
transcriptional activation. It is possible that trr- or EHMT-mediated regulation is only relevant 
in specific cells or in response to certain stimuli, such as the formation or retrieval of memory. 
Such activity-dependent or cell-specific gene expression mechanisms are likely to escape 
detection in our analyses in which steady-state expression is determined in whole heads. 
Clinical convergence in chromatin-related ID disorders
The investigation into the molecular convergence between EMHT and KMT2 proteins 
in this study was motivated by the identification of an overlapping clinical phenotype 
resulting from mutations in these genes. This convergence likely goes beyond EHMT1/
G9a and KMT2C/trr. Apart from KMT2C/trr, mutations in additional components of the 
well-defined COMPASS protein complex, including the KMT2C paralog KMT2D, and the 
histone demethylase KDM6A, are causative for Kabuki syndrome, another ID disorder which 
shares autistic behavior and developmental delay with Kleefstra syndrome and the patients 
described here [8]. Molecular and clinical convergence has also been demonstrated 
between Pitt-Hopkins syndrome (causative gene TCF4) and Kleefstra syndrome [8, 53]. 
Further fundamental research will likely reveal additional molecular connections between 
genes that are mutated in other ID/ASD disorders showing clinical overlap with KMT2C 
halpoinsufficiency. Promising candidates to be involved in a common molecular network 
include TCF4 [54], RAI1 [55], MECP2 [56], MBD5 [57, 58], KMT2D [59], UBE3A [60], which are 
all ID genes encoding proteins involved in gene regulation. Expanding our knowledge of 
these molecular networks may help to understand pathways underlying ID/ASD that could 
be exploited in the development of therapies for genetically distinct but clinically related 
disorders.
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Materials and Methods 
Identification and prioritization of variants
Individuals 1-4 had unexplained ID or developmental delay and were ascertained through 
family-based whole exome sequencing in a diagnostic setting in the Department of Human 
Genetics at Radboudumc and MaastrichtUMC. Exome sequencing and data analysis were 
performed as previously described in the probands and their unaffected parents [29]. 
Individual 5 was ascertained during a clinical genetic workup due to failure to thrive and 
lack of expected normal childhood development at Children’s Hospital Colorado (Aurora, 
Colorado). Chromosomal microarray analysis for individual 5 was performed using both 
copy number and single-nucleotide polymorphism (SNP) probes on a whole genome array 
(CytoScan HD platform; Affymetrix, Santa Clara, CA). The KMT2C deletion was confirmed 
to be de novo by parental microarray testing. Additionally, this deletion was confirmed 
using locus-specific qPCR. The primer pairs used were directed to KMT2C and two adjacent 
negative control regions (Table S10). All data were analyzed and reported using the 
February 2009 (hg19) human genome build. 
 Although all individuals harbored de novo loss of function mutations in KMT2C 
(Figure 1A), exome results revealed that individual 1 and 2 carry one or two additional de 
novo mutations that do not appear to be related to the core phenotype of the individuals 
presented here. Individual 1 carried a second de novo truncating mutation in PHF21A, which 
is located in the 11p11.2 contiguous gene deletion syndrome named Potocki-Shaffer 
syndrome, PSS (OMIM #601224) [61, 62]. Three individuals with translocation breakpoints 
through PHF21A were reported previously and it was concluded that this gene was 
associated with the PSS. However, no intragenic loss of function mutations are reported in 
association with this syndrome so far. The mutation in individual 1 is present in the last exon 
of the gene and is therefore not subjected to nonsense mediated RNA decay, however it is 
possible that this variant may contribute to the phenotype observed in this patient.  
 In individual 2 we found the KMT2C change c.7550C>G (p.Ser2517*) in mosaic 
in blood. Individual 2 carries two additional de novo missense mutations in C11orf35 
(p.Pro602Leu) and UBR5 (p.Arg1907His). Protein function or mutations associated with other 
diseases for C11orf35 are not known and thus we cannot rule out this variant to the patient 
phenotype. With respect to UBR5, the same mutation has been previously described in a 
family with adult myoclonic epilepsy [63], but that family was not associated with ID/Neuro 
Developmental Delay. The missense change in UBR5 individual 2 is therefore unlikely to 
cause his ID and autism. Moreover, no epilepsy is present in this individual at age 10.
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Fly stocks and genetics
Flies were reared on standard cornmeal-agar media at 25°C on a light/dark cycle of 12h/12h 
in 50% or 70% humidity. The following stocks were obtained from Bloomington Drosophila 
Stock Center: UAS-trr-RNAi generated by the Transgenic RNAi Project (TRiP) (stock #36916: 
y1 sc*v1;P{TRiP.HMS01019}attP2), UAS-mCD8::GFP (Stock #5137: y [1] w [*]; P{w [+mC]=UAS-
mCD8::GFP.L}LL5, P{UAS-mCD8::GFP.L}2), UAS-mCherry-RNAi (stock #35785: y [1] sc [*] v [1]; 
P{y [+t7.7] v [+t1.8]=VALIUM20-mCherry}attP2), Elav-Gal4; UAS-dicer2 (stock #25750: P{w 
[+mW.hs] = GawB}elav [C155] w [1118]; P{w [+mC] = UAS-Dcr-2.D}2), and R14H06-Gal4 (stock 
#48667: P{GMR14H06-GAL4}fattP2) [33]. G9aDD1 mutants and the precise excision control 
were generated previously [18]. To study the effects of trr down regulation, the UAS/Gal4 
system was used with UAS-trr-RNAi combined with pan-neuronal (elav-Gal4) or mushroom 
body (MB) specific (R14H06-Gal4) Gal4 driver lines. For all trr knockdown experiments, 
genetic control animals without the RNAi hairpin were generated using the (AttP2) genetic 
background control strain (Bloomington #36303) or the mCherry-RNAi strain (Bloomington 
#35785). For trr ChIP-seq experiments, a Nijmegen wild type strain was used. 
Imaging of mushroom bodies and immunohistochemistry
R14H06-Gal4 combined with UAS-mCD8::GFP was used to visualize the calyx region of 
the Drosophila MB in controls and trr knockdown flies. The following genotypes were 
analyzed: UAS-mCD8::GFP/+;R14H06-Gal4/UAS-trr-RNAi (trr knockdown) and UAS-
mCD8::GFP/+;R14H06-Gal4/+ (control). Adult brains were dissected in PBS (pH 7.2) and 
fixed with ice cold methanol for 2 minutes, washed three times with PBS for 5 minutes each 
and permeabilized in PBS with 0.3% Triton-X 100 (PBT) for 1 hour. Fixed and permeabilized 
brains were blocked (5% normal goat serum (NGS)) at room temperature for 2 hours and 
incubated in 300nM DAPI solution for three minutes, followed by three five minute washes 
in PBT. Next, brains were incubated with the primary antibody (rabbit anti-trr [24], 1:5000) in 
PBT with 5% NGS for 72 hour at 4°C followed by five 20 minute washes in PBT. Brains were 
incubated with the secondary antibody (goat anti-rabbit Alexa Fluor 568, 1:250; Invitrogen) 
for 48 hour in PBT with 5% NGS at 4°C and washed at room temperature in PBT five times 
for 20 minutes. Brains were mounted in Vectashield (Vector Laboratories) and imaged on a 
confocal microscope (Zeiss LSM 510 duo vario confocal microscope). Confocal stacks were 
processed using ImageJ software [64].
Courtship Conditioning Assay
Courtship conditioning assays were performed on 5-day-old males raised at 25 °C, 70% 
humidity, and a 12h day/night rhythm as previously described [18, 35]. The following 
genotypes were analyzed: R14H06-Gal4/UAS-mCherry-RNAi (control) and R14H06-Gal4/
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UAS-trr-RNAi (trr-RNAi). These genotypes were generated by crossing females containing 
the trr-RNAi or mCherry-RNAi inserted into the TRiP attP2 genetic background (genotypes: 
trr RNAi - y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.HMS01019}, mCherry RNAi - y[1] sc[*] 
v[1]; P{y[+t7.7] v[+t1.8]=VALIUM20-mCherry}attP2), with identical males containing the 
Gal4 driver (genotype: P{GMR14H06-GAL4}fattP2. Males were randomly assigned to 
either trained (n
control
 = 59, n
trr-RNAi
= 62) or naïve (n
control
 =56, n
trr-RNAi
 = 60) groups. Training 
was performed by pairing individual males in with 5-day-old mated wild type females. All 
experiments were conducted with a one-hour training period, and tested after a one-hour 
isolation period. For each fly pair, a courtship index (CI) was calculated as the percentage of 
a 10 minute time period spent courting. Courtship behaviour was manually quantified by 
observing videos for all 237 fly pairs analyzed in this study. Quantification was performed by 
trained observers that were naïve to the nature of the experiment. Comparisons of average 
CI between naïve and trained groups of the same genotype were calculated using a Mann-
Whitney test. A learning index (LI = (CInaive-CItrained)/CInaive) was calculated to compare 
courtship memory between genotypes. Statistical comparisons between genotypes were 
conducted using a randomization test [65] with a custom bootstrapping script created in R 
(10,000 replicates) (chapter 2). 
ChIP-seq and identification of trr binding sites
Chip was performed using an antibody directed against trr [14, 34]. This antibody was 
originally validated by the lack of staining in trr homozygous null mutant embryos [14]. 
Additionally, this antibody shows complete lack of signal in mutant clones of the Drosophila 
salivary gland, and has been used for ChIP experiments showing very specific trr binding 
patterns at EcR response genes during ecdysone-mediated developmental transitions [34]. 
Here, we provide additional evidence for specificitiy of this antibody by showing reduced 
immunofluorescent staining in mushroom body target cells expressing a trr-RNAi construct 
(Figure 2). 
 Chromatin was extracted from 50 µL aliquots of frozen wildtype fly heads, 
aged between 0 and 5 days old, in biological duplicates. Fly heads were crushed in PBS 
(Sigma) and crosslinked with formaldehyde (Sigma) at a final concentration of 1% for 30 
minutes. Crosslinking was terminated using glycine (Invitrogen) at a final concentration of 
125mM and crosslinked material was immediately washed twice in PBS and centrifuged 
at 13000rpm, for 15 minutes at 4 degrees. The pellet was resuspended in buffer 1 (15 mM 
Tris-HCl (pH 7.5), 60 mM KCl, 15 mM NaCl, 1 mM EDTA, 0.1 mM EGTA, 0.15 mM spermine, 0.5 
mM spermidine, 0.1 mM sucrose) and the solution was homogenized using a QiaShredder 
column (Qiagen). Cells were lysed using buffer 1 supplemented by 2% triton-X-100 (Sigma) 
and a crude nuclear extract was collected by centrifugation (6000 rpm, 10 minutes at 4 
degrees). Nuclei were re-suspended in incubation buffer (0.15% SDS, 1% triton x-100, 150 
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mM NaCl, 1 mM EDTA, 0.5 mM EGTA, 10 mM Tris) supplemented with 0.1% BSA (Sigma) 
and 1x protease inhibitor (Roche) and subjected to sonication (Diagenode Bioruptor) for 
30 minutes (30 seconds on/off cycle using the “high intensity” mode), yielding average 
DNA fragments of 150-300 base pairs. Immunoprecipitation reactions were performed 
overnight in incubation buffer with 3 ng of anti-trr antibody (gift from Dr. A. Mazo [14]), 
protease inhibitor cocktail (Roche), BSA, and pre-blocked protein A/G agarose beads (Santa 
Cruz). Chromatin-antibody-bead complexes were recovered by centrifugation (4000 rpm, 
2 minutes at four degrees) and washed twice with low salt buffer (0.1% SDS, 1% Triton, 2 
mM EDTA, 20 mM Tris pH 8, 150 mM NaCl), once with high salt buffer (0.1% SDS, 1% Triton, 
2 mM EDTA, 20 mM Tris pH 8, 500 mM NaCl), once with LiCl wash buffer (10 mM Tris pH 
8.0, 1% Na-deoxycholate, 1% NP-40, 250 mM LiCl, 1 mM EDTA) and twice with TE buffer. 
Chromatin was eluted in 1% SDS, 0.1M NaHCO3, 200 mM NaCl and de-crosslinked at 65° 
Celsius (C) for four hours. DNA was purified by phenol/chloroform extraction and ethanol 
precipitated using linear acrylamide (Ambion) and sodium acetate at -20 degrees. Library 
preparation for Illumina sequencing was performed using the Truseq DNA sample prep 
kit V2 (Illumina) with approximately 3 ng of starting DNA 15 PCR cycles for amplification. 
Library fragment size was assessed using the 2100 Agilent Bioanalyser and was shown 
to be between 200 and 400 bp. Cluster generation and sequencing-by-synthesis (50bp) 
was performed using the Illumina Hiseq 2000 according to standard protocols of the 
manufacturer. The image files generated by the HiSeq were processed to extract DNA 
sequence data. The raw sequence data from this study are available at the NCBI Gene 
Expression omnibus series (accession number GSE89459). We obtained between 30 and 54 
million reads per sample. Reads were mapped to the Drosophila genome (BDGP R5/dm3) 
using the Burrows Wheeler Aligner (BWA, version 0.6.1) with standard settings allowing 1 
mismatch [66]. Total alignment efficiency was more than 95%. Duplicate reads and reads 
with a mapping quality score (MAPQ) below 15 were excluded from downstream analysis 
(Table S1). For each biological replicate, trr binding sites were identified using MACS2 
[36] with input DNA as control (Table S1). Bindings sites on chromosome U, Uextra and 
mitochondrial genome were not used for further analysis. Remaining putative trr binding 
regions were visualized in a heatmap that was sorted based on k-means clustering of read 
intensity around the centre of the peak using the python script fluff_heatmap.py (https://
github.com/simonvh/fluff ) (Figure S3A). Individual clusters were examined visually in the 
genome browser to assess the quality of the peaks within the clusters. Two clusters (8 and 
15) of replicate 1 were identified that contained many false positive peaks with a relatively 
small binding region and cluster 15 had very few reads around the centre. Peaks within 
these clusters were removed from downstream analysis. For trr_rep2 all clusters appeared 
to represent high quality trr binding sites. Trr binding regions from both biological replicates 
were merged and concatenated and the number of reads present in these regions were 
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counted in each sample individually using HTSeq [67] and normalized to library size. The 
ratio and mean of reads in each binding region was calculated between the two biological 
duplicates to identify trr binding sites that were consistent between the two biological 
replicates. We included all binding sites with a mean number of reads > 100 and < 2 fold 
difference in normalized read count between the two biological replicates (Figure S3B). 
Using these criteria we identified 3371 predicted trr binding regions, which appeared to 
be very consistent upon visual inspection in the UCSC genome browser (Figure S3D). 
These predicted trr binding sites were allocated to the nearest genomic feature using the 
pearl script annotatePeaks.pl [68] with standard settings. In order to find out if detected 
binding sites of trr are overrepresented in any genomic regions, we compared trr binding 
sites to an equal set of randomly selected genomic positions using https://www.random.
org/ (Figure 3B). The average trr occupancy profile over all transcription start sites (Figure 
3C) was calculated using ensemble annotations from release 84 [69] with read count data 
generated by HTseq-count [67] in 50-bp bins spanning all transcription start sites. 
 To validate the ChIP-seq data, independent ChIP reactions were performed as 
described above and tested by qPCR. Validation targets were selected based on ChIP-
seq data with representative binding regions on the promoters of mor, lis-1, Atg9, Hsc70-
4, Socs36e, Tsp42ed, smid and med21. Additionally, we selected two trr-negative regions in 
the promoters of drm99B and CG1646 (Table S10). All primers were tested and approved 
for amplification efficiency according to standard methods. qPCR was performed on the 
ChIPed and input samples using SYBRgreen master mix (Promega) and the 7900HT Fast 
Real Time PCR system (Applied biosystems) according to the manufacturer’s instructions. 
Fold enrichments per target were calculated using the mean of the percent input of the 
two negative regions relative to the positive region. Mean fold enrichments are plotted 
with standard error of the mean as error bars (Figure S3C). All regions tested confirmed the 
ChIP-seq results. In addition we compared our trr ChIP-seq targets to published trr ChIP-seq 
data from cultured Drosophila S2 cells that was obtained using a different trr antibody [25]. 
In S2 cells, 1482 genes were identified with a trr peak at the promoter [25]. 943 of these 
genes were also identified as trr targets in this study. This is a very high overlap considering 
the vastly different starting material (cultured S2 cells versus fly heads), suggesting a high 
degree of concordance between the two antibodies. 
Transcriptional profiling 
Mutant and control lines for trr and G9a were aged between 1 and 5 days and snap frozen 
in liquid nitrogen. Frozen fly heads were harvested by vortexing and separated from other 
body parts through a series of standard laboratory sieves. Total RNA was extracted from 
50 µL aliquots of frozen fly heads using the RNAeasy lipid tissue mini kit (Qiagen). For trr 
knockdown, two biological replicates were used, for G9a mutants, three biological replicates 
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were used for each condition. mRNA was purified using the Oligotex kit (Qiagen) and cDNA 
was synthesized using the SuperScript III First Strand synthesis kit (Thermo Fisher) using 
random hexamers as primers. Second strand cDNA was synthesized using E. Coli polymerase 
and T4 ligase (New England Biolabs Inc. (NEB)). Remaining RNA was removed using 2 units 
RNaseH (NEB) before the cDNA was purified using the MinElute PCR purification kit (Qiagen). 
DNA end repair was performed followed by ligation of Illumina sequencing adaptors and 
size selection for 300 bp by 2% E-gel (Invitrogen). Fragments were linearly amplified (15 PCR 
cycles), as validated by quantitative real-time PCR (qPCR), and sample quality was assessed 
using the Agilent Bioanalyser 2100. Cluster generation and sequencing-by-synthesis (36bp) 
was performed using the Illumina Genome Analyser IIx (GAIIx) according to standard 
protocols of the manufacturer. The image files generated by the GAIIx were processed to 
extract DNA sequence data. The raw sequence data from this study are available at the 
NCBI Gene Expression omnibus series (accession number GSE89459). From the GAIIx, we 
obtained between 27 and 35 million reads. Reads were mapped to the Drosophila genome 
(BDGP R5/dm3) using the Burrows Wheeler Aligner (BWA, version 0.6.1) with standard 
settings allowing 1 mismatch [66]. Only the uniquely mapped reads were used for further 
analysis and total alignment efficiency was between 63% and 79% for G9a samples and 
between 79% and 81% for trr samples (Table S5). Total read count data was generated 
by the python script HTSeq-count (http://www-huber.embl.de/HTSeq/doc/overview.html) 
with gene annotations extracted from the file Drosophila_melanogaster.BDGP5.75.gtf, 
available at http://www ensembl.org. In all samples, over 96% of aligned reads, mapped 
unambiguously to exons. The unambiguously mapped reads, ranging from 18 to 25 million 
reads for G9a samples and from 26 to 28 million reads for trr samples, were used for further 
analysis of differential gene expression by DeSeq2 [70]. Hierarchical clustering based on 
Euclidean distances with Pearson correlation using the normalized expression values and 
variance stabilizing transformation, revealing a high degree of similarity between biological 
replicates (Figure S4A and S4C). In order to perform statistical comparisons, dispersion 
values were estimated using the DESEQ method. As expected, we observed a high degree 
of correlation between gene expression and dispersion values with decreasing dispersion 
upon increasing expression patterns (Figure S4B and S4D). We then used DESeq2 to 
identify genes that are differentially expressed in mutant fly heads based on negative 
binominal distribution (adjusted p-value < 0.05, fold change > 1.5, Figure 4A and C, Table 
S6 and S7). 
 Validation of trr knockdown was performed using using SYBRgreen master mix 
(Promega) and the 7900HT Fast Real Time PCR system (Applied Biosystems) according 
to the manufacturer’s instructions on a new biological replicate cDNA (described above) 
performed in triplicate technical replicates. Beta-cop and RP49 were used as reference 
genes for normalization and calculation of fold change differences upon pan-neuronal 
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knockdown in fly heads using the ΔΔ Ct procedure (Figure S1). All RT-qPCR primers (Table 
S10) are validated for amplification efficiency according to standard procedures.
Gene Ontology enrichment and hypergeometric analysis 
Gene Ontology (GO) enrichment analysis was performed using the Panther software version 
11.1 [52] on http://geneontology.org/ (GO Ontology database released on 2015-08-06 and 
2016-10-24) using the GO-SLIM function for GO enrichment datasets that showed a high 
degree of redundancy (Figure 4 and Figure S2). For GO enrichment analysis of differential 
gene expression, list was used with genes expressed in fly heads as background control. 
This list was generated by exclusion of 4579 genes that had less than 10 reads, leaving 
11103 genes. Overlap between datasets was determined and visualized as a Venn diagram 
by BioVenn [71] (Figure 3E and 4E). Hypergeometric statistics on overlaps were calculated 
using https://www.geneprof.org/GeneProf/tools/hypergeometric.jsp.
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Supporting information 
 
Figure S1: Pan-neuronal knockdown of trr in fly heads. 
Knockdown as determined by RT-qPCR. Error bar represents standard deviation of mean knockdown relative to 
two reference genes. 
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Figure S2: GO enrichment analysis of “potential direct” and “potential indirect” trr and G9a target 
genes. 
(A-D) All enriched gene ontology (GO) terms identified using the Panther software (GO-slim setting) for 
potential direct trr (A) and G9a (B) target genes, and potential indirect and trr (C) and G9a (D) targets. Panther 
overrepresentation test from GO ontology database version 11.1 (released 2016-10-24). The reference list is a set of 
11103 genes that show expression in our RNA-seq datasets (see materials and methods). 
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Figure S3: Filter criteria and 
validation of trr ChIP-seq. 
(A) Flow chart describing the filtering 
steps for trr ChIP-seq starting with 
called peaks by MACS2 are quality 
assed by the python script fluff_
heatmap.py (kmeans clustering). 
Regions of approved peaks are 
merged and concatenated and the 
number of reads are counted in 
each replicate individually. Average 
number of reads per peak in each 
replicate relative to the ratio of 
reads between replicates is plotted 
(B) and further quality assessed by 
visual inspection of the wiggle file 
in the genome browser. Black dots 
represents the 3371 high confident 
peaks with mean number of reads 
> 100 and ratio < 2 fold the number 
of reads in the replicate suggesting 
similar binding affinity (height). (C) 
Bar graph of ChIP-qPCR validation 
of targets identified by ChIP-seq 
are enriched over negative regions 
relative to the input. Error bars 
represent the standard error of the 
mean. (D) screenshot of the UCSC 
genome browser from two trr ChIP-
seq replicates and input control at 
genomic loci identified as binding 
positions.
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Figure S4: Validation of differential gene expression analysis.
(A,C) Dendrogram and heat map illustrating euclidean distances and Pearson correlation between samples of 
G9a- (A) and trr mutant (C). (B,D) Scatter plot showing dispersion estimates as determined using DESeq2, plotted 
against the mean of normalized reads for EMHT (B) and trr (D) RNA-seq datasets (black dots - gene-wise maximum-
likelihood estimates, red dots - fitted values, blue dots - final dispersion. Genes with dispersion outliers were not 
used for further analysis. Note the decreasing dispersion values as the gene expression increases.
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Supplemental tables 
(available upon request)
Table S1: ChIP-seq depth, alignment, mapping efficiency and MACS2 settings. Total 
number of reads, and the percentage aligned reads are shown. Next, the percentage of 
aligned reads to unambiguous places relative to total aligned reads and the percentage of 
reads with MAPQ scores higher than 15 are shown. Lastly, the total number of high quality 
reads that was used for analysis is shown.
Table S2: Annotation of trr ChIP-seq peaks to nearest genomic feature using HOMER 
software (Raw data to Figure 3A).
Table S3: Gene ontology analysis of trr promoter associated genes (Raw data to Figure 3D).
Gene Ontology analysis for trr associated genes. PANTHER overrepresentation test (release 
20150430) from GO ontology database (released 2015-08-06). As reference list is all genes 
in database used.
Table S4: Gene ontology analysis of trr and H3K9me2 LOMB associated genes in the G9a 
mutant (Raw data to Figure 3F).
Gene Ontology analysis for genes associated with a trr binding site and a H3K9me2 LOMB. 
PANTHER overrepresentation test (release 20150430) from GO ontology database (released 
2015-08-06). As reference list is all genes in database used.
Table S5: RNA-seq depth. Alignment and mapping efficiency of trr- and G9a mutant 
samples. Shown are the total number of reads, and the percentage aligned. Next, the 
percentage of aligned reads relative to the total number of aligned reads and unambiguous 
mapped reads are shown. Lastly, the total number of high quality reads that was used for 
analysis is shown.
Table S6: Differential expressed genes in trr mutant (Raw data to Figure 4A).
All genes with altered expression in trr knockdown versus wildtype.
Table S7: Differential expressed genes in G9a mutant (Raw data to Figure 4C).
All genes with altered expression in G9a knockout versus wildtype.
Table S8: Statistical analysis of up and down regulated genes that are differentially expressed 
genes in both trr and G9a mutant fly heads.
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Table S9: Gene ontology annotations for the five potential direct targets of both G9a and 
trr.
Table S10: List of primers used in this study.
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Abstract
Kleefstra syndrome (KlS) and Kabuki syndrome (KaS) are rare intellectual disability (ID) 
disorders with unique characteristics. However, both syndromes also harbor common 
phenotypes such as ID, hypotonia, developmental delay, seizures and autism-like 
behaviour. Mutations in EHMT1 and KMT2D are causative for KlS and KaS respectively, 
which encode broadly expressed histone H3 methyltransferases. Mutations in the genes 
encoding these enzymes are predicted to affect the epigenetic landscape in a variety of 
tissues. To investigate this, we analyzed the peripheral blood transcriptome of affected 
individuals. Comparison of genome wide mRNA expression profiles of five KlS, five KaS and 
five healthy control individuals revealed 595 differentially expressed genes in KlS patients 
and 1318 in KaS patients (1.5 fold change, p-value < 0.05). Strikingly, a significant overlap 
was observed between the identified misregulated genes of both syndromes. The direction 
(up- or downregulated) of these commonly misregulated genes was nearly identical. Gene 
ontology terms describing the misregulated genes were generated and revealed “cell-cell 
adhesion”, “signaling” and “regulation of neuron differentiation” for KlS. For KaS, “nervous 
system development”, “neurogenesis”, and “signaling” were identified. When comparing all 
gene ontology terms, another striking overlap was observed between both disease entities 
on the functional level. Common terms include “central nervous system development”, 
“brain development”, and “cell surface signaling pathway”. Taken together, these results 
support a shared etiology between KlS and KaS. 
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Introduction
Epigenetic control of developmental processes is a cellular mechanism by which spatial 
and temporal expression of distinct genes and pathways are regulated. Mutations in genes 
coding for epigenetic factors have been attributed to cause several syndromic disorders 
characterized by intellectual disability (ID) [1-3]. Kleefstra Syndrome (OMIM#610253, KlS) is 
one such disease caused by haploinsufficiency of euchromatin histone methyl transferase 1 
(EHMT1) [4, 5]. EHMT1 is involved in the mono- and dimethylation of histone H3 lysine (K) 
9 [6-9]. KlS patients are characterized by ID, childhood hypotonia and facial characteristics 
[5, 10]. Additionally, other clinical features are described such as autism spectrum disorder, 
micro/brachycephaly, heart defects, seizures and difficulties in adaptive behaviour [11, 
12]. Recently, additional mutations have been described in four genes (MBD5, KMT2C, 
SMARCB1, NR1I3) in individuals with Kleefstra syndrome phenotypic spectrum (KSS)[13]. 
Genetic interaction studies and protein-protein interactions between the KSS associated 
genes identified an epigenetic network underlying KlS and KSS [13]. Interestingly, a very 
strong antagonistic genetic interaction was identified between the Drosophila orthologs of 
EHMT1 and KMT2C/D, called G9a and trithorax related (trr), respectively [13]. Additionally, a 
significant proportion of G9a and trr target genes and functions are overlapping (chapter 
3) [14], suggesting that these proteins converge on similar biological processes. 
 Another example of an ID syndrome caused by mutations in an epigenetic factor is 
Kabuki syndrome (OMIM#147920, KaS) [15, 16]. Kabuki syndrome patients are characterized 
by postnatal dwarfism, distinct facial appearance, cardiac anomalies, skeletal abnormalities, 
immunological defects and mild to moderate ID [17]. Kabuki syndrome is associated with 
mutations in the histone methyltransferase KMT2D [15]. At the molecular level, KMT2D has 
been found as a component three unique protein complexes. First, KMT2D is a member of 
the complex of proteins associated with Set1 (COMPASS) which is a major contributor to 
mono- di- and trimethylation of H3K4 [18-20]. The COMPASS complex consists of several 
proteins that are conserved from yeast to human [21]. Human paralogs KMT2C and KMT2D 
are conserved as trr in Drosophila which is responsible for monomethylation of H3K4 at 
enhancer associated sites [22] and H3K4me3 in a developmental context [23, 24]. Second, 
KMT2C and KMT2D are part of the ASC-2 complex (ASCOM) [25, 26] which has been 
shown to regulate transcription by trimethylation of H3K4 [27]. Third, KMT2C and KMT2D 
have been associated with Pax transactivation domain-interacting protein (PTIP) [28]. This 
protein has been shown to be involved in the DNA damage response by interaction with 
53BP1 [29]. In addition, PTIP is associated with histone H3K4 trimethylation as part of a 
complex consisting of the structural and functional proteins PA1, ASH2L, RBBP5, WDR5, 
hDPY-30, NCOA6, KMT2C, KMT2D, and UTX [28]. The main differences between ASCOM 
and PTIP containing complexes is that hDPY-30, PA1, and UTX are only present together 
with PTIP [28, 30]. Second, α- and β-tubulins are only present in ASCOM and, third, the 
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PTIP containing complex shows more robust methyltransferase activity [28, 31]. It should be 
noted that mutations in UTX (KDM6A) are reported to cause Kabuki syndrome type 2, which 
is characterized by highly similar clinical characteristics as KaS [32]. Thus, KMT2C and KMT2D 
are associated with a large range of interaction partners and are responsible for methylation 
of H3K4. 
 Phenotypically, KlS and KaS have many overlapping characteristics such as ID, 
hypotonia, developmental delay, seizures, feeding difficulties and autism-like behaviour 
[33]. Given this clinical overlap between both syndromes, the co-occurrence of KMT2C 
(associated with KSS) and KMT2D (associated with KaS) in molecular complexes, and 
our previous studies showing a very strong genetic interaction between the Drosophila 
orthologs of EHMT1 and KMT2D [13], we reasoned that both proteins may regulate the 
expression of common genes and/or biological pathways. Here, we describe the previously 
unknown transcriptome in whole blood of KlS (EHMT1 mutations) and KaS (KMT2D 
mutations) patients. The gene ontology terms describing the function of differentially 
expressed genes are directly relevant for the human phenotype. Additionally, we show a 
significant overlap of differentially expressed genes and a striking common direction of 
these commonly misregulated genes. Lastly, we present putative protein-protein networks 
for the differentially expressed genes in KlS and KaS. Using this approach we identified 
shared differentially expressed genes that may lead to the observed common phenotype 
between Kleefstra and Kabuki syndrome. 
Results
Transcriptional changes in Kleefstra syndrome
To explore the transcriptional changes brought about by EHMT1 mutations in Kleefstra 
syndrome, we performed next generation mRNA sequencing (RNA-seq) on whole blood. 
We compared mRNA levels from five Kleefstra syndrome patients carrying an EHMT1 loss-
of-function mutation (Table 1) to five control individuals. Sequenced reads were aligned to 
the human genome and the number of unique reads mapped to each gene was quantified 
and normalized for library size. Differential gene expression was performed using DeSeq2 
[34]. We identified a high number of differential expressed genes in Kleefstra syndrome with 
595 genes misexpressed by at least 1.5-fold (p-value < 0.05) (Figure 1A, Table S1). Of these 
genes, 356 genes were upregulated and 239 genes downregulated. Of these, 11 genes 
were more than 2-fold upregulated and 22 genes were more than 2-fold downregulated. 
To provide insights into the functions of the up- and downregulated genes, we performed 
gene ontology (GO) enrichment analysis [35]. The genes that were upregulated showed 
enrichment for neuronal terms “dopamine catabolic process”, “synapse assembly” and 
“neuron differentiation” (Figure 1B, Table S2). Additionally, terms related to “behaviour”, “cell 
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adhesion”, “cardiac-, and skeletal muscle formation” are also present along with many other 
terms. Considering only downregulated genes, neuronal terms involved in “signaling” and 
“axonogenesis” are found (Figure 1C, Table S3). Notably, 16 genes from the protocadherin 
gamma subfamily were downregulated in Kleefstra syndrome patients accounting for 
the high enrichment of cell adhesion GO terms. Additionally, “negative regulation of 
circadian sleep/wake cycle, wakefulness”, “negative regulation of behavior” and “G-protein 
coupled receptor signaling pathway” are among the many associated GO terms. GO terms 
associated with all (595) misregulated genes revealed again “cell-cell adhesion”, “signaling” 
and “regulation of neuron differentiation” among the many associated GO terms (Figure 1D, 
Table S4). Taken together, GO term analysis of differentially expressed genes from whole 
blood of Kleefstra syndrome patients indentified enriched terms that strikingly describe the 
clinical phenotype. 
Figure 1: Transcriptional changes in Kleefstra syndrome. 
(A) Scatter plots showing Log2 fold changes plotted against the Log10 normalized expression in whole blood of 
Kleefstra syndrome patients. Red and blue dots indicate significant up- and downregulated genes, respectively 
(fold change > 1.5; p< 0.05 (Wald test)). Top 10 enriched gene ontology terms identified using the Panther software 
for upregulated genes (B), downregulated genes (C), and misregulated genes (D). 
0 5 10 15 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0 5 10 15 20 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
0 1 2 3 4 5 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
-2 
-1.5 
-1 
-0.5 
0 
0.5 
1 
1.5 
2 
0.01 0.1 1 10 100 1000 10000 100000 1000000 10000000 
Lo
g 
2 
(F
o
ld
 C
h
an
ge
) 
Log 2 (Base Mean) 
Differential Gene expression Kleefstra syndrome 
grey_1 
grey_2 
upregulated 
downregulated 
A B
D
-Log (p-value)
5
heart valve formation
oxygen transport
endocardial cushion development
endocardial cushion to mesenchymal 
transition involved in heart valve formation
gas transport
dopamine catabolic process
movement of cell or subcellular component
catecholamine catabolic process
epithelial to mesenchymal transition
catechol-containing compound catabolic process
homophilic cell adhesion via plasma 
membrane adhesion molecules
cell-cell adhesion
biological adhesion
multicellular organism development
developmental process
nervous system development
system development
single-organism developmental process
cell-cell adhesion 
via plasma-membrane adhesion molecules
-Log (p-value)
1 20
-Log (p-value)
homophilic cell adhesion via plasma 
membrane adhesion molecules
cell-cell adhesion via 
plasma-membrane adhesion molecules
cell adhesion
biological adhesion
system development 
multicellular organism development
nervous system development
single-multicellular organism process
cell-cell adhesion
developmental process
15
2.0
1.5
1.0
0.5
0.0
-0.5
-1.0
-1.5
-2.0
1 -2 10-1 1 1 2 3 1 4 1 5 1 6
Log10 (Base Mean)
Lo
g2
 (F
ol
d 
C
ha
ng
e)
C
cell adhesion
n = 356
n = 239
Koemans.indd   107 10-1-2018   12:25:21
108
Chapter 4
Transcriptional changes in Kabuki syndrome 
RNA-seq was also performed on mRNA from five Kabuki syndrome patients carrying a 
KMT2D loss-of-function mutation and compared to mRNA levels in the same five control 
individuals (Table 1). Using the same thresholds as the differential gene expression analysis 
in Kleefstra syndrome patients (1.5-fold, p-value < 0.05), we identified 1318 differential 
expressed genes in Kabuki syndrome patients (Figure 2A, Table S5). Of these genes, 779 
genes are upregulated and 539 genes are downregulated. Of these, 73 and 81 genes are 
2-fold up- and downregulted respectively. GO term analysis of the 1.5 fold upregulated 
genes revealed many genes important for “neuronal functioning” and “synapse assembly” 
(Figure 2B, Table S6). Go term analysis of the downregulated genes revealed terms 
describing “cell surface receptor signaling”, “chemotaxis”, and neuronal terms like “signaling”, 
“neurogenesis” and “regulation of synaptic transmission” (Figure 2C, Table S7) along with 
many others. GO term analysis of the total (1318) misregulated genes revealed terms 
describing “nervous system development”, “neurogenesis”, and “signaling” (Figure 2D, Table 
S8). Interestingly, 11 misregulated genes were found to be involved in “learning”. Thus, the 
differentially expressed genes may provide clues to the underlying mechanisms of the 
clinical phenotype of the patients. 
Figure 2: Transcriptional changes in Kabuki syndrome. 
(A) Scatter plots showing Log2 fold changes plotted against the Log10 normalized expression in whole blood of 
Kabuki syndrome patients. Red and blue dots indicate significant up- and downregulated genes, respectively (fold 
change > 1.5; p< 0.05 (Wald test)). Top 10 enriched gene ontology terms identified using the Panther software for 
upregulated genes (B), downregulated genes (C), and misregulated genes (D). 
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A signifi cant overlap between diﬀ erential expressed genes in Kleefstra- and 
Kabuki syndrome
In order to identify commonly misregulated genes between KlS and KaS syndrome, an 
overlap analysis was performed using biovenn [36]. Of the 595 and 1318 genes that are 1.5-
fold misregulated in KlS and KaS, respectively, 219 genes were identifi ed to be present in 
both groups (10.43 fold enriched, p-value < 10-203 (hypergeometric distribution), Figure 3A, 
Table S9). Interestingly, 214 of these 219 genes, (98%) were regulated in the same direction 
(both up- or downregulated) (Table S9). Examples of GO terms describing this group of 
overlapping genes are “axon development”, “MAPK signaling” and development of many 
brain structures such as “cerebellum”, “forebrain”, and “hypothalamus” (Figure 3B, Table S10). 
These GO terms can be directly relevant to the overlapping phenotypes between KlS and 
KaS. Additionally, comparison of associated GO terms from KlS (Table S4, 652 GO terms) to 
KaS (Table S8, 1129 GO terms) confi rmed a strong functional overlap. 299 overlapping GO 
terms (of 20972 total GO terms) were found to be associated to both diseases (8.5x enriched, 
p-value 10-210 (hypergeometic distribution), Figure 3C). Thus, apart from the transcriptome 
that is unique for each disease, overlapping diff erential expressed genes and functionality 
could be established. 
Figure 3: Genes misregulated in Kleefstra syndrome and Kabuki syndrome show a signifi cant overlap. 
(A) Venn diagram showing the overlap between misregulated genes in Kleefstra syndrome and Kabuki syndrome. 
The overlap of 219 genes is larger than expected by random chance, based on a hypergeometric test (p-value= 
10-203 and 10.34 times). (B) Top 20 enriched gene ontology terms identifi ed using the Panther software for 219 
overlapping genes. (C) Venn diagram showing the overlap between gene ontology terms associated with Kleefstra 
- and Kabuki syndrome misregulated genes. The overlap of 299 gene ontology terms is larger than expected by 
random chance, based on a hypergeometric test (p-value= 10-210 and 8.52 times enriched).
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Functional clusters of misregulated genes identified in Kleefstra and Kabuki 
syndrome
In order to identify more functional connections within the differential expressed genes, 
gene networks were assembled using String [37]. String combines several databases 
and computes scores for the level of protein-protein interaction. For all differentially 
regulated genes in KlS, a high confidence interaction network was generated (Figure 4) 
(PPI enrichment p-value: 2.33*10-15). One main network can be appreciated within several 
small connections and consists of chemokine receptors and G-protein coupled receptors 
(GPR17 as example). The other smaller networks are involved in kinase function (NTRK1), 
cell-adhesion (CADM1), dopamine hydroxylase (DBH), MAPK10, and neuropilin (NRP1). 
 A high confidence network for differentially expressed genes in KaS was also 
generated (Figure 5) (PPI enrichment p-value: 3.61*10-12). This network shows high 
interconnectivity and consists of three larger clusters. The first (middle, oval shape) cluster 
contains reelin/MAPK associated genes (RELN, SRC, DOK2, MAPK11 and CDH1 (Arc-1)). The 
second large cluster (right, round shape) contains chemokine receptors and G-protein 
coupled receptors (PGR55, PTGER3), whereas the third large cluster (left, round shape) 
contains RAS (RHOC), Rho (STARD8) and transcription factors (GATA1). Additionally, sub-
clusters within the network are involved in potassium (KCNS1) and calcium (CACNA1I) 
voltage gated ion channels, choline (CHDH), wnt (SFRP5) and hedgehog (GLI1) signaling. 
Thus, these protein-protein networks give functional insights in the underlying mechanisms 
of KlS and KaS. 
Next, a network was also generated from the 219 commonly differential expressd 
genes (PPI enrichment p-value: 7.44*10-9) in order to detect common connections (not 
shown in this thesis). 19 proteins show interconnection of which 10 are within the cytokine 
cluster (ie containing CCL5 wich is within the cluster of GPR17 in Figure 4). Thus, this 
network represents common pathways affected in KlS and KaS. However, the functional 
overlap between KlS and KaS is less pronounced than the common GO terms (figure 3C) 
which could be due to technical limitations of the String database. 
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Figure 4: Protein network modules within the diff erentially expressed genes of Kleefstra syndrome. 
Modules within the gene network of diff errentially expressed genes reveal underlying pathways aff ected in 
Kleefstra syndrome. One mayor cluster of receptor function can be identifi ed. Circled as example for this module is 
GRP17. Additional smaler clusters can also be appreciated. Examples are NTRK1 for kinase activity, CADM1 for cell 
adhesion, dopamine beta hydroxylase (DBH), MAPK, and neuropillin (NRP1). 
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Figure 5: Protein network modules within the diff erentially expressed genes of Kabuki syndrome.
Modules within the gene network of diff erentially expressed genes reveal underlying pathways aff ected in Kabuki 
syndrome. Three mayor clusters can be indentifi ed (red circles) within the dense network. The fi rst one contains 
reeling/MAPK signaling factors (RELN, SRC, MAPK11, ARC-1(CDH1)). Additionally, a prominent cluster of receptors 
such as G-protein coupled receptors (GPR55) can be appreciated. The third large cluster contains members of the 
RAS family (RHOC and STARD8) and is closely linked to the fi rst cluster. Smaller groups containing members of 
Potassium (KCNS1) and calcium (CACNA1I) gated ion channels and signaling pathways such as hedgehog (GLI1) 
and wnt signaling (SFRP5) are marked. Lastly, choline dehydrogenase (CHDH) forms a separate cluster.   
Discussion 
Kleefstra- and Kabuki syndrome have many common phenotypes such as ID and autism 
spectrum disorder, facial features, developmental delay, sleep- and eating diffi  culties, 
seizures, and hypotonia [33]. Mutations associated with these syndromes are in the genes 
EHMT1 and KMT2D respectively. Additionally, mutations in KMT2C, the paralog of KMT2D, is 
associated with KSS, and is within an overlapping phenotypic spectrum. Here, we describe 
the identifi cation of diff erentially expressed genes in blood of fi ve KlS (EHMT1 mutations) 
and fi ve KaS (KMT2D mutations) compared to fi ve healthy control individuals. We identifi ed 
1
2
3
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many differential expressed genes in whole blood of both disease entities. Additionally, a 
high degree of overlap was identified between differentially expressed genes and associated 
GO terms describing the functions of these genes.  
 In this study, we used whole blood as surrogate tissue to the brain. Peripheral 
blood offers a major advantage in contrast to other tissues because it is easily accessible, 
minimally invasive to the individual to collect, and can support large population based 
collections. Blood cells are in contact with many other organs and carry bioactive molecules 
such as oxygen, metabolites, nutrients, cytokines and hormones and thereby potentially 
reflecting the physiological state of other organs. In addition, blood can be regarded 
as an organ by itself. However, dispite the large difference seen in expression profiles 
between blood and brain samples, comparative studies have revealed common patterns 
of deregulation, biological functions and targets of transcription factors [38]. Furthermore, 
over 80% of the human peripheral blood transcriptome is co-expressed in any given tissue 
[39]. Many studies report blood biomarkers in neurodevelopmental disorders such as ID 
syndromes [40], schizophrenia [41], and autism [42]. Thus, peripheral blood can be used to 
apply the functional genomics tools for discovering of biomarkers for other organs such 
as the brain. However, the observed differential expressed genes could still reflect a blood 
specific transcriptome. 
GO enrichment analysis of misregulated genes in KlS revealed many terms 
relevant to the underlying pathogenesis of the human phenotype (Table S2-S4). For 
instance, upregulation of the catecholamine “dopamine”, terms related to the “synapse” and 
“action potential propagation” could provide clues to the pathology. “Negative regulation of 
circadian sleep/wake cycle, wakefulness” and “positive regulation of heart growth” are terms 
describing the down regulated genes and are other examples of terms directly relevant 
to the phenotype. These underlying genes could provide clues to the etiology of the 
neurodevelopmental and behavioural phenotype. Next, a group of sixteen protocadherins 
was found to be downregulated in Kleefstra syndrome. Protocadherins are transmembrane 
proteins involved in cell-cell connectivity of synapses and neuronal growth cones. The 
protocadherins are known to be implicated in ID syndromes such as RETT syndrome 
[43], but may also contribute to the pathogenesis of the neurological features observed 
in Kleefstra syndrome. 
 Similar to the observations of differentially expressed genes in KlS, the KaS 
transcriptome shows GO terms directly relevant to the phenotype (Table S6-S8). First, the 
terms “cognition” (17 genes) and “learning” (11 genes) are directly relevant to the phenotype 
as these terms potentially give clues to the etiology of ID in Kabuki syndrome patients. 
Second, the term “odontogenesis” refers to a group of genes responsible for the proper 
development of teeth and their arrangement in the mouth. Dentition abnormalities, 
including wide spread teeth and/ or hypodontia have been reported frequently in Kabuki 
Koemans.indd   113 10-1-2018   12:25:24
114
Chapter 4
syndrome [17]. Cleft lip/ palate is also observed however with lower frequencies [17]. Lastly, 
structural abnormalities of the brain such as ventricular dilatation, brain atrophy, agenesis/ 
hypoplasia of the corpus callosum and white matter abnormalities are observed frequently 
in Kabuki syndrome patients [17]. These observations could be related to the misregulated 
genes that clustered together in the term ”brain development”. Thus, these results provide 
a hint towards the underlying mechanisms of these structural brain abnormalities. 
 In the GO terms for the overlapping genes (Figure 3) and gene network analysis 
of both diseases entities (Figure 4 and 5) prominent themes are found. Many GO terms can 
be directly related to ID. For instance, “positive regulation of inhibitory G-protein coupled 
receptor phosphorylation”, “calcium mediated signaling” and “signal transduction” are 
all related to mitogen-activated protein kinase (MAPK) signaling. This signaling pathway 
has been attributed to learning and memory but also to synaptic plasticity in the adult 
brain [44]. The MAPK signaling cascade is triggered by N-methyl-D-aspartate- and voltage 
gated calcium channels. Increased calcium inside the neuron will promote the RAS-
GTP form and activate the RAF-MEK-ERK signaling cascade that is required for processes 
underlying synaptic plasticity by long term potentiation and/or long term depression. 
The MAPK signaling pathway is shown to regulate spacial memory in mice [45] and fear 
conditioning in rats [46]. Other examples of signaling pathways identified in this study are 
Wnt signaling which has been linked to learning and memory in the object recognition 
test [47] and sonic hedgehog signaling that has been implicated in neuronal plasticity 
and neuronal differentiation in the hippocampus [48]. These latter examples were seen as 
highly interacting genes in the network analysis of Kabuki syndrome (Figure 5). Thus, via 
clustering analysis of genes misregulated in KlS and KaS, common functional themes could 
be identified that hint towards the underlying molecular etiology of the ID aspect of both 
disease entities. 
Another prominent theme in the results presented here is the large overlap of 
differentially expressed genes (Figure 3A) and the nearly identical direction (up- or 
downregulated) of commonly misregulated genes (Table S9). EHMT1 has been shown to 
regulate H3K9me2 involved in transcriptional repression [6] and on the other hand is KMT2D 
a methyltransferase involved in H3K4me3 and transcriptional activation [28, 49]. Drosophila 
genetic interaction studies has shown that there is a strong antagonistic interaction 
between the KMT2D ortholog trr and G9a, the ortholog of EHMT1 [13]. It has also been 
shown that the targets of the Drosophila G9a and trr significantly overlap on the genomic 
and transcriptome level (Chapter 3). The study described here presents a similar finding. 
Disruption of either EHMT1 or KMT2D results in a strikingly similar altered transcriptome. 
Thus, this study underscores that phenotypically overlapping syndromes that originate 
from mutations in distinct epigenetic factors show molecular convergence. 
Koemans.indd   114 10-1-2018   12:25:24
115
Convergence of differentially expressed genes and their function
4
Materials and Methods
Patients selection 
Participating patients were selected from the Kleefstra- and Kabuki syndrome cohort of the 
Radboudumc and the Maastricht university medical center. Control individual were healthy 
adult volunteers. All patients with KlS or KaS were clinically diagnosed as described before 
[50] and showed a heterozygous loss of function mutation in EHMT1 (Kleefstra syndrome) 
or KMT2D (Kabuki syndrome) (Table 1). Full blood was drawn of individuals according to 
standard procedures. Whole blood was stored in PAXgene Blood RNA Tubes (Qiagen) at -80 
°C until processed further. 
Table 1: Control, Kleefstra- and Kabuki syndrome patients with corresponding variants in EHMT1 or 
KMT2D used for this study. 
Number Patient 
number
Group DNA variant Protein variant Gene Inheritance 
type
KlS_1 RNA15-00280 Kleefstra syndrome c.2704C>T p.(Arg902*) EHMT1 de novo
KlS _2 RNA15-00248 Kleefstra syndrome c.3072_3073del p.(Val1026fs) EHMT1 de novo
KlS _3 RNA15-00423 Kleefstra syndrome c.2380del p.(Gln794fs) EHMT1 de novo
KlS _4 RNA15-00150 Kleefstra syndrome c.2587C>T/+ p.(Gln83*) EHMT1 de novo
KlS _5 RNA15-00540 Kleefstra syndrome c.2713-1G>T p.(?) EHMT1 de novo
KaS_1 RNA15-00351 Kabuki syndrome c.9329delG p.(Arg3110Profs*9) KMT2D de novo
KaS_2 RNA15-00298 Kabuki syndrome c.11416C>T# p.(Gln3806*) KMT2D de novo
KaS_3 RNA15-00147 Kabuki syndrome c.11707C>T p.(Gln3903*) KMT2D de novo
KaS _4 RNA15-00281 Kabuki syndrome c.12164_12165-
delCT 
p.(Pro4055Argfs*6) KMT2D unknown
KaS _5 RNA15-00300 Kabuki syndrome c.5320-2A>G p.(?) KMT2D unknown
CON_1 RNA15-00279 Control - - - -
CON_2 RNA15-00278 Control - - - -
CON_3 RNA15-00526 Control - - - -
CON_4 RNA15-00527 Control - - - -
CON_5 RNA15-00530 Control - - - -
Control individuals were healthy adults. # =mosaic 5-20%. Genome reference version GRCh37 (hg19) was used for 
variant annotation. 
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RNA isolation, library preparation, and sequencing 
Total RNA was extracted from whole blood in PAXgene Blood RNA Tubes (Qiagen) using 
standard procedures from the manufacturer. Ribosomal RNA and globin mRNA was 
depleted using the Globin-Zero Gold rRNA Removal Kit (Illumina). The isolated mRNA 
was subjected to 7.5 minutes fragmentation at 95 °C in fragmentation buffer (40 mM Tris-
acetate, 10 mM Potassium Acetate, 30 mM Magnesium Acetate, pH 8.2) after which the 
samples were immediately placed on ice. First strand cDNA synthesis was performed using 
superscript (Invitrogen) with random hexamers as primers. Second strand synthesis was 
performed using E. coli polymerase (New England Biolabs) and random hexamers. DNA end 
repair was performed on 5 ng of double stranded cDNA followed by ligation of Illumina 
sequencing adaptors (Next-flex) and size selection for 300 bp. Fragments were amplified 
linearly (9 PCR cycles) as validated by quantitative real-time PCR (qPCR). Sample quality was 
assessed using the Agilent 2200 TapeStation system. Additionally, quality and quantity of 
the obtained libraries were assessed by library quantification by qPCR (Kapa technologies). 
Cluster generation and paired-end sequencing-by-synthesis (43 bp) was performed using 
the Illumina NextSeq500 according to standard protocols of the manufacturer. The image 
files generated by NextSeq 500 were processed to extract DNA sequence data. From the 
NextSeq 500, we obtained between 33 and 102 million reads (Table S11). Sequenced 
reads were aligned to the Human genome (GRCh37/hg19) using STAR [51] (version 2.5). 
Only reads that uniquely aligned to the genome were considered for further analysis and 
total alignment efficiency was between 21% and 36% (Table S11). The number of aligned 
reads mapping to gene coding sequences was counted in the same step as mapping using 
STAR (quantMode “GeneCounts” column four comparable with htseq-count [52] option 
-s reverse) with gene annotations extracted from the file Homo_sapiens.GRCh37.75.gtf, 
available at http://www.ensembl.org. The unambiguously mapped reads (ranging from 
7.2–37.7 million reads) were used for further analysis. The number of reads per gene were 
normalized using DESeq2 software [34]. DESeq2 was then used to identify genes that were 
differentially expressed in the five individuals with Kleefstra syndrome relative to the five 
control individuals (p-value < 0.05 (Wald-test), fold change > 1.5). Additionally, we identified 
differential expressed genes in the five Kabuki syndrome patients relative to the (same) five 
control individuals (p-value < 0.05 (Wald-test), fold change > 1.5). 
Gene Ontology enrichment, hypergeometric analysis, and String database 
Gene Ontology (GO) enrichment analysis was performed using the Panther software [53] 
on http://geneontology.org/ (GO Ontology database released on 2016-07-15). Overlap 
between datasets was determined and visualized as a Venn diagram by BioVenn [36]. 
Hypergeometric statistics on overlaps were calculated using https://www.geneprof.org/
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GeneProf/tools/hypergeometric.jsp. The full data set of differentially expressed genes and 
GO-terms are in the supplemental tables (Tables S1-S8). 
The String database (https://string-db.org/, version 10.0) was used to visualize 
protein networks of all differentially expressed genes per disease entity [37]. Only text mining, 
experiments and databases were visualized. Thickness of lines represents the interaction 
score with thin lines representing 0.700 (“high confidence”) thicker lines represents 0.900 
(“highest confidence”). Color of nodes represents individual proteins. Disconnected nodes 
are hidden. 
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Table S1: Misexpressed genes in Kleefstra syndrome compared to control individuals based on 
Deseq2. 
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Abstract 
Kleefstra syndrome is defined by mutations in the EHMT1 gene and is characterized 
by intellectual disability (ID), childhood hypotonia, autistic traits, characteristic facial 
dysmorphisms, and other variable clinical features. However, EHMT1 mutations account 
for 25% of Kleefstra syndrome cases which leaves a large “EHMT1-negative” group with 
strikingly similar clinical characteristics, alluded to as the Kleefstra syndrome phenotypic 
spectrum (KSS). In a previous study we have shown that mutation in the KSS cohort include 
MBD5, MLL3, SMARCB1, and NR1I3 and contribute to a epigenetic network involved in ID 
and autism. Here, we apply two approaches to further expand this EHMT1 network. First, 
clinical characterization followed by whole exome sequencing of two novel KSS patients 
identified POGZ and DDX3X as potentially causing factors. However, after initial findings, 
more patients were identified with mutations in these genes, but without the characteristic 
features of KSS. Additionally, genetic interaction studies showed no association between 
EHMT1 and these two genes, which supports the paucity of clinical similarity between the 
associated phenotypes. Hence, POGZ and DDX3X are not added to the EHMT1 network. 
The second approach is based on affinity purification followed by mass spectrometry in 
order to identify interaction partners of the Drosophila EHMT1 ortholog, G9a, by using a 
Drosophila fosmid line. This pull-down experiment identified a so far uncharacterized zinc 
finger protein CG9932 as a physical interaction partner of G9a which has orthology to 
human RE1-silencing transcription factor and ZNF462. 
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Introduction
Haploinsufficiency of the EHMT1 gene causes Kleefstra Syndrome (KS, MIM #610253) which 
is characterized by intellectual disability (ID), autism spectrum disorder, hypotonia, facial 
dysmorphisms, and other features that occur in subsets of patients [1-3]. Around 25% of KS 
patients carry loss-of-function mutations in the EHMT1 gene and we previously hypothesized 
that the “EHMT1 negative” cohort might carry mutations in genes with a shared biological 
function with EHMT1 [4]. Via a next generation sequencing approach in patients with 
Kleefstra phenotypic spectrum (KSS), de novo mutations have been found in MBD5, MLL3, 
SMARCB1, and NR1I3, all of which encode epigenetic regulators or transcription factors [4]. 
Our hypothesis that these genes are engaged in shared biological processes was further 
supported by established protein-protein interactions and genetic interaction studies of 
these genes in Drosophila melanogaster, which revealed a conserved epigenetic module 
underlying KSS [4]. Here we aimed to expand this module using two different approaches 
to identify additional members of the EHMT1 network related to KSS. The first approach is 
based on de novo variant identification in KSS patients using exome sequencing. The second 
approach uses affinity purification followed by mass spectrometry experiments to identify 
interactions partners of the Drosophila EHMT1 ortholog, G9a in a Drosophila fosmid line. This 
fly line expresses a G9a fusion protein with a molecular “tag” in an endogenous pattern [5, 
6]. In this way, we identified a previously unknown protein, CG9932, as interaction partner. 
ZNF462 and RE-1 silencing transcription factor (REST) rank amongst the human genes with 
the highest sequence similarity to CG9932 and could be hits for further research to the 
human EHMT1 protein network. 
Results
Identification of de novo mutations in individuals with clinical characteristics 
to Kleefstra syndrome
The two individuals described in this study with clinical features of KSS (Figure 1) were 
ascertained through family-based exome sequencing in a diagnostic setting in the 
Department of Human Genetics at the Radboudumc. Exome sequencing and data analysis 
were performed as previously described in the probands and their unaffected parents [7]. 
Individual 1 is diagnosed with severe ID, hypotonia, epilepsy, movement disorder, corpus 
callosum hypoplasia, hyperlaxity and visual problems. The proband carried a c.1126C>T 
(p.Arg376Cys) de novo variant in DEAD-Box Helicase 3, X-Linked (DDX3X). Individual 2 was 
diagnosed with severe ID, speech and language delay, motor delay, autism spectrum 
disorder, microcephaly, and behaviour difficulties such as characteristic mouth movements, 
sleeping problems, restless, and no eye contact. Patient 2 carried a c.2590C>T (p.Arg864∗) de 
Koemans.indd   127 10-1-2018   12:25:31
128
Chapter 5
novo variant in pogo transposable element with ZNF domain (POGZ). These results suggested 
that these genes may also be a part of the EHMT1-related network underlying KSS. In order 
to investigate this, we turned to Drosophila experiments to test genetic interaction between 
the respective orthologs. 
Figure 1: Clinical photograph of individual 1 (A) with a de novo mutation in DDX3X at the age of 4 and 
individual 2 with a de novo mutation in POGZ at the ages of 1 year (B) and 3 years (C). Reprints of figure 
panels are from Snijders-blok et al., AJHG (2015) and Stessman et al., AJHG (2016) with permission.  
Absence of genetic interaction of EHMT1 with DDX3X and POGZ
Previously, we used the Drosophila wing phenotype to test genetic interactions between KSS 
genes and to validate the EHMT1 network [4]. Here, we applied the same approach to test 
genetic interactions between the Drosophila orthologs of EHMT1, DDX3X and POGZ. Human 
paralogs EHMT1 and EHMT2 have one ortholog in Drosophila, G9a [8, 9]. Gene orthologs of 
DDX3X and POGZ were identified using the reverse BLAST method [10] and analysis of the 
Treefam database [11]. For DDX3X a clear ortholog was identified with 58% of the human 
amino acid sequence matched the sequence of belle including the ATP-dependent RNA 
helicase DEAD-box domain. 48% of the amino acid sequence of belle matched the sequence 
of human DDX3X. POGZ is less conserved in fly with 10% of the amino acid sequence of 
POGZ matching the amino acid sequence of relative of woc, row. 14% of the amino acid 
sequence of row matched the amino acid sequence of human POGZ including the C2H2-
type zinc finger domain. Next, to test for genetic interaction we observed modulation of 
the established G9a induced overexpression phenotype in the fly wing by modulating gene 
expression of the orthologs of the putative KSS genes [4, 12]. Classification of wing vein 
phenotypes was performed as described previously with categories ranging from wild type 
(not affected) to severe (strongly affected) [4]. Overexpression of G9a in the Drosophila wing 
individual 1
p.Arg376Cys
(DDX3X)
individual 2
p.Arg864*
(POGZ)
Individual 1 Individual 2 Individual 3 Individual 4 Individual 5 Individual 7 
Individual 8 Individual 9 Individual 10 Individual 11 Individual 12 Individual 13 
Individual 14 Individual 15 Individual 16 Individual 17 Individual 18 Individual 19 
Individual 20 Individual 22 Individual 23 Individual 24 Individual 26 Individual 27 
Individual 31 Individual 32 Individual 33 Individual 34 Individual 35 Individual 37 
A B C
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consistently causes extra vein formation (Figure 2, bar 1). Rescue of the G9a overexpression 
phenotype was performed by using RNA interference against G9a (Figure 2, bar 2) and 
restored the wings to wild type levels. Next, we tested the modulation of the G9a-induced 
extra veins by genetic manipulation of belle and row expression (Supplemental file S1). 
Down regulation of belle expression by three different RNAi lines did not change ectopic 
wing formation caused by G9a overexpression (Figure 2, bars 3-5). Heterozygous deletion 
of belle by the p-element excision allele in combination to G9a overexpression gave a 
slight tendency towards more severe ectopic vein formation (Figure 2, bar 6), but this 
trend is not sufficient to conclude positively about a genetic interaction. Overexpression 
of belle using the enhancer trap line (Figure 2, bar 7) showed no modulation of the G9a 
extra vein phenotype. Additionally, this phenotype is not opposite to the phenotype of 
lines that reduce belle expression. Modulation of belle expression alone (in absence of 
G9a overexpression) in the fly wing causes no phenotype in vein nor wing formation (not 
shown). Thus, these results indicate that G9a and belle do not genetically interact in the 
developing Drosophila wing. 
Next, the genetic interaction between G9a and row was investigated by modulation 
of row expression in combination with G9a overexpression in the fly wing. Three different 
lines that reduce row expression were assessed. First, RNAi-mediated downregulation of 
row did not change the vein phenotype induced by G9a overexpression in two RNAi-lines 
(Figure 2, bar 8-9). Next, reduced expression of row by the p-element excision allele in 
combination with G9a overexpression caused a modest increase of ectopic vein formation 
(Figure 2, bar 10), but this trend is also not large enough to conclude a genetic interaction. 
Modulation of row expression alone (in absence of G9a overexpression) caused no 
phenotype in the fly wing (not shown). Taken together, these results suggest that G9a and 
row do not genetically interact. 
In addition to these initial findings, more patients were identified with mutations 
in POGZ [13] and DDX3X [14], but without clinical features reminiscent of KSS. These latest 
clinical findings thus disqualified DDX3X and POGZ as members of the EHMT1 network, but 
confirmed the results of the genetic interaction experiments. In addition, these results show 
the power of genetic interaction studies to validate networks of genes that are associated 
with overlapping clinical characteristics. 
After elimination of DDX3X and POGZ as potential components of an EHMT1-
related module, we sought to identify additional components through identification 
of novel Drosophila G9a interaction partners using affinity purification followed by mass 
spectrometry. To do this, we used a Drosophila strain that expresses a “tagged” G9a protein 
[5].
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Figure 2: Drosophila orthologs of DDX3X and POGZ do not genetically interact with G9a. 
Bar graph showing ectopic vein formation due to G9a overexpression in the wing in combination with various 
genetic elements. G9a overexpression causes a wing vein phenotype (bar 1). This phenotype is rescued by RNA 
interference (RNAi) against G9a (bar 2). Overexpression of G9a in combination with three individual Belle RNAi 
transgenes caused no increase in vein formation in the wing (bar 3-5). The heterozygous p-element allele BelleL4740 
in combination with G9a overexpression caused a modest increase of the G9a induced wing vein phenotype 
(bar 6), however, this is not convincing enough to conclude enhancement of the phenotype. The enhancer trap 
allele BelleEY08943 in combination with G9a overexpression did not change the wing vein phenotype (bar 7). 
Reduced levels of row by two individual RNAi lines did not change the wing vein phenotype in combination 
with G9a overexpression (bar 8-9). The allele rowBG02781 did not change the wing vein phenotype due to G9a 
overexpression (bar 10). All transgenes alone (without UAS-G9a) caused no aberrant vein formation (not shown). 
Genotypes are described in supplemental file S1. + indicates present, - indicates absent. LOF = loss of function, 
GOF = gain of function, NA indicates not applicable. Examples of severety of G9a-induced ectopic wing vein 
formation between veins L2 and L3 is variable in severity and can be quantified accordingly into wild-type, mild, 
medium, and strong. Upper panels of wings taken from Kramer et al. (2012) [4] with permission. 
The G9a fusion protein is expressed in fly heads 
In order to find physical interaction partners of G9a, affinity purification followed by mass 
spectrometry was performed. Drosophila fosmid lines are generated by using φC31-mediated 
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site-specifi c transgenesis [15] of a large genomic piece, including potential cis-regulatory 
DNA elements, using the Flyfos vector [5]. This approach resulted in a tagged version of 
the G9a gene in the Attp2 site of the genome as additional copy to the natural occurring 
allele and is hereafter called “tagged G9a fosmid line” (for genoype see supplemental fi le S1). 
This approach ensures a stable and endogenous expression pattern and level of the G9a 
protein with a “multitag” [5], consisting of 2xTY1 amino acid sequence, super folder green 
fl uorescent protein (sGFP), tobacco etch virus (TEV), and a biotin ligase recognition peptide 
(BLRP) (Figure 3A). The G9a protein is predicted to be 181 kDa and the tag 38 kDa by the 
Expasy program “compute pI/Mw” [16]. We fi rst validated the expression of the tagged G9a 
protein in adult fl y heads by Western blot, using an antibody directed against TY1 (Figure 
3B) and two commercial generated antibodies against the sGFP epitope (Figure 3C and 
3D). This analysis consistently revealed one band of the expected size (219 kDa) in two 
independent tagged G9a fosmid lines. As expected, this band is absent in the extract from 
wild type fl y heads (Figure 3B, C, D). Taken together, these data show that the G9a fusion 
protein is expressed in fl y heads and can be detected by Western blot analysis using the 
epitopes included in the tag. 
Figure 3: The G9a fusion protein is expressed in heads of the tagged G9a fosmid line
(A) Schematic protein motif overview and close up of the multi-tag of G9a fusion protein based on SMART analysis 
[18] of evolutionarily conserved protein domains. Domains are indicated with colours on the grey backbone: 
light green: coiled coil domain, pink: low complexity, orange: ankyrin domain, light brown: pre-SET domain, dark 
brown: SET domain, light bue: 2xTy1 peptide, dark green: sGFP, red: TEV, purple: BLRP, numbers indicate amino acid 
positions. (B-D) Western blot analysis visualizing the G9a fusion protein using antibodies from Diagenode directed 
against Ty1 (B), from Thermo Fischer (C), and from Abcam (D) directed against GFP. The following genotype was 
used: FlyFos028501(pRedFlp-Hgr)(G9a[24641]::2xTY1-SGFP-3xFLAG)dFRT
Abbreviations: cc: coiled coil, SET: Su(var)3-9, Enhancer-of-zeste, Trithorax, sGFP: super folder green fl uorescent 
protein, TEV: tobacco etch virus, BLRP: biotin ligase recognition peptide
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The G9a fusion protein can be purified from a protein extract 
Next, we aimed to affinity purify the tagged G9a protein from a total fly head protein extract 
of tagged G9a fosmid line 1. Any interaction partners of G9a will be co-immunoprecipitated 
since this reaction is under physiological, non-stringent conditions and potential physical 
interactors can be subsequently identified using mass spectrometry. Briefly, the lysate is 
centrifuged to exclude intact cells and other debris (pellet) from the input. Next, this input 
is incubated with agarose beads coated with antibodies directed against super folder GFP 
(Chromotec). After the immunoprecipitation reaction, the beads bound by proteins are 
centrifugated to separate the bound from the unbound fraction. All fractions were loaded 
on a western blot and the blot was incubated with antibodies directed against GFP (Abcam 
#Ab290) and visualized using chemiluminescence (Figure 4). Indeed, we found G9a fusion 
protein in the input of the immunoprecipitation experiment (Figure 4, lane 3) and in the 
bound fraction (Figure 4, lane 1), confirming that the G9a fusion protein is bound to the 
antibody-coated beads. Next, this purified fraction was subjected to mass spectrometry to 
identify proteins that are physically associated to G9a. 
Figure 4: The G9a fusion protein can be purified in a protein extract from heads of the tagged G9a 
Drosophila fosmid line. 
Western blot showing tagged G9a protein throughout different steps of the immunoprecipitation protocol 
visualized by an antibody directed against GFP (Abcam) in combination with chemiluminescence. G9a fusion 
protein can be detected in the input (lane 3), the bound fraction (lane 1), and the pellet (lane 4), but not in the 
unbound fraction (lane 2). The following genotype was analysed: FlyFos028501(pRedFlp-Hgr)(G9a[24641]::2xTY1-
SGFP-3xFLAG)dFRT.
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The zinc finger protein CG9932 is a novel binding partner of G9a
To address which proteins are physically associated to G9a, the immunoprecipitated fraction 
was subjected to mass spectrometry analysis. Briefly, lysates were subjected to single step 
GFP-affinity enrichments (ipGFP) in triplicate. In addition to these samples, the same lysates 
were incubated with beads that do not contain the GFP antibody (control). The precipitated 
proteins were then subjected to on-bead trypsin digestion after which peptide mixtures 
were analysed by nanoLC-MS/MS. Raw data processing was done using MAXQuant 
software [17] and the obtained normalized, log2 transformed, label free quantification 
(LFQ) intensities were used to determine outliers using a two-tailed t-test (p<0.05) (Table 
1). Multiple testing correction was applied by using a permutation-based false discovery 
rate (FDR) method on a Perseus software platform. The ratio of mean LFQ values from GFP 
immunoprecipitated samples versus control were plotted against the FDR values (Figure 5) 
per protein. FDR and fold change (FC) cut-offs were determined based on a custom made 
R-script (Vermeulen lab). Since this method of protein identification also includes the bait 
itself, G9a, serves as a internal positive control and was significantly enriched among other 
proteins represented in the right upper corner of the graph (Figure 5). Other peptides that 
were identified were Q9VZQ7 and sallimus (sls). However, another co-immunoprecipitation 
experiment with an unrelated bait protein also identified these peptides as interaction 
partners (not shown), suggesting that these proteins were not specific G9a interactors but 
contaminants. The peptide Q9VK42 was identified as significant interaction partner, and 
this protein is encoded by the so far uncharacterized CG9932 gene. Analysis of evolutionary 
conserved protein domains by SMART analysis [18] revealed that CG9932 contains sixteen 
C
2
H
2
 zinc finger domains and a coiled coil domain. Taken together, an uncharacterized zinc 
finger protein has been identified as novel interaction partner of G9a in Drosophila fly heads. 
Next, we reasoned that since G9a and CG9932 are physically associated, we also tested a 
potential genetic interaction. 
Table 1: Significant hits of G9a interaction partners identified by mass spectrometry. 
Shown are the normalized number of counts per peptide in the tagged G9a fosmid line in triplicates (GFP) and 
control line in triplicates (non). Additionally, -log 10 transformation of the p-value and log2 transformation of 
average GFP/control signal is shown.  
GFP_1 GFP_2 GFP_3 NON_1 NON_2 NON_3
-Log10 
(P-value)
2Log (GFP/
control)
peptide 
names
1 1 1 2 2 2 4.961 -6.405 Sgs7
47 48 41 0 0 0 2.962 8.033 G9a
4 4 4 1 2 1 3.697 7.555 sls
17 17 15 0 0 0 2.990 5.251 Q9VK42
3 4 6 1 1 2 3.699 5.866 Q9VZQ7
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Figure 5: Identification of Q9VK42 as interaction partner of G9a. 
Vulcanoplot showing significant binding partners of tagged G9a protein based on affinity purification followed by 
detection by mass spectrometry. The mean Log2 transformed LFQ intensity of the GFP pull-down over the control 
is plotted against the log10 FDR (p-value). Cut-offs (grey dashed lines) of Log2 transformed mean LFQ values and 
FDR are determined by a custom R-script based on the variability of the data points. The proteins in the right upper 
corner represent the bait and putative interactors. 
Genetic interaction between G9a and CG9932
Besides the physical association between G9a and CG9932, a potential genetic interaction 
was investigated in the same way as described above (Figure 2). We first confirmed the 
extra wing vein formation due to overexpression of G9a in the fly wing in two different 
genetic backgrounds (Figure 6A, bars 1-2). Next, modulation of the G9a induced wing 
vein phenotype was investigated upon RNAi mediated down regulation of CG9932 in the fly 
wing. We used three different lines in two different genetic backgrounds, corresponding to 
the background of the control lines, respectively. No major modification of the G9a-induced 
phenotype was observed in combination with UAS-CG9932(IR1) (Figure 6A, bar 3) while 
the RNAi alone caused no wing phenotype (Figure 6B, bar 3). However, the two RNAi lines 
alone in genetic background 2 (UAS-CG9932(IR2) and UAS-CG9932(IR3)) gave a very severe 
wing phenotype and this precludes interpretation of possible genetic interaction (Figure 
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6B, bar 4-5). Thus, since two out of three RNAi lines alone (without G9a overexpression) 
give such severe wing phenotypes, it was not possible to conclude on a genetic interaction 
between G9a and CG9932. 
Figure 6: Lack of evidence to conclude on the genetic interaction between G9a and CG9932. 
(A) Bar graph showing ectopic vein formation due to G9a overexpression in the wing in combination with various 
genetic elements. G9a overexpression causes a wing vein phenotype in two genetic backgrounds (bar 1 and 
2). No difference in wing phenotype was observed by modulating CG9932 expression using UAS-CG9932(IR1) 
(bar 3). The phenotype of UAS-CG9932(IR2) and UAS-CG9932(IR3) in combination with UAS-G9a was very severe 
in all wings assessed (bar 4 and 5). (B) Wing phenotypes with the row transgenes alone (no G9a overexpression) 
revealed wild type wings in the genetic backgrounds (bar 1 and 2) and in the UAS-CG9932(IR1) alone (bar 3). 
UAS-CG9932(IR2) and UAS-CG9932(IR3) alone showed a very severe effect (bar 4 and 5). Genotypes are described 
in supplemental file S1. + indicates present, - indicates absent. LOF = loss of function, GOF = gain of function. 
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CG9932 is evolutionary conserved to human REST and zinc finger proteins 
Next, we reasoned that CG9932 might have evolutionary conservation with human proteins. 
In order to identify homologous proteins to CG9932, the evolutionary conservation was 
investigated using the protein sequence of CG9932. This Drosophila sequence was analysed 
using a protein BLAST on the human proteome by the uniprot website (http://www.uniprot.
org). 123 high quality and non-redundant protein sequences were identified with identity 
scores between 21% and 33%, mainly based on the zinc finger motifs of CG9932 (Table S1). 
The top hits on this list (Table 2) include RE1-silencing transcription factor (REST), and many 
zinc finger proteins with RE-1-silencing transcription factor showing the lowest E-value. 
Table 2: Top-5 of human proteins with orthology to Drosophila CG9932 sorted on E-value.  
Peptide Gene name Identity 
score
E-value
Q13127 RE1-silencing transcription factor 33% 2.70E-12
Q96JM2-2 Isoform 2 of Zinc finger protein 462 22% 1.30E-10
Q96JM2 Zinc finger protein 462 22% 1.40E-10
Q96JM2-3 Isoform 3 of Zinc finger protein 462 22% 1.40E-10
Q9P243-4 Isoform 4 of Zinc finger protein ZFAT 33% 4.70E-10
Discussion 
Gene transcription is a tightly regulated process in which multi-protein complexes allow a 
cell to respond on environmental changes. Mutations in genes encoding epigenetic factors 
that regulate these transcriptional changes are implicated in ID [19]. Here we identified two 
genes (POGZ and DDX3X) involved in chromatin and gene transcription originally implicated 
in KSS by exome sequencing. However, after our initial findings, more patients were identified 
with mutations in POGZ [13] and DDX3X [14] but without phenotypic features suggestive 
of KSS. Additionally, no genetic interaction between the Drosophila orthologs of EHMT1 
with POGZ and DDX3X was identified, which is consistent with these clinical findings. For 
these reasons, the two proteins are not likely to be involved in an EHMT1 protein network. 
However, the absence of genetic interactions between G9a and belle and row, together 
with a clinical spectrum different from KSS strengthens the validity of the wing interaction 
assay. It confirms that the assay probably only identifies members of the EHMT1 network [4]. 
The second approach, protein-protein interaction studies to enlarge the network 
of EHMT1 underlying KS and KSS identified CG9932 as interaction partner of Drosophila 
G9a. While other zinc finger interactors have been identified in mice and human such as 
ZNF644 and WIZ [20-22], this is the first identified zinc finger interactor of G9a in Drosophila. 
However, no additional known protein interactors such as CoREST or HDAC proteins were 
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co-immunoprecipitated in this experiment. This lack of other interactors could be due 
to tissue specificity of protein-protein interactions or can be due to technical limitations. 
Homology searches revealed REST and ZNF462 as human orthologs with low E-values. 
It could be that mutations in REST and ZNF462 are among the elusive genes underlying 
the unexplained cases of KSS. Taken together, CG9932 is a novel binding partner of G9a 
in Drosophila. However, the functionality of CG9932 and the exact interaction with G9a 
remains to be elucidated.
Potential future experiments that could follow up on the findings of the approach 
using the Drosophila tagged fosmid line would first be a confirmation of the physical 
interaction between G9a and CG9932. This could be done by a reverse affinity purification 
reaction in which CG9932 is tagged. After immunoprecipitation, G9a should be confirmed 
as interactor in order strengthen the evidence of a physical interaction further. Next, besides 
a genetic interaction in the wing, other tissue could be more suitable for this interaction 
specifically. The Drosophila eye is another well known tissue to test such an interaction [12]. 
Furthermore, yeast-two-hybrid experiments could also be used to verify an interaction 
between CG9932 and G9a. Additionally, CG9932 together with G9a can be investigated for 
co-regulatory properties to identify the exact function of this protein-protein interaction for 
instance in the process of transcription and modification of the epigenetic landscape. Lastly, 
CG9932 can be studied in disease-relevant processes such as learning and/or memory for 
instance using courtship conditioning (chapter 2) [23]. Taken together, understanding the 
neuronal regulatory mechanisms controlled by the G9a protein network in relation to KS 
and KSS is essential. These two approaches could be used further to detect new genes and 
confirm members of this network. 
REST-related ID disorders
Paralogs EHMT1 and EHMT2 are reported to be present as a heterodimeric protein complex 
[24] and are associated with several zinc finger proteins [20, 25]. For instance REST, a major 
factor in neuronal development [26-28], is a direct interaction partner of EHMT2 [29]. REST 
can bind the 21bp RE-1 silencing motif and recruit the co-repressor complexes CoREST 
and SIN3 [30]. Both complexes contain histone deacetylases (HDAC) 1 and 2 and catalyse 
de-acetylation [31] and demethylation [32] of histone H3 at genes important for neuronal 
functioning and thereby causing initial transcriptional silencing. Silencing of transcription at 
REST binding sites is prolonged through DNA methylation by methyl CpG binding protein 
2 (MeCP2) [33]. Thus, these proteins have important functions in neuronal functioning. In 
Drosophila, panneuronal loss of CoREST results in a reduced olfactory memory [34]. Thus, 
EHMT proteins seem to be present in transcription repression complexes important for 
neuronal functioning. 
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Several of these proteins involved in REST-mediated neuronal gene repression 
are also implicated in ID. REST has been isolated in complex with SMCX (JARID1C/KDM5C), 
a histone demethylase implicated in X-linked ID and epilepsy [35]. Haploinsufficiency of 
SIN3A causes mild ID and autism spectrum disease [36]. MECP2, which has no counterpart 
in Drosophila, is a well-studied protein in brain function and is implicated in classic Rett 
syndrome [37]. These syndromes have several aspects in common, including ID, speech 
delay, seizures, and neurological regression [38]. Taken together, REST related transcriptional 
plasticity is crucial for normal neuronal functioning, however is not included in the EHMT1-
network underlying Kleefstra syndrome and KSS. Drosophila experiments using modulation 
of expression of CG9932 and G9a could elucidate fundamental epigenetic processes 
underlying ID. 
Materials and methods
Identification of variants in POGZ and DDX3X
Individuals were ascertained through family-based exome sequencing (ES) in individuals 
with unexplained ID or developmental delay in a diagnostic setting in the department 
of Human genetics at the Radboudumc. Exome sequencing in the probands and their 
unaffected parents and data analysis were performed as previously described [7]. These 
patients have been part of two previous studies in which large cohorts of individuals with 
DDX3X and POGZ mutations were presented [13, 14].
Fly stocks and maintenance
All flies were reared on standard medium (cornmeal/sugar/yeast) at 25 °C and 50% humidity 
with a 12-h light/dark cycle. Fly stocks were obtained from the Bloomington Drosophila Stock 
Center (Indiana University) and the Vienna Drosophila RNAi Center (Institute for Molecular 
Pathology) [39]. 
For belle we used stocks BL35302, BL28049, VDRC6299, BL10222, BL19945. For row we 
used BL25971, VDRC28196, BL13910. For CG9932 we used VDRC45686, VDRC45687, 
VDRC107846. For G9a we used VDRC110662, VDRC25473, VDRC25474. As controls we used 
VDRC60000, VDRC60100, BL36303. UAS-G9a flies were described previously [8]. MS1096-
Gal4 and MS1096-Gal4/FM7d;UAS-G9a were described previously [4]. G9a fosmid lines 1 and 
2 were a gift from Dr. P. Tomancak and Dr. M. Zuberova (Max Planck Institute of Molecular 
Cell Biology and Genetics, Dresden Germany) and genotype is described in supplemental 
file S1. A Nijmegen specific control line was used for western blot experiments.
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Genetic interaction assay
We performed genetic interaction studies in Drosophila by using the UAS/Gal4 ectopic 
expression system [40] to induce overexpression or RNAi-mediated knockdown of gene 
orthologs implicated in KSS. Gene orthologs were identified using the reverse BLAST 
method [10] and analysis of the Treefam database (Release 9, March 2013) [11]. Females 
of the genotypes MS1096-Gal4 and MS1096-Gal4/FM7d;UAS-G9a were crossed to males 
from fly stocks of Belle, Row and CG9932 as indicated in Table 1. Wing phenotypes were 
examined in female progeny and scored for severity as described previously [4]. Genotypes 
of the progeny analysed are described in supplemental file S1. 
Western blot analysis
G9a fusion protein line 1 and 2 and wild type flies (males and females) were aged between 1-5 
days. The following genotype was analysed: FlyFos028501(pRedFlp-Hgr)(G9a[24641]::2xTY1-
SGFP-3xFLAG)dFRT. Aged flies were snap frozen in liquid nitrogen. Frozen fly heads were 
harvested by vortexing and separated from other body parts through a series of standard 
laboratory sieves. Around 50 µl of frozen fly heads was crushed in lysisbuffer (10mM Tris/ HCl 
(pH=7.5), 150 mM NaCl, 0.5mM EDTA, 0.5% NP40) supplemented with 1x protease inhibitor 
cocktail (PIC) (Sigma) using Readyprep mini grinders (Bio-rad). Proteins in the extracts were 
separated using an 8% acrylamide gel with the Bio-rad electrophoresis system according 
to standard operating procedures. Proteins were transferred to nitrocellulose blotting 
paper (Sigma) using the Bio-rad Mini Trans-Blot cell. Blots were probed with mouse-anti-
Ty1 at a 1/2000 dilution (Diagenode, catalog number C15200054), rabbit-anti GFP at a 
1/1000 dilution (Abcam, catalog number Ab290), or rabbit-anti GFP at a 1/1000 dilution 
(Thermofisher, catalog number A-11122). Proteins were visualized using a goat-anti-mouse-
HRP antibody or goat-anti-rabbit-HRP antibody at a 1/3000 dilution (Invitrogen) and the 
supersignal west pico chemiluminescent substrate (Pierce) on a ChemiDoc MP system (Bio-
rad). 
As a control for equal loading of samples the same blots were probed with a rat-
anti-α-tubulin antibody (AbD Serotec) at a 1/1000 dilution and visualized using a goat-ant-
rati-IRdye800 antibody (Invitrogen) on an Odyssey infrared imager (LI-COR Biosciences). 
Immunoprecipitation of G9a fusion protein
Flies of the G9a fusion protein line 1 were aged between 1-5 days. The following genotype 
was analysed: FlyFos028501(pRedFlp-Hgr)(G9a[24641]::2xTY1-SGFP-3xFLAG)dFRT. Around 50 
µl of frozen fly heads was crushed in lysis buffer (10mM Tris/HCl (pH=7.5), 150 mM NaCl, 
0.5mM EDTA, 0.5% NP40) supplemented with 1x protease inhibitor cocktail (PIC) (Sigma) 
using Readyprep mini grinders (Bio-rad). Crude protein extracts were vigorously vortexed 
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for ten minutes while maintained on ice. Lysates were centrifuged at 14.000 rpm for 10 
minutes at 4 °C and the supernatant was transferred to a new vial. The remaining pellet was 
resuspended in 300 µl dilution buffer (10 mM Tris/HCl (pH=7.5), 150 mM NaCl, 0.5 mM EDTA) 
and referred to as pellet. The supernatant (cell lysate) was adjusted to 500 µl with dilution 
buffer supplemented with 1x protease inhibitor cocktail (Sigma) and referred to as input. 
200 µl of the cell lysate with 20 µl of equilibrated GFP-Trap agarose beads (Chromotec) 
and 1x PIC was used in a total volume of 500 µl and incubated over night at 4 °C on a 
gently rotating wheel. The next day, bead-immuno-protein complexes were isolated by 
centrifugation (2700x g for 2 minutes at 4 °C). Supernatant was referred to as ‘unbound’, and 
bound proteins were eluted from the beads in 25 µl washing buffer (10 mM Tris/Cl (pH=7.5), 
150 mM NaCl, 0.5 mM EDTA) supplemented with 1x PIC and Western blot loading dye. All 
fractions of the immunoprecipiation were subjected to Western blot analysis (described 
above) using antibodies directed to GFP (Abcam, Ab290). 
Mass spectrometry 
Flies of the G9a fusion protein line 1 were aged between 1-5 days. The following genotype 
was analysed: FlyFos028501(pRedFlp-Hgr)(G9a[24641]::2xTY1-SGFP-3xFLAG)dFRT. Around 50 
µl of frozen fly heads were lysed by adding RIPA lysis buffer (150mM NaCl; 50mM Tris pH 8.0; 
1% NP-40; 1mM DTT supplemented with 1x protease inhibitor cocktail (PIC)). To help the 
lysis, heads were dounced with a type A pestle. The extract was cleared by centrifugation 
at 21,100 x g for 15 minutes at 4°C. The label free pull down was performed in triplicate 
by adding 7,5 µl GFP beads (chromotek, GFP-Trap) or 7,5 µl non-GFP (Chromotek, bab-20) 
per immunoprecipitation. The following mixture was used per immunoprecipitation: 100 µl 
extract, 300ul RIPA lysis buffer supplemented with Ethidiumbromide to a final concentration 
of 50 µg/µl. Samples were incubated for 90min at 4°C in order to let the protein complexes 
bind the antibody coated beads. The beads were then washed three times with 1ml RIPA 
lysis buffer and 2 times washed with 1ml PBS. Precipitated proteins were subjected to on-
bead trypsin digestion and nanoLC-MS/MS mass spec analysis as described before [41]. The 
raw mass spectrometry data were analyzed using the MAXQuant software version 1.3.0.5 
[17] to filter for contaminants, reverse hits, and number of peptides (>1) and to retrieve 
normalized log2 transformed LFQ values. These values were subjected to a two tailed t-test 
(p<0.05) to exclude outliers and the mean normalized LFQ values were used to calculate the 
ratio of LFQ (GFP)/ LFQ (control). False discovery rate (FDR) analysis was performed using 
a custom R-script based on a permutation test. The same R-script calculated the cut-off 
values for ratio (GFP/control) and FDR and was based on the variability of the dataset (Table 
2). All amino acid sequences were searched against the Drosophila proteome (Uniprot, 
February 2012).  
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Identification the orthologs proteins of CG9932 in human
The protein sequence of CG9932 (Q9VK42) was downloaded from the Uniprot database 
(The Uniprot consortium, 2014). This sequence was used as input for protein BLAST version 
2.2.29+ with BLOSUM62 as matrix. E-value threshold was set bigger than 10 and only 
curator-assessed orthologs were used as output to focus on the high confidence hits. 
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Supplemental File S1: genotypes used in this study
Figure 2:
W118/MS1096-Gal4;+/UAS-G9a (not shown)
y,w[1118]/MS1096-Gal4;;P{attP,y[+],w[3`]}/UAS-G9a (column 1)
y[1] v[1] /MS1096-Gal4;;P{y[+t7.7]=CaryP}attP2/UAS-G9a (not shown)
y,w[1118]/MS1096-Gal4;;P{KK100579}VIE-260B/UAS-G9a (column 2)
+/MS1096-Gal4;;y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.GL00205}attP2/UAS-G9a (column 3)
+/MS1096;;y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02884}attP2/UAS-G9a (column 4)
w[1118]/ MS1096-Gal4;;P{GD1324}v6299/UAS-G9a (column 5)
y[1] w[67c23]/MS1096-Gal4;;P{w[+mC] y[+mDint2]=EPgy2}bel[EY08943]/UAS-G9a (column 6)
y[1] w[1118]/MS1096-Gal4;;P{w[+mC]=lacW}bel[L4740]/UAS-G9a (column 7)
y1 v1/MS1096-Gal4;;P{TRiP.JF01993}attP2/UAS-G9a (column 8)
w1118/MS1096;;P{GD12377}v28196/UAS-G9a (column 9)
w1118/MS1096-Gal4; +/P{GT1}rowBG02781;+/UAS-G9a (column 10)
W118/MS1096-Gal4;+ (not shown)
y,w[1118]/MS1096-Gal4;;P{attP,y[+],w[3`]} (not shown)
y[1] v[1] /MS1096-Gal4;;P{y[+t7.7]=CaryP}attP2 (not shown)
+/MS1096-Gal4;;y[1] sc[*] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.GL00205}attP2 (not shown)
+/MS1096;;y[1] v[1]; P{y[+t7.7] v[+t1.8]=TRiP.JF02884}attP2 (not shown)
w[1118]/ MS1096-Gal4;;P{GD1324}v6299 (not shown)
y[1] w[1118]/MS1096-Gal4;;P{w[+mC]=lacW}bel[L4740] (not shown)
y[1] w[67c23]/MS1096-Gal4;;P{w[+mC] y[+mDint2]=EPgy2}bel[EY08943] (not shown)
y1 v1/MS1096-Gal4;;P{TRiP.JF01993}attP2 (not shown)
w1118/MS1096;;P{GD12377}v28196 (not shown)
w1118/MS1096-Gal4; +/P{GT1}rowBG02781; (not shown)
Figure 3
FlyFos028501(pRedFlp-Hgr)(G9a[24641]::2xTY1-SGFP-3xFLAG)dFRT
Figure 6A: 
y,w[1118]/MS1096-Gal4;;P{attP,y[+],w[3`]}/UAS-G9a (column 1)
W118/MS1096-Gal4;+/UAS-G9a (column 2)
y,w[1118]/MS1096-Gal4;; P{KK103450}VIE-260B/UAS-G9a (column 3)
w[1118] P{GD14726}v45686;; UAS-G9a (column 4)
w[1118] P{GD14726}v45687;;UAS-G9a (column 5)
Koemans.indd   145 10-1-2018   12:25:33
146
Chapter 5
Figure 6B:
y,w[1118]/MS1096-Gal4;;P{attP,y[+],w[3`]} (column 1)
W118/MS1096-Gal4; (column 2) 
y,w[1118]/MS1096-Gal4;; P{KK103450}VIE-260B (column 3) 
w[1118] P{GD14726}v45686;; (column 4) 
w[1118] P{GD14726}v45687;; (column 5) 
Supplemental Table S2: Complete list of human proteins with orthology to Drosophila CG9932 
Peptide Gene name Identity 
score
E-value
Q13127 RE1-silencing transcription factor 33% 2.70E-12
Q96JM2-2 Isoform 2 of Zinc finger protein 462 22% 1.30E-10
Q96JM2 Zinc finger protein 462 22% 1.40E-10
Q96JM2-3 Isoform 3 of Zinc finger protein 462 22% 1.40E-10
Q9P243-4 Isoform 4 of Zinc finger protein ZFAT 33% 4.70E-10
Q9P243-2 Isoform 2 of Zinc finger protein ZFAT 33% 4.70E-10
Q9P243 Zinc finger protein ZFAT 33% 4.80E-10
Q8N8E2-3 Isoform 3 of Zinc finger protein 513 29% 6.40E-10
Q8N8E2-2 Isoform 2 of Zinc finger protein 513 29% 4.10E-09
Q8N8E2 Zinc finger protein 513 29% 4.60E-09
Q9NPA5-2 Isoform 2 of Zinc finger protein 64 homolog, isoforms 1 and 2 33% 2.00E-08
Q9NTW7-4 Isoform 6 of Zinc finger protein 64 homolog, isoforms 3 and 4 33% 2.10E-08
Q9NPA5 Zinc finger protein 64 homolog, isoforms 1 and 2 33% 2.20E-08
P52746 Zinc finger protein 142 33% 5.00E-08
Q9NTW7-3 Isoform 5 of Zinc finger protein 64 homolog, isoforms 3 and 4 28% 5.50E-08
Q6IV72 Zinc finger protein 425 30% 6.70E-08
Q9NTW7 Zinc finger protein 64 homolog, isoforms 3 and 4 28% 8.10E-08
P17035-2 Isoform 2 of Zinc finger protein 28 29% 8.30E-08
P17035 Zinc finger protein 28 29% 8.60E-08
Q8NI51-11 Isoform 11 of Transcriptional repressor CTCFL 24% 9.70E-08
Q13127-4 Isoform 4 of RE1-silencing transcription factor 28% 1.00E-07
Q13127-3 Isoform 3 of RE1-silencing transcription factor 35% 1.20E-07
Q13127-2 Isoform 2 of RE1-silencing transcription factor 21% 1.40E-07
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Peptide Gene name Identity 
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E-value
Q8NI51-6 Isoform 6 of Transcriptional repressor CTCFL 24% 1.60E-07
Q8NI51-5 Isoform 5 of Transcriptional repressor CTCFL 24% 1.70E-07
Q8NI51-10 Isoform 10 of Transcriptional repressor CTCFL 24% 1.90E-07
Q8NI51-2 Isoform 2 of Transcriptional repressor CTCFL 24% 2.20E-07
Q8NI51 Transcriptional repressor CTCFL 24% 2.50E-07
Q8NI51-3 Isoform 3 of Transcriptional repressor CTCFL 24% 2.50E-07
Q8NI51-7 Isoform 7 of Transcriptional repressor CTCFL 24% 2.50E-07
Q13422 DNA-binding protein Ikaros 25% 2.70E-07
P10074 Telomere zinc finger-associated protein 30% 3.30E-07
Q6AHZ1 Zinc finger protein 518A 27% 4.20E-07
Q08AN1 Zinc finger protein 616 28% 4.60E-07
Q96IR2 Zinc finger protein 845 34% 5.00E-07
Q68EA5 Zinc finger protein 57 28% 5.00E-07
Q6ZNG1 Zinc finger protein 600 31% 5.80E-07
Q4V348 Zinc finger protein 658B 31% 6.10E-07
Q9NTW7-2 Isoform 4 of Zinc finger protein 64 homolog, isoforms 3 and 4 27% 6.90E-07
Q8NI51-8 Isoform 8 of Transcriptional repressor CTCFL 25% 9.20E-07
P49711 Transcriptional repressor CTCF 23% 1.00E-06
Q9P243-3 Isoform 3 of Zinc finger protein ZFAT 37% 1.10E-06
Q9H5V7 Zinc finger protein Pegasus 30% 1.20E-06
Q9BSK1-2 Isoform 2 of Zinc finger protein 577 30% 1.20E-06
Q86V71 Zinc finger protein 429 28% 1.30E-06
Q8N782 Zinc finger protein 525 27% 1.30E-06
Q9BSK1 Zinc finger protein 577 30% 1.30E-06
Q86XN6-3 Isoform 3 of Zinc finger protein 761 28% 1.70E-06
Q86XN6-2 Isoform 2 of Zinc finger protein 761 28% 1.70E-06
Q86XN6 Zinc finger protein 761 28% 1.70E-06
Q9UID6 Zinc finger protein 639 28% 1.80E-06
Q5TYW1 Zinc finger protein 658 30% 2.00E-06
Q96PE6 Zinc finger imprinted 3 30% 2.30E-06
P17010-2 Isoform 2 of Zinc finger X-chromosomal protein 28% 3.50E-06
Supplemental Table S2: Complete list of human proteins with orthology to Drosophila CG9932 
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P17010 Zinc finger X-chromosomal protein 28% 4.10E-06
P17010-3 Isoform 3 of Zinc finger X-chromosomal protein 28% 4.10E-06
Q9BY31 Zinc finger protein 717 28% 4.20E-06
Q6U7Q0 Zinc finger protein 322 32% 4.50E-06
P08048-2 Isoform 2 of Zinc finger Y-chromosomal protein 29% 4.70E-06
Q0VGE8 Zinc finger protein 816 29% 4.90E-06
P08048-3 Isoform 3 of Zinc finger Y-chromosomal protein 29% 5.10E-06
Q5VIY5-2 Isoform 2 of Zinc finger protein 468 28% 5.20E-06
P08048 Zinc finger Y-chromosomal protein 29% 5.30E-06
Q8N4W9-2 Isoform 2 of Zinc finger protein 808 30% 5.40E-06
Q8N4W9 Zinc finger protein 808 30% 5.50E-06
Q5VIY5 Zinc finger protein 468 28% 5.60E-06
O94892 Zinc finger protein 432 30% 6.40E-06
Q9C0G0-2 Isoform 2 of Zinc finger protein 407 26% 6.40E-06
Q9C0G0 Zinc finger protein 407 26% 6.60E-06
Q5HY98 Zinc finger protein 766 31% 6.80E-06
Q8WXB4 Zinc finger protein 606 28% 6.90E-06
Q96JB3-2 Isoform 2 of Hypermethylated in cancer 2 protein 28% 8.00E-06
O43830 Zinc finger protein 73 26% 8.10E-06
Q96JB3 Hypermethylated in cancer 2 protein 28% 8.20E-06
Q8N823-2 Isoform 2 of Zinc finger protein 611 28% 8.30E-06
Q8N823 Zinc finger protein 611 28% 8.70E-06
Q9NPC7-3 Isoform 3 of Myoneurin 27% 9.50E-06
Q9ULM2 Zinc finger protein 490 29% 9.80E-06
Q8IZC7-2 Isoform 2 of Zinc finger protein 101 29% 1.00E-05
Q16587-4 Isoform 4 of Zinc finger protein 74 29% 1.00E-05
Q16587-2 Isoform 1 of Zinc finger protein 74 29% 1.00E-05
Q9NPC7-2 Isoform 2 of Myoneurin 27% 1.00E-05
Q9NPC7 Myoneurin 27% 1.10E-05
Q16587-3 Isoform 3 of Zinc finger protein 74 29% 1.10E-05
Q16587 Zinc finger protein 74 29% 1.10E-05
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Q9NV72-2 Isoform 2 of Zinc finger protein 701 28% 1.20E-05
Q5JVG2-2 Isoform 2 of Zinc finger protein 484 30% 1.20E-05
Q5JVG2 Zinc finger protein 484 30% 1.20E-05
Q5JVG2-3 Isoform 3 of Zinc finger protein 484 30% 1.20E-05
Q96C28 Zinc finger protein 707 29% 1.30E-05
Q9NV72 Zinc finger protein 701 28% 1.30E-05
P15621-2 Isoform 2 of Zinc finger protein 44 29% 1.40E-05
P15621-3 Isoform 3 of Zinc finger protein 44 29% 1.40E-05
P15621 Zinc finger protein 44 29% 1.50E-05
Q8IZC7 Zinc finger protein 101 29% 1.50E-05
Q2VY69 Zinc finger protein 284 27% 1.80E-05
Q8N972 Zinc finger protein 709 29% 1.90E-05
Q6ZMW2 Zinc finger protein 782 29% 2.00E-05
Q9NZL3 Zinc finger protein 224 28% 2.00E-05
A6NDX5 Putative zinc finger protein 840 26% 2.00E-05
Q9P2J8-2 Isoform 2 of Zinc finger protein 624 28% 2.00E-05
Q8TA94 Zinc finger protein 563 27% 2.10E-05
Q9P2J8 Zinc finger protein 624 28% 2.10E-05
Q8NHY6 Zinc finger protein 28 homolog 28% 2.10E-05
Q6ZN19-2 Isoform 2 of Zinc finger protein 841 30% 2.20E-05
A2RRD8 Zinc finger protein 320 29% 2.20E-05
P35789-3 Isoform 3 of Zinc finger protein 93 27% 2.30E-05
Q96N38-3 Isoform 3 of Zinc finger protein 714 28% 2.40E-05
Q7Z7L9 Zinc finger and SCAN domain-containing protein 2 28% 2.40E-05
P35789 Zinc finger protein 93 27% 2.40E-05
Q17R98-3 Isoform 3 of Zinc finger protein 827 34% 2.60E-05
Q9UKN5 PR domain zinc finger protein 4 28% 2.70E-05
Q9NYT6 Zinc finger protein 226 29% 2.70E-05
Q6ZN19 Zinc finger protein 841 28% 2.70E-05
Q6ZN19-3 Isoform 3 of Zinc finger protein 841 28% 2.80E-05
P17019 Zinc finger protein 708 28% 2.80E-05
Q9NQX1-4 Isoform 4 of PR domain zinc finger protein 5 31% 2.80E-05
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Q96N38-2 Isoform 2 of Zinc finger protein 714 28% 2.90E-05
P17031 Zinc finger protein 26 29% 3.00E-05
O43345-2 Isoform 2 of Zinc finger protein 208 28% 3.00E-05
Q8TBZ8 Zinc finger protein 564 27% 3.00E-05
Q96N38 Zinc finger protein 714 28% 3.00E-05
P49711-2 Isoform 2 of Transcriptional repressor CTCF 26% 3.10E-05
Supplemental Table S2: Complete list of human proteins with orthology to Drosophila CG9932 
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The EHMT1 network underlying intellectual disabilities 
The enzyme euchromatin histone methyltransferase1 (EHMT1) is involved in mono- and 
dimethylation of the lysine residue on the 9th position of the N-terminal tail of histone 
H3. Heterozygous loss-of-function mutations in EHMT1 are known to be causative for 
Kleefstra syndrome (OMIM #610253). Kleefstra syndrome is a neurodevelopmental 
disorder characterized by deficits in cognitive functioning, facial characteristics, childhood 
hypotonia and autism spectrum disorder [1-3]. However, within the cohort of patients 
based on clinical features reminiscent of Kleefstra syndrome, around 25% have mutations in 
EHMT1. It was previously hypothesized that the other 75% of patients, the EHMT1-negative 
group, harbor mutations in genes with similar biological function. Via a next generation 
sequencing approach mutations in MBD5, SMARCB1, NR1l3, and KMT2C were identified 
[4]. The phenotype of these patients highly resembles that of Kleefstra syndrome, but are 
commonly referred to as Kleefstra syndrome phenotypic spectrum (KSS) [4]. Additionally, 
a conserved epigenetic network was suggested underlying intellectual disabilities (ID) [4] 
(chapter 1, figure 3). 
 In this doctoral thesis, I have aimed to further elucidate the molecular mechanisms 
underlying Kleefstra syndrome, KSS and other clinical overlapping syndromes. First, I focused 
on the strong genetic interaction between EHMT1 and KMT2C using a next generation 
sequencing approach (chapter 3). At the same time, I made improvements to an existing 
protocol [5] to use Drosophila courtship conditioning to test general learning, short-term 
memory and long-term memory (chapter 2). Additionally, differential gene expression in 
whole blood of patients with Kleefstra syndrome and Kabuki syndrome (KMT2D mutations) 
are characterized (chapter 4). Lastly, I identified novel interaction partners of the EHMT1 
molecular network underlying KSS (chapter 5). Here, I discuss my main discoveries and 
current challenges in characterizing molecular networks underlying clinical overlapping ID 
syndromes such as Kleefstra syndrome, KSS and other neurodevelopmental disorders.  
Shared pathway-shared phenotype paradigm 
Within the “EHMT1-negative” KSS cohort, putative causative de novo mutations have been 
described and these factors are involved in a conserved epigenetic network (Figure 1) [4]. I 
have closely investigated the strong genetic interaction between the Drosophila orthologs 
of EHMT1 and KMT2C, G9a and trithorax related (trr) respectively (chapter 3). By means of 
ChIP-sequencing, I found 3371 genomic targets of trr in Drosophila heads mainly at the 
transcription start site of genes (chapter 3, figure 3). These genes are generally involved 
in neuronal functioning. The predicted genomic targets of EHMT in Drosophila larvae were 
already reported [6] and I found a significant overlap of 1047 common targets between 
G9a and trr (chapter 3, figure 3E). Additionally, differentially expressed genes in Drosophila 
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heads lacking either G9a or trr were also significantly overlapping with 119 commonly 
misexpressed genes (chapter 3, figure 4). Furthermore, I identified 5 “hub genes” that 
are commonly misexpressed and show a binding site for G9a and trr suggesting direct 
transcriptional regulation. Screening of trr mutant Drosophila males revealed a courtship 
conditioning short-term memory phenotype that closely resembles that of G9a mutants 
(chapter 3, figure 2). Thus, EHMT1 and KMT2C are associated with the highly overlapping 
clinical phenotypes and the Drosophila orthologs G9a and trr show highly overlapping 
molecular targets and functionality. 
 As Drosophila trr is also orthologous to the KMT2C paralog KMT2D, I also 
investigated this protein (chapter 4). KMT2D is also a member of the COMPASS family of 
proteins and mutations in KMT2D are associated with Kabuki syndrome (OMIM #147920). 
Overlapping clinical phenotypes have been described between Kleefstra syndrome and 
Kabuki syndrome and include ID, hypotonia, developmental delay, seizures and autism-
like behaviour [7]. Since both proteins possess histone methyltransferase activity it was 
postulated that both proteins could also affect transcriptional processes. I investigated 
this hypothesis, and I report many common differentially expressed genes in Kleefstra- 
and Kabuki syndrome patients (chapter 4, figure 1, 2 and 3). Although the investigated 
blood cells might not be strictly relevant to the mental impairments in Kleefstra- and Kabuki 
syndrome (in contrast to brain tissue), this tissue was chosen because it is relatively easy to 
obtain and analyze. Furthermore, it turned out that the identified differentially expressed 
genes might be disease relevant. For example, in Kleefstra syndrome cells I found a large 
group of protocadherin genes down regulated. Protocadherins are involved in cell-cell 
connectivity of synapses, and neuronal growth cones [8]. The protocadherins are known 
to be involved in ID syndromes such as RETT syndrome [9]. Other groups of genes that 
are differentially expressed were found via gene ontology term analysis [10]. The terms 
that described these groups of genes relevant for ID were “dopamine catabolic process”, 
“synapse”, “action potential propagation” and “negative regulation of circadian sleep/wake 
cycle, wakefulness”. Further research of the corresponding genes could provide more 
insight into the nature of the cognitive and behavioural impairments in Kleefstra syndrome. 
 Similar to the observations of differentially expressed genes in Kleefstra syndrome 
patients, the transcriptome of Kabuki syndrome patients seems to be directly relevant to this 
phenotype (chapter 4, figure 2). Kabuki syndrome patients are characterized by postnatal 
dwarfism, distinct facial appearance (including wide spread teeth and/ or hypodontia), 
cardiac anomalies, skeletal abnormalities, immunological defects and mild to moderate ID 
[11]. Gene ontology terms like “cognition” and “learning” as well as “odontogenesis” appeared 
as examples that are directly relevant. Additionally, there are many specific terms related to 
brain regions in which those misregulated genes function. These genes could also be direct 
leads towards further investigation. 
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Figure 1: A conserved epigenetic network underlying neuronal functioning. 
The Kleefstra associated protein EHMT1 is linked to various other Kleefstra syndrome phenotypic spectrum 
disorder (KSS) proteins (blue) via genetic interaction and protein-protein interaction. A very strong antagonistic 
interaction was observed between the Drosophila orthologs EHMT and trr. Other members of the COMPASS 
complex show phenotypic overlap with Kleefstra syndrome patients such as Kabuki syndrome (KMT2D mutations), 
and the candidate ID gene KMT2B. Members of the SWI/SNF have been implicated in ID of which SMARCB1 is 
found mutated in one KSS patient. Other KSS genes are NR1l3 and MBD5. In this thesis a protein-protein interaction 
was found between Drosophila EHMT and CG9932 (human ZNF462). No genetic interaction was found between 
Drosophila EHMT and row and belle respectively. 
ZNF = zinc finger proteins, SWI/SNF = Switch/Sucrose nonfermentable, ASCOM = activating signal cointegrator-2 
(asc-2) complex, COMPASS = complex of proteins associated with Set1. PPI = protein-protein interaction, GI = 
genetic interaction. PPI1 is based on Kim et. al and Sedkov et al. [17, 18]. PPI2 is based on Lee et. al., Vicent et al., and 
Choi et al.  [19-21]. PPI3 is based on Simon et. al [22]. GI1,2,3 are based on Kleefstra et al.[4]. GI4 is based on Sedkov 
et al. [18] Figure adapted from Kramer (2013) [23].  
 When comparing the genes that are differentially expressed in both disease 
entities a large and significant overlap was observed (chapter 4, figure 3). Interestingly, 
some contributors of two major intracellular signaling pathways were detected (chapter 
4, figure 4 and 5). First, RAS signaling that controls signal transduction was affected. 
Members of the RAS super family of proteins are corrupted in a series of ID disorders 
referred to as RASopathies [12]. Briefly, extracellular signaling molecules activate the RAF-
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MEK-ERK kinases which can lead to synaptic plasticity involved in neuronal functioning. 
For instance, knock-out of B-raf, encoding a Ras-isoform, in the forebrain of mice disrupted 
hippocampus specific spatial learning and contextual discrimination [13]. Second, 
players of the wnt signaling pathway are identified which have important functions 
during synapse development and refinement [14]. Briefly, extracellular activation of the 
frizzled receptor causes an intracellular signaling cascade to ultimately result in gene 
expression induced by β-catenin and TCF4. RAS and wnt signaling pathways converge 
on transcriptional processes ultimately resulting in protein synthesis, which is required 
to consolidate “new” memories and thus suggesting a role in long-term memory [15, 16]. 
Other chromatin modification complexes in human cognitive disorders
Besides KMT2C and KMT2D, other members of the COMPASS complex of proteins are KMT2A 
and KMT2B (Figure 1). KMT2A is associated with Wiedemann-Steiner syndrome (OMIM 
#605130) and is characterized by a short stature, ID, and a distinctive facial appearance 
combined with excessive growth of terminal hair around the elbows. A phenotypic 
overlap is described between Wiedemann-Steiner syndrome and Kabuki syndrome type 1 
(KMT2D mutations) and type 2 (KDM6A mutations) and includes similar facial features and 
hypertrichosis [24]. KMT2B is shown to be mutated in three brothers of a consanguineous 
Pakistani family [25]. These boys showed a remarkable resemblance to Kleefstra syndrome. 
Thus, mutations in genes coding for members of the COMPASS family of proteins result in a 
clinically distinguishable phenotypes with overlapping characteristics. 
 In addition to the COMPASS complex of proteins, the switch/sucrose non-
fermentable (SWI/SNF) chromatin remodeling complex is also involved in ID (Figure 1). 
One patient with Kleefstra syndrome phenotypic spectrum is described with a mutation 
in SMARCB1 [4]. Other members of this complex are associated with Nicolaides-Baraitser 
syndrome (SMARCA2) and Coffin-Siris syndrome (ARID1A, ARID1B, SMARCA2, SMARCA4, 
SMARCB1, and SMARCE1) [26-32]. A large phenotypic overlap is described for these 
syndromes such as ID and facial features [33, 34]. However, in contrast to the novel 
interactions between Kleefstra associated factors, some of these patients were identified 
by targeted sequencing based on the known protein-protein interactions of the SWI/SNF 
complex. Thus, the SWI/SNF complex also illustrates the occurrence of overlapping clinical 
phenotypes caused by mutations in different genes with similar biological function. 
 Another class of proteins involved in ID are the nuclear receptors (Figure 1). A de 
novo mutations in NR1I3 has been described in one KSS patient (Figure 1) [4]. This gene 
is so far the only one in which mutations have been described causing ID. Thus, definite 
causality might need the identification of mutations in other patients. Nuclear receptors 
can bind a ligand, such as a steroid hormone and induce transcription. It has been shown 
that the COMPASS complex of proteins links the SWI/SNF complex to nuclear receptors 
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via direct protein-protein interactions [17, 19-21, 35]. The estrogen- and glucocorticoid 
receptor are other examples of factors known to be involved in learning and memory [36, 
37]. However, it is largely unknown how exactly these factors play a role in learning and 
memory. It is plausible that stress can be a trigger to stimulate processes like learning and 
memory especially in light of evolution. It could be highly beneficial to organisms when 
stress-related cues are remembered well. 
 Another factor involved in neurodevelopmental delay is transcription factor 4 
(TCF4) which is linked to Pitt-Hopkins syndrome (OMIM # 610954) [38, 39]. Pitt-Hopkins 
syndrome is a rare autism-spectrum ID syndrome and is associated with developmental 
delay, epilepsy, lack of motor coordination, language impairment, and breathing difficulties. 
Additionally, genome wide association studies correlate TCF4 to schizophrenia [40, 41]. 
Modeling Pitt-Hopkins syndrome in TCF4 heterozygous knockout mice revealed several 
deficits reminiscent of ID such as social interaction, prepulse inhibition, and deficits in 
associative and spacial learning and memory [42]. Many of the phenotypes of Pitt-Hopkins 
syndrome are also associated with Kleefstra syndrome such as ID, speech delay, seizures, 
sleep disturbances, and developmental delay [7]. Additionally, it has been shown that TCF4 
and EHMT1 show molecular convergence [43]. 
 Taken together, mutations in genes coding for members of the above mentioned 
molecular network (Figure 1) are examples in which the clinical spectrum of associated 
disorders partly overlap. However, clinical variability can be caused by several other factors 
such as the genetic context or background that enhance or suppress the core phenotype 
of a patient [44]. The consequences of pre- and postnatal environmental stressors are other 
examples that might influence core phenotypes of individuals. These aspects lead to a more 
diffuse spectrum of mental illnesses as seen in the clinic and this phenomenon is described 
as “dimensionality in mental illnesses” [45]. 
Experiments using Drosophila could uncover fundamental processes in cognitive 
disorders caused by mutations in epigenetic factors. Many experimental procedures have 
already been set up to elucidate underlying genetic defects that are reminiscent of ID such 
as habituation [46-48], aggression [49], circadian rhytm [50], spacial context [51] and the 
larval neuromuscular junction [52]. It would be interesting to investigate individual mutants 
of the complete library of Drosophila ID orthologs with epigenetic function in these 
paradigms. This could reveal common patterns and sub-clusters of shared phenotypes 
between mutants of one gene. On the molecular level, a library of tagged protein lines 
is available for the Drosophila community [53]. These lines could be used for genomic 
targets of all Drosophila ID orthologs with epigenetic function. Identification of overlapping 
genomic targets could reveal molecular convergence between certain factors. 
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Higher order chromatin in ID
In recent years it has become evident that the spacial organization of a genome is crucial for 
normal brain development. Correct folding of DNA is partly regulated by the nuclear lamina 
which is a filamentous protein mesh functioning as inner scaffold of the nuclear membrane 
[54]. Molecular mapping of DNA sequences has revealed that some regions are long-
term repressed and others that are more dynamically regulated [55, 56]. Local chromatin 
composition is crucial for the interaction with lamins and it is shown that EHMT proteins are 
involved in this process [57]. Human G9a has been shown to co-immunoprecipitate with 
the Barrier-to-autointegration factor which is an essential component of the nuclear lamina 
[58]. It is also shown that human G9a is required for the silencing of late-replicating genes at 
the nuclear periphery [59]. H3K9me2 is enriched in lamina associated domains [60] which 
is potentially deposited by EHMT family members. Thus, a damaged association between 
G9a and the nuclear lamina could contribute to the transcriptional deregulation of gene 
expression observed in flies (chapter 3) and human (chapter 4).
The borders of lamina associated domains are often bound by CCCTC-binding 
factor (CTCF). CTCF is an insulator protein that is found between active and repressed forms 
of chromatin forming a molecular “barrier” [61]. Stabilization of these barrier complexes is 
done by structural proteins such as cohesin [62-64]. Mutations in genes coding for factors 
associated with the nuclear lamina are also associated with ID syndromes [65-67]. For 
instance, Cornelia de Lange syndrome (OMIM #122470) is a form of ID and is characterized 
by several facial features including arched eyebrows and synophrys and other multisystem 
malformations [68]. Mutations causing Cornelia de Lange syndrome so far include five 
members of the cohesin family with NIPBL being the most frequent one [65]. Mutations in 
CTCF are also causative for ID and microcephaly [66, 67]. Thus, the phenotypes observed in 
ID patients with mutations in genes coding for nuclear lamina associated proteins could 
be related to transcriptional de-repression of genomic regions important for proper brain 
functioning. 
Besides association with cohesin, CTCF is also found in enhancer-promoter looping 
[69]. Enhancers are short DNA sequences that can be bound by transcription factors and 
influence transcription of distal genes [70-72]. Enhancers can be in an active or poised state 
with H3K27ac as a mayor discriminator for activation [73]. The histone acetyltransferase 
that is responsible for this acetylation is P300 [74, 75]. Activation of enhancer-promoter 
interactions are highly cell and tissue specific [76]. Mutations in the gene coding for P300 
are found in patients with Rubinstein-Taybi syndrome subtype 2 (OMIM #613684) [77]. 
Rubinstein Taybi syndrome subtype 1 (OMIM #180849) is defined by mutations in the 
closely related histone acetyltransferase gene CREBBP [78]. Rubinstein-Taybi syndrome 
is characterized by ID, postnatal growth deficiency, microcephaly, broad thumps and 
halluces, and a distinct facial appearance [79, 80]. The protein products of these two genes 
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are involved in cAMP dependant formation of long-term memory [81, 82]. Thus, these 
examples show that wrongly formed enhancer-promoter interactions in the brain could 
contribute to the etiology of ID. 
Enhancer function has also been associated with factors involved in Kleefstra 
syndrome phenotypic spectrum. KMT2C and its ortholog trithorax related have been shown 
to be involved in enhancer associated monomethylation of H3K4 [83, 84]. Additionally, the 
EHMT family member G9a has also been associated with enhancers [85, 86]. It was shown 
that in early mouse development G9a deposits H3K9me2 over active enhancers and thereby 
blocking their function [85]. Recently, it was shown that G9a co-regulates poised and active 
enhancers with the lysine-specific demethylase Jmjd2c (KDM4C) [86]. By using a ChIP-
sequencing approach, a large overlap was found between genomic binding sites of G9a, 
Jmjd2c, P300, mediator and cohesin. These sites highly co-occur with the H3K27 acetylation 
which is the mark associated with active enhancers [86]. However, the exact mechanism 
through which enhancers regulate brain function is still poorly understood. Four models 
have so far been proposed which in principle could all co-occur [87]. First, distal sequences 
carrying a “cargo” of transcription factors into close proximity of the target gene promoter. 
With respect to learning and memory, this process has been shown for genes important 
for GABA synthesis [88]. The second mechanism involves locally transcribed enhancer 
RNA (eRNA). eRNA sequences can be bound by “cargo” transcription factors in order to 
facilitate DNA looping. This process has been shown at the promoter of the Arc gene 
with nuclear elongation factor (NELF) acting as a transcription repressor that binds these 
eRNA molecules [89]. The third mechanism described is based on competition between 
enhancer sequences over one promoter. This has been shown at the GRIN2B locus where 
silencer proteins compete over the binding of the promoter of GRIN2B [90]. GRIN2B has 
been shown to be involved in intellectual disabilities, and other neurodevelopmental and 
neurodegenerative disorders [91, 92]. The fourth mechanism of transcriptional regulation 
by enhancer sequences is associated with DNA double strand breaks in the context of 
immediate early genes like Fos, Fosb and Npas4 [93]. However, it remains unclear if these 
double strand DNA breaks have negative side effects for important processes like learning 
and memory.
 With the examples described above in mind, DNA enhancers could be involved 
in Kleefstra syndrome. It would be interesting to investigate how EHMT1 is associated with 
enhancers and how enhancers function in the context of ID. Drosophila seems to be a very 
good model to investigate this concept. Many factors involved in enhancer functioning 
are conserved during evolution in Drosophila such as CTCF, cohesins, EP300 [94-96]. For 
instance, one suggested experiment using Drosophila is to investigate transcriptional 
plasticity during the course of learning and memory. Male flies could be subjected to 
the courtship assay (chapter 2) and brain tissue could be isolated before and after the 
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training phase. However, since enhancer-promoter interactions are highly cell-type 
specific and since the brain consists of many different cell types, it would be beneficial 
to isolate neuronal subtypes using the cell enrichment technique based on UNC84 [97]. 
This technique genetically labels subsets of neurons using the Gal4/UAS system after which 
the labeled neurons can be isolated ex vivo by cell pull-down techniques with specific 
antibodies. Selected neural populations can be used to investigate transcriptional plasticity 
by RNA-sequencing [98], looping of DNA [99] by for instance HiC [100] or ChIA-PET [101], or 
other methods that elucidate open chromatin by accessibility such as ATAC-seq [102]. In this 
way courtship conditioning evoked learning and memory could be assessed in two ways. 
First, genome wide changes could be investigated in control males. It is currently poorly 
understood which molecular pathways are involved in normal courtship conditioning 
learning and memory. Second, by using G9a mutant males [6] it could be investigated 
which mechanisms underlie differentially expressed genes or enhancer-promoter loops in 
Kleefstra syndrome. Taken together, Drosophila can be used to uncover fundamental roles 
of DNA enhancers involved in Kleefstra syndrome. 
Toward treatment of ID
ID disorders are generally considered to be untreatable [103] and only very few 
pharmacological intervention therapies are now established treatments of human ID 
disorders [104]. However, recently a number of mouse models has shown potential treatment 
in adulthood by pharmacological and/or genetic rescue for instance for neurofibromatosis 
I (NF1) [105], Rett syndrome (MECP2) [106], Rubinstein-Tabi syndrome (CPB) [107], Angelman 
syndrome (UBE3A) [108], and Kabuki syndrome [109]. For Kleefstra syndrome, it has been 
shown that re-expression of G9a in adult male flies restores short-term courtship conditioning 
memory [6]. Learning deficits of Fragile X flies were successfully rescued by mGluR agonists 
and lithium [110, 111]. Additionally, a large screen of 2000 compounds revealed nine hits 
that were able to rescue glutamate-induced lethality of Fragile X flies [112]. Taken together, 
despite some encouraging laboratory results, knowledge on potential treatment is still 
very limited [113]. Drosophila experiments have a high potential to elucidate fundamental 
aspects of potential treatments of ID syndromes. 
 An interesting novel therapeutic approach could come from the strong 
antagonistic genetic interaction between the Drosophila orthologs of EHMT1 and KMT2C 
[4]. These results imply that loss of one factor could potentially compensate for the loss 
of the other. It would therefore be interesting to measure courtship conditioning learning 
and memory (chapter 2) in double mutant flies. In short, it would require knockdown 
of the KMT2C ortholog trr in the mushroom bodies of G9a mutant animals and thereby 
rescuing the G9a [6] and trr courtship phenotype (chapter 3). Another angle of the same 
approach would be to use chemical inhibitors [114]. The inhibition of G9a with chemicals 
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UNC0638 [115] or A-366 [116] could be applied to trr mutant flies. The reverse approach of 
inhibiting KMT proteins in G9a mutant flies seems to be more difficult since specific KMT 
inhibitors are not available at present [117]. However, certain drugs are available to inhibit 
interactors of KMT such as the bromodomain and extra terminal (BET) family of proteins 
[118] or PI3K [119]. These drug have only been tested in the context of KMT fusion proteins 
in heamatological cancers. In my opinion, it would be unfeasible to subscribe these drugs 
for the treatment of Kleefstra syndrome based on a interaction with an MLL fusion protein 
that has genetic interaction with EHMT1. 
 Another experiment to get more insight into pharmacological rescue would 
be to screen a library of drugs that bind epigenetic regulators [120]. This library of drugs 
could be tested on mutant males in the courtship conditioning assay (chapter 2) in order 
to investigate improvements in learning and/or memory. Therapeutic intervention to 
compensate for disruption in the epigenetic machinery has been considered to have a 
great potential [121]. 
A potential treatment for Kleefstra syndrome and many other genetic disorders 
could come from genome-editing techniques. The use of CRISPR/Cas9 (clustered regulatory 
interspaced short palindromic repeats (CRISPR)/CRISPR associated protein 9) has the 
potential to relatively easy modify the genome at defined loci [122]. This bacteria-derived 
system combines a guide RNA with the RNA-guided endonuclease Cas9. Cas9 introduces 
double strand breaks at defined loci which can be repaired by homologous recombination. 
When using a specific application of CRISPR, the RNA-guide strand can also be designed 
to add the EHMT1 gene to the genome. This approach can thus be used to reincorporate 
EHMT1 in the genome of Kleefstra syndrome patients and potentially restore EHMT1 protein 
levels. However, there are many ethical and practical roadblocks ahead for this approach. 
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Summary 
Intellectual disability (ID) is a grouping of a large and heterogeneous collection of disorders 
characterized by an IQ below 70, significant limitations in adaptive behaviour, and an 
onset before the age of eighteen. It is estimated that the prevalence lies between 1 and 
3 percent of the Western population and this equates to almost 400.000 children born per 
year worldwide. Because of this high frequency and the lifelong need for care, ID represents 
a major unsolved medical and socio-economic challenge for society. One of the genetic 
factors causing ID is the euchromatin histone methyltransferase1 (EHMT1) gene which encodes 
a histone methyltransferase. Haploinsufficiency of EHMT1 cause Kleefstra syndrome that is 
characterized by ID, childhood hypotonia, general developmental delay, autism spectrum 
disorder, and facial characteristics. Around 25% of Kleefstra syndrome patients harbor 
mutations in EHMT1. It was thus hypothesized that the other 75% of patients, the “EHMT1-
negative” group termed Kleefstra syndrome phenotypic spectrum (KSS), have mutations in 
other genes with a shared biological function. Via a next generation sequencing approach, 
four additional genes have been identified and their protein products form a conserved 
epigenetic module underlying ID. The main goal of this doctoral thesis is to uncover shared 
mechanisms through which affected proteins ultimately result in shared clinical phenotypes 
in human. 
In the introductory chapter (chapter 1), I discuss the importance of epigenetic mechanisms 
underlying ID. It introduces Kleefstra syndrome and Kleefstra syndrome phenotypic 
spectrum and the known mechanisms through which the affected proteins function, 
focusing on the strong genetic interaction between Drosophila G9a and trithorax related 
(trr). It concludes on the thesis aims and outline. 
For functional analysis of proteins involved ID, reliable, reproducible, and well-controlled 
experimental procedures are needed. In chapter 2, I provide optimizations to an established 
protocol using Drosophila courtship conditioning. I describe guidelines, practical handling 
of the flies and an R-script to validate experimental data of general learning, short-term- and 
long-term memory. 
In chapter 3 I continue on the strong antagonistic genetic interaction between EHMT1 and 
KMT2C. I show five additional ID patients disrupting KMT2C and thereby refining the clinical 
characteristics already known for one KSS patient. I then turned to the model organism 
Drosophila to further show that the ortholog of KMT2C, trithorax related (trr), is involved 
in courtship conditioning short-term memory, but not in the general morphology of the 
mushroom body which are neuropils known to be involved in this plastic behaviour. The 
chapter further continues on the genomic targets of trr in Drosophila heads and those are 
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mainly associated with the transcription start site of genes. The genes with a trr binding 
site at the transcription start site are generally involved in neuronal processes and are 
significantly overlapping with G9a associated genes. I further show that upon knockdown 
of trr or knockout of G9a in Drosophila heads the differentially expressed genes significantly 
overlap. I found five genes that are putative direct targets of both G9a and trr. Overall, in this 
chapter I show substantial proof of molecular convergence between EHMT1 and KMT2C. 
Chapter 4 describes the study to further elucidate the common molecular mechanism 
underlying Kleefstra syndrome (EHMT1 mutations) and Kabuki syndrome (KMT2D mutations). 
KMT2D is the paralog of KMT2C, which both share sequence orthology with Drosophila 
trr (chapter 3). The two disease entities are also associated with clinically overlapping 
characteristics such as ID, hypotonia, developmental delay, seizures and autism-like 
behaviour. I analyzed the transcriptome in whole blood of Kleefstra- and Kabuki syndrome 
patients and I show differentially expressed genes in both disease entities. Moreover, I 
identified a high overlap between differentially expressed genes and that the commonly 
misregulated genes have a highly similar function. In conclusion, I show in this chapter 
strong evidence for molecular convergence between EHMT1 and KMT2D. 
Chapter 5 reports on the identification of novel interaction partners of EHMT1 using two 
approaches. The first approach uses clinical studies that describe two additional patients 
with characteristics of Kleefstra syndrome. The two patients have mutations in DDX3X 
and POGZ and I tested genetic interaction of Drosophila G9a with the orthologs “belle” 
and “row” respectively. However, I report lack of genetic interaction and this was later 
confirmed by further clinical characterization. Both genes are currently associated to other 
ID syndromes, not related to Kleefstra syndrome. The second approach uses a Drosophila 
line that expresses a molecularly tagged G9a protein. Affinity purification followed by mass-
spectrometry identified a so far uncharacterized zinc finger protein, CG9932, interacting 
with G9a in Drosophila heads. CG9932 shares sequence orthology with human RE1-silencing 
transcription factor and zinc finger protein ZNF462. However, future studies are needed to 
understand the exact function of CG9932 and link with G9a. Taken together, this chapter 
expands the knowledge about interaction partners within the EHMT protein network. 
In chapter 6 I discuss the main findings in a broader context and in the light of recently 
published literature. I show other protein complexes involved in other ID syndromes and 
potential links with EHMT1. I also discuss the role of higher order chromatin conformation 
in ID. Finally, I discuss potential treatments of ID syndromes and how Drosophila can help 
to focus on specific novel therapeutic interventions based on epigenetic mechanisms 
underlying ID. 
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Samenvatting
Verstandelijke beperking is een overkoepelende term voor een groep aandoeningen 
die zowel fenotypisch als genotypisch erg heterogeen is. Cognitief disfunctioneren 
is één van de overeenkomstige kenmerken, waarbij een IQ lager dan 70, deficiënties in 
adaptief gedrag en een aanvangsleeftijd onder de achttien jaar gezamenlijke symptomen 
zijn. Verstandelijke beperking komt bij één tot drie procent van de Westerse bevolking 
voor. Extrapolerend naar de wereldbevolking zou dit betekenen dat er grofweg 400.000 
aangedane kinderen per jaar geboren worden met een verstandelijke beperking. Door deze 
hoge prevalentie, in combinatie met de behoefte tot levenslange zorg, is verstandelijke 
beperking momenteel in zowel medisch- als socio-economisch opzicht een grote uitdaging. 
Eén van de genetische factoren die bij mutatie verstandelijke beperking kan veroorzaken 
is het gen euchromatin histone methyltransferase1 (EHMT1), wat codeert voor een histon 
methyltransferase. Haploinsufficiëntie van het EHMT1 gen veroorzaakt het Kleefstra 
syndroom wat gekenmerkt wordt door verstandelijke beperking, een lage spierspanning, 
een ontwikkelingsachterstand, autisme, en karakteristieke gezichtskenmerken. Ongeveer 
25% van de patiënten met het Kleefstra syndroom heeft een mutatie in het EHMT1 gen. 
Door dit gegeven werd de hypothese opgesteld dat de andere 75% van de patiënten, 
de EHMT1-negtieve groep en later genaamd “Kleefstra syndroom fenotypisch spectrum”, 
wellicht mutaties hebben in andere genen, maar met een vergelijkbare biologische functie. 
Door middel van “next generation sequencing” zijn vier nieuwe genen geïdentificeerd in 
patiënten met het Kleefstra syndroom fenotypisch spectrum en de eiwit producten van 
deze genen vormen een geconserveerd epigenetisch netwerk wat onderliggend is aan 
verstandelijke beperkingen. Het hoofddoel van het hier beschreven onderzoek was daarom 
het ontdekken van gezamenlijke moleculaire mechanismen die uiteindelijk resulteren in 
gedeelde klinisch fenotypes in de mens. 
In hoofdstuk 1 bespreek ik de rol van epigenetische factoren die kunnen leiden tot 
verstandelijke beperking. Ik introduceer het Kleefstra syndroom en het Kleefstra syndroom 
fenotypisch spectrum en de bekende functies van de aangedane eiwitten, waarbij ik focus 
op de sterke genetische interactie tussen Drosophila G9a en trithorax related (trr). Ik eindig 
met een beschrijving van de doelstellingen van het onderzoek.  
In hoofdstuk 2 beschrijf ik optimalisaties van een bestaand protocol wat het baltsgedrag van 
Drosophila gebruikt om de algemene mogelijkheid tot leren (zeer kortetermijngeheugen), 
het korte- en langetermijngeheugen te testen. Er worden richtlijnen genoemd, praktische 
zaken omtrent de handelingen tijdens een experiment beschreven en een R-script om de 
onderzoeksresultaten te valideren. 
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In hoofdstuk 3 ga ik dieper in op de sterke antagonistische genetische interactie tussen 
EHMT1 en KMT2C. Ik beschrijf klinische karakteristieken in vijf patiënten met “Kleefstra 
syndroom fenotypisch spectrum disorder” met mutaties in KMT2C. Daarnaast beschrijf ik mijn 
resultaten met het model organisme Drosophila om verder aan te tonen dat de ortholoog 
van KMT2C, trithorax related (trr), betrokken is bij het baltsgedrag kortetermijngeheugen, 
maar niet in de algehele morfologie van het paddenstoelvormige lichaam welke de 
structuren zijn die betrokken zijn bij deze plastische vorm van gedrag. Het hoofdstuk 
beschrijft verder wat de genomische plekken zijn waar het trr eiwit bindt in cellen van de 
kop van de fruitvlieg en, specifiek, zijn dit met name de transcriptie start posities van genen 
in het genoom. De genen met een trr bindingsplek zijn over het algemeen betrokken bij 
neuronale processen en overlappen significant met genen die geassocieerd worden met 
binding van G9a. Tot slot laat ik in Drosophila zien dat door vermindering van trr mRNA 
moleculen en door disruptie van het G9a gen een significant aantal genen verkeerd tot 
expressie komt in beide condities. Bovendien vond ik vijf genen die mogelijk onder directe 
invloed van transcriptie staan door trr én G9a. Kortom, deze studie toont sterk bewijs voor 
moleculaire convergentie tussen EHMT1 en KMT2C. 
Hoofdstuk 4 beschrijft de studie naar overeenkomstige moleculaire mechanismen 
onderliggend aan het Kleefstra syndroom (EHMT1 mutaties) en Kabuki syndroom (KMT2D 
mutaties). KMT2D is de paraloog van KMT2C, welke beide sequentie homologie vertonen 
met het trr eiwit in Drosophila (hoofdstuk 3). Beide aandoeningen zijn ook geassocieerd 
met klinisch overeenkomstige kenmerken zoals verstandelijke beperking, een lage 
spierspanning, een ontwikkelingsachterstand, epileptische aanvallen en autisme. In mijn 
studie heb ik het transcriptoom in het bloed van Kleefstra- en Kabuki syndroom patiënten 
bestudeerd. Ik laat genen zien die verschillend tot expressie komen in beide syndromen 
vergeleken met een controle groep. Daarnaast laat ik een grote en significante overlap 
zien tussen de genen die verkeerd tot expressie komen, gecombineerd met een overlap 
in functie van deze groep genen. In dit hoofdstuk geef ik dus bewijs voor moleculaire 
convergentie tussen EHMT1 en KMT2D. 
Hoofdstuk 5 beschrijft de identificatie van nieuwe interactiepartners van EHMT1 door 
gebruik te maken van twee verschillende methoden. De eerste aanpak maakt gebruik van 
klinische studies van twee nieuwe patiënten met een grote gelijkenis met het Kleefstra 
syndroom. Deze twee patiënten hebben mutaties in het DDX3X en POGZ gen en in deze 
studie ik heb een genetische interactie getoetst tussen Drosophila G9a en de orthologen 
“belle” en “row” respectievelijk. In mijn experiment vond ik geen genetische interactie en dit 
werd later bevestigd door verdere klinische bevindingen. Beide genen zijn op dit moment 
geassocieerd met andere type verstandelijke beperkingen die niet gerelateerd zijn aan het 
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Kleefstra syndroom. De tweede aanpak maakt gebruik van Drosophila lijnen waarin het G9a 
eiwit moleculair gemarkeerd is. Affiniteitzuiveringen gevolgd door massa spectometrie op 
basis van G9a heeft een vooralsnog niet getypeerd eiwit aangetoond, CG9932, met een 
zinc vinger motief. CG9932 heeft sequentie orthologie met de humane eiwitten “RE1-
silencing transcription factor” en “zinc finger protein ZNF462”. Er is echter meer onderzoek 
nodig om de exacte functie en link met G9a verder te ontrafelen. Dit hoofdstuk geeft een 
goede uitbereiding op de interactie partners binnen het EHMT1 netwerk. 
In hoofdstuk 6 bespreek ik mijn bevindingen in een breder kader en in het licht van recent 
gepubliceerde literatuur. Ik laat bijvoorbeeld andere eiwitcomplexen zien die betrokken zijn 
bij verstandelijke beperking met een mogelijke link met EHMT1. Daarna ben ik ingegaan 
op de rol van hogere orde chromatine vouwing; een fenomeen wat mogelijk betrokken is 
bij verstandelijke beperkingen. Tot slot bespreek ik potentiele therapeutische interventies 
waarbij Drosophila modellen, gebaseerd op epigenetische mechanismen, een rol kunnen 
spelen.  
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